John C. Ball
Form N-PX is to be used by a registered
management investment company, other than a small business investment company registered on Form N-5 (17 CFR 239.24 and 274.5), to file
reports with the Commission, not later than August 31 of each year, containing the registrant’s proxy voting record for the most recent
twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4).
The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose
the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond
to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”)
control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing
the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed
this collection of information under the clearance requirements of 44 U.S.C. § 3507.
| |
NOMAD
FOODS LIMITED |
|
|
| |
Security |
G6564A105 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
NOMD |
|
|
|
Meeting Date |
01-Jul-2022 |
|
| |
ISIN |
VGG6564A1057 |
|
|
|
Agenda |
935650855 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
|
Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Sir Martin Ellis Franklin, KGCN |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Noam Gottesman |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Ian G.H. Ashken |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Stéfan Descheemaeker |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: James E. Lillie |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Stuart M. MacFarlane |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Victoria Parry |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Amit Pilowsky |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Melanie Stack |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Samy Zekhout |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratify the selection of PricewaterhouseCoopers
LLP as
our independent registered public accounting firm for the
2022 fiscal year. |
Management |
|
For |
|
For |
|
|
| |
PETS
AT HOME GROUP PLC |
|
|
| |
Security |
G7041J107 |
|
|
|
Meeting Type |
Annual General Meeting |
| |
Ticker Symbol |
|
|
|
|
Meeting Date |
07-Jul-2022 |
|
| |
ISIN |
GB00BJ62K685 |
|
|
|
Agenda |
715764848 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1 |
TO RECEIVE THE COMPANY'S AUDITED
FINANCIAL
STATEMENTS FOR THE FINANCIAL YEAR ENDED 31
MARCH 2022 |
Management |
|
For |
|
For |
|
|
| |
2 |
TO APPROVE THE DIRECTORS' REMUNERATION
REPORT FOR THE YEAR ENDED 31 MARCH 2022 |
Management |
|
For |
|
For |
|
|
| |
3 |
TO DECLARE A FINAL DIVIDEND
RECOMMENDED BY
THE DIRECTORS OF 7.5 PENCE PER ORDINARY
SHARE FOR THE YEAR ENDED 31 MARCH 2022 |
Management |
|
For |
|
For |
|
|
| |
4.A |
TO RE-ELECT MIKE IDDON AS A
DIRECTOR OF THE
COMPANY |
Management |
|
For |
|
For |
|
|
| |
4.B |
TO RE-ELECT DENNIS MILLARD
AS A DIRECTOR OF
THE COMPANY |
Management |
|
For |
|
For |
|
|
| |
4.C |
TO RE-ELECT SHARON FLOOD AS
A DIRECTOR OF
THE COMPANY |
Management |
|
For |
|
For |
|
|
| |
4.D |
TO RE-ELECT STANISLAS LAURENT
AS A DIRECTOR
OF THE COMPANY |
Management |
|
For |
|
For |
|
|
| |
4.E |
TO RE-ELECT SUSAN DAWSON AS
A DIRECTOR OF
THE COMPANY |
Management |
|
For |
|
For |
|
|
| |
4.F |
TO RE-ELECT IAN BURKE AS A
DIRECTOR OF THE
COMPANY |
Management |
|
For |
|
For |
|
|
| |
4.G |
TO RE-ELECT ZARIN PATEL AS
A DIRECTOR OF THE
COMPANY |
Management |
|
For |
|
For |
|
|
| |
5 |
TO ELECT LYSSA MCGOWAN AS DIRECTOR
OF THE
COMPANY |
Management |
|
For |
|
For |
|
|
| |
6 |
TO RE-APPOINT KPMG LLP AS AUDITOR
OF THE
COMPANY |
Management |
|
For |
|
For |
|
|
| |
7 |
TO AUTHORISE THE DIRECTORS
TO SET THE FEES
PAID TO THE AUDITOR OF THE COMPANY |
Management |
|
For |
|
For |
|
|
| |
8 |
AUTHORITY TO ALLOT SHARES |
Management |
|
For |
|
For |
|
|
| |
9 |
AUTHORITY TO MAKE POLITICAL
DONATIONS AND
EXPENDITURE |
Management |
|
For |
|
For |
|
|
| |
10 |
PARTIAL DISAPPLICATION OF PRE-EMPTION
RIGHTS |
Management |
|
Abstain |
|
Against |
|
|
| |
11 |
ADDITIONAL PARTIAL DISAPPLICATION
OF PRE-
EMPTION RIGHTS |
Management |
|
For |
|
For |
|
|
| |
12 |
AUTHORITY TO PURCHASE OWN SHARES |
Management |
|
For |
|
For |
|
|
| |
13 |
THAT A GENERAL MEETING OTHER
THAN AN
ANNUAL GENERAL MEETING MAY BE CALLED ON
NOT LESS THAN 14 CLEAR DAYS' NOTICE |
Management |
|
For |
|
For |
|
|
| |
CMMT |
09 JUN 2022: PLEASE NOTE THAT
THIS IS A
REVISION DUE TO MODIFICATION OF THE-TEXT OF
RESOLUTION 1. IF YOU HAVE ALREADY SENT IN
YOUR VOTES, PLEASE DO NOT-VOTE AGAIN
UNLESS YOU DECIDE TO AMEND YOUR ORIGINAL
INSTRUCTIONS. THANK YOU |
Non-Voting |
|
|
|
|
|
|
| |
CLOVIS
ONCOLOGY, INC. |
|
|
| |
Security |
189464100 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
CLVS |
|
|
|
Meeting Date |
07-Jul-2022 |
|
| |
ISIN |
US1894641000 |
|
|
|
Agenda |
935632326 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Brian G. Atwood |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
James C. Blair |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Richard A. Fair |
|
|
|
For |
|
For |
|
|
| |
|
|
4 |
Paul H. Klingenstein |
|
|
|
For |
|
For |
|
|
| |
2. |
Approval of an amendment to
our Amended and
Restated Certificate of Incorporation to effect a reverse
stock split of our common stock at a ratio of 1-for-7 (the
"Reverse Stock Split"). |
Management |
|
For |
|
For |
|
|
| |
3. |
Approval
of an amendment to our Amended and
Restated Certificate of Incorporation to decrease,
concurrent with and conditioned upon the implementation
of the Reverse Stock Split, the number of authorized
shares of common stock from 200,000,000 to 57,142,000
shares. |
Management |
|
For |
|
For |
|
|
| |
4. |
Approval
of an amendment and restatement of our
Amended and Restated 2020 Stock Incentive Plan to
increase the number of shares available for issuance
under the plan by 4,000,000 shares (prior to giving effect
to the Reverse Stock Split), concurrent with and
conditioned upon the implementation of the Reverse
Stock Split. |
Management |
|
Against |
|
Against |
|
|
| |
5. |
Approval of an advisory proposal
on compensation of the
Company's named executive officers, as disclosed in the
attached proxy statement. |
Management |
|
For |
|
For |
|
|
| |
6. |
Ratification of the appointment
of Ernst & Young LLP as
the independent registered public accounting firm of the
Company for the fiscal year ending December 31, 2022. |
Management |
|
For |
|
For |
|
|
| |
7. |
Approval of an adjournment
of the Annual Meeting, if
necessary or appropriate, to solicit additional proxies. |
Management |
|
For |
|
For |
|
|
| |
OPKO
HEALTH, INC. |
|
|
| |
Security |
68375N103 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
OPK |
|
|
|
Meeting Date |
14-Jul-2022 |
|
| |
ISIN |
US68375N1037 |
|
|
|
Agenda |
935671405 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Phillip
Frost, M.D. |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Jane
H. Hsiao, Ph.D., MBA |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Steven
D. Rubin |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Elias
A. Zerhouni, M.D. |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Jon R.
Cohen, M.D. |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Gary
J. Nabel, M.D., Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Alexis
Borisy |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Richard
M. Krasno, Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Prem
A. Lachman, M.D. |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Roger
J. Medel, M.D. |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: John
A. Paganelli |
Management |
|
For |
|
For |
|
|
| |
1l. |
Election of Director: Richard
C. Pfenniger, Jr. |
Management |
|
For |
|
For |
|
|
| |
1m. |
Election of Director: Alice
Lin-Tsing Yu, M.D., Ph.D. |
Management |
|
For |
|
For |
|
|
| |
2. |
To approve a non-binding advisory
resolution regarding
the compensation paid to the Company's named
executive officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
To amend the OPKO Health, Inc.
2016 Equity Incentive
Plan to increase the number of shares issuable
thereunder from 30,000,000 to 60,000,000. |
Management |
|
Against |
|
Against |
|
|
| |
4. |
To ratify the appointment of
Ernst & Young LLP as the
Company's independent registered public accounting firm
for the fiscal year ending December 31, 2022. |
Management |
|
For |
|
For |
|
|
| |
MCKESSON
CORPORATION |
|
|
| |
Security |
58155Q103 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
MCK |
|
|
|
Meeting Date |
22-Jul-2022 |
|
| |
ISIN |
US58155Q1031 |
|
|
|
Agenda |
935672027 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director for a
one-year term: Richard H.
Carmona, M.D. |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director for a
one-year term: Dominic J.
Caruso |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director for a
one-year term: W. Roy Dunbar |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director for a
one-year term: James H. Hinton |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director for a
one-year term: Donald R.
Knauss |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director for a
one-year term: Bradley E.
Lerman |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director for a
one-year term: Linda P. Mantia |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director for a
one-year term: Maria Martinez |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director for a
one-year term: Susan R. Salka |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director for a
one-year term: Brian S. Tyler |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director for a
one-year term: Kathleen Wilson-
Thompson |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of Appointment
of Deloitte & Touche LLP as
the Company's Independent Registered Public
Accounting Firm for Fiscal Year 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory vote on executive
compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
Approval of our 2022 Stock
Plan. |
Management |
|
For |
|
For |
|
|
| |
5. |
Approval of Amendment to our
2000 Employee Stock
Purchase Plan. |
Management |
|
For |
|
For |
|
|
| |
6. |
Shareholder Proposal on Special
Shareholder Meeting
Improvement. |
Shareholder |
|
Against |
|
For |
|
|
| |
7. |
Shareholder Proposal on Transparency
in Rule 10b5-1
Trading Policy. |
Shareholder |
|
Against |
|
For |
|
|
| |
ITO
EN,LTD. |
|
|
| |
Security |
J25027103 |
|
|
|
Meeting Type |
Annual General Meeting |
| |
Ticker Symbol |
|
|
|
|
Meeting Date |
28-Jul-2022 |
|
| |
ISIN |
JP3143000002 |
|
|
|
Agenda |
715860450 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
|
Please reference meeting materials. |
Non-Voting |
|
|
|
|
|
|
| |
1 |
Approve Appropriation of Surplus |
Management |
|
For |
|
For |
|
|
| |
2 |
Amend Articles to: Approve
Minor Revisions Related to
Change of Laws and Regulations, Reduce the Board of
Directors Size, Reduce Term of Office of Directors to One
Year |
Management |
|
For |
|
For |
|
|
| |
3.1 |
Appoint a Director Honjo, Hachiro |
Management |
|
For |
|
For |
|
|
| |
3.2 |
Appoint a Director Honjo, Daisuke |
Management |
|
For |
|
For |
|
|
| |
3.3 |
Appoint a Director Honjo, Shusuke |
Management |
|
For |
|
For |
|
|
| |
3.4 |
Appoint a Director Watanabe,
Minoru |
Management |
|
For |
|
For |
|
|
| |
3.5 |
Appoint a Director Nakano,
Yoshihisa |
Management |
|
For |
|
For |
|
|
| |
3.6 |
Appoint a Director Kamiya,
Shigeru |
Management |
|
For |
|
For |
|
|
| |
3.7 |
Appoint a Director Yosuke Jay
Oceanbright Honjo |
Management |
|
For |
|
For |
|
|
| |
3.8 |
Appoint a Director Hirata,
Atsushi |
Management |
|
For |
|
For |
|
|
| |
3.9 |
Appoint a Director Taguchi,
Morikazu |
Management |
|
For |
|
For |
|
|
| |
3.10 |
Appoint a Director Usui, Yuichi |
Management |
|
For |
|
For |
|
|
| |
3.11 |
Appoint a Director Tanaka,
Yutaka |
Management |
|
For |
|
For |
|
|
| |
3.12 |
Appoint a Director Takano,
Hideo |
Management |
|
For |
|
For |
|
|
| |
3.13 |
Appoint a Director Abe, Keiko |
Management |
|
For |
|
For |
|
|
| |
HAEMONETICS
CORPORATION |
|
|
| |
Security |
405024100 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
HAE |
|
|
|
Meeting Date |
05-Aug-2022 |
|
| |
ISIN |
US4050241003 |
|
|
|
Agenda |
935677178 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1.1 |
Election of Director: Robert
E. Abernathy |
Management |
|
For |
|
For |
|
|
| |
1.2 |
Election of Director: Catherine
M. Burzik |
Management |
|
For |
|
For |
|
|
| |
1.3 |
Election of Director: Michael
J. Coyle |
Management |
|
For |
|
For |
|
|
| |
1.4 |
Election of Director: Charles
J. Dockendorff |
Management |
|
For |
|
For |
|
|
| |
1.5 |
Election of Director: Lloyd
E. Johnson |
Management |
|
For |
|
For |
|
|
| |
1.6 |
Election of Director: Mark
W. Kroll |
Management |
|
For |
|
For |
|
|
| |
1.7 |
Election of Director: Claire
Pomeroy |
Management |
|
For |
|
For |
|
|
| |
1.8 |
Election of Director: Christopher
A. Simon |
Management |
|
For |
|
For |
|
|
| |
1.9 |
Election of Director: Ellen
M. Zane |
Management |
|
For |
|
For |
|
|
| |
2. |
To approve, on an advisory
basis, the compensation of
our named executive officers |
Management |
|
For |
|
For |
|
|
| |
3. |
To ratify the appointment of
Ernst & Young LLP as our
independent registered public accounting firm for the
fiscal year ending April 1, 2023 |
Management |
|
For |
|
For |
|
|
| |
THE
J. M. SMUCKER COMPANY |
|
|
| |
Security |
832696405 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
SJM |
|
|
|
Meeting Date |
17-Aug-2022 |
|
| |
ISIN |
US8326964058 |
|
|
|
Agenda |
935684351 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Directors whose
term of office will expire in
2023: Susan E. Chapman-Hughes |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Directors whose
term of office will expire in
2023: Paul J. Dolan |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Directors whose
term of office will expire in
2023: Jay L. Henderson |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Directors whose
term of office will expire in
2023: Jonathan E. Johnson III |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Directors whose
term of office will expire in
2023: Kirk L. Perry |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Directors whose
term of office will expire in
2023: Sandra Pianalto |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Directors whose
term of office will expire in
2023: Alex Shumate |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Directors whose
term of office will expire in
2023: Mark T. Smucker |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Directors whose
term of office will expire in
2023: Richard K. Smucker |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Directors whose
term of office will expire in
2023: Jodi L. Taylor |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Directors whose
term of office will expire in
2023: Dawn C. Willoughby |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of appointment
of Ernst & Young LLP as the
Company's Independent Registered Public Accounting
Firm for the 2023 fiscal year. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory approval of the Company's
executive
compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
Adoption of amendments to the
Company's Amended
Articles of Incorporation to eliminate the time phased
voting provisions. |
Management |
|
Against |
|
Against |
|
|
| |
NEOGEN
CORPORATION |
|
|
| |
Security |
640491106 |
|
|
|
Meeting Type |
Special |
| |
Ticker Symbol |
NEOG |
|
|
|
Meeting Date |
17-Aug-2022 |
|
| |
ISIN |
US6404911066 |
|
|
|
Agenda |
935691914 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
To
approve the issuance of shares of Neogen common
stock (the "Share Issuance") in connection with the
Merger contemplated by the Agreement and Plan of
Merger (as it may be amended from time to time, the
"Merger Agreement"), dated as of December 13, 2021,
by and among 3M Company, Garden SpinCo
Corporation, Neogen Corporation ("Neogen") and Nova
RMT Sub, Inc. (the "Share Issuance Proposal"). |
Management |
|
For |
|
For |
|
|
| |
2. |
To
approve the amendment of Neogen's Restated
Articles of Incorporation, as amended, to (a) increase the
number of authorized shares of Neogen common stock
from 240,000,000 shares of Neogen common stock to
315,000,000 shares of Neogen common stock and (b)
increase the maximum number of directors on the
Neogen board of directors (the "Board") from nine
directors to eleven directors (the "Charter Amendment
Proposal"). |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve the amendment of
Neogen's bylaws to
increase the maximum number of directors that may
comprise the Board from nine directors to eleven
directors (the "Bylaw Board Size Proposal"). |
Management |
|
For |
|
For |
|
|
| |
4. |
To approve the amendment of
Neogen's bylaws in order
to authorize the Board to amend the bylaws without
obtaining the prior approval of Neogen's shareholders. |
Management |
|
Against |
|
Against |
|
|
| |
5. |
To
approve the adjournment of the special meeting, if
necessary, to solicit additional proxies in the event there
are not sufficient votes at the time of the special meeting
to approve the Share Issuance Proposal, the Charter
Amendment Proposal or the Bylaw Board Size Proposal. |
Management |
|
For |
|
For |
|
|
| |
VITASOY
INTERNATIONAL HOLDINGS LTD |
|
|
| |
Security |
Y93794108 |
|
|
|
Meeting Type |
Annual General Meeting |
| |
Ticker Symbol |
|
|
|
|
Meeting Date |
30-Aug-2022 |
|
| |
ISIN |
HK0345001611 |
|
|
|
Agenda |
715944066 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
CMMT |
PLEASE
NOTE THAT THE COMPANY NOTICE AND
PROXY FORM ARE AVAILABLE BY CLICKING-ON THE
URL LINKS:-
https://www1.hkexnews.hk/listedco/listconews/sehk/2022/
0725/2022072500345.pdf-AND-
https://www1.hkexnews.hk/listedco/listconews/sehk/2022/
0725/2022072500365.pdf |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
IN THE HONG KONG MARKET A VOTE
OF ABSTAIN
WILL BE TREATED THE SAME AS A VOTE-OF TAKE
NO ACTION. |
Non-Voting |
|
|
|
|
|
|
| |
1 |
TO RECEIVE AND ADOPT THE AUDITED
FINANCIAL
STATEMENTS AND THE REPORTS OF THE
DIRECTORS AND AUDITORS FOR THE YEAR ENDED
31ST MARCH, 2022 |
Management |
|
For |
|
For |
|
|
| |
2.A.I |
TO RE-ELECT MR. WINSTON YAU-LAI
LO AS AN
EXECUTIVE DIRECTOR |
Management |
|
Against |
|
Against |
|
|
| |
2.AII |
TO RE-ELECT MR. PAUL JEREMY
BROUGH AS AN
INDEPENDENT NON-EXECUTIVE DIRECTOR |
Management |
|
Against |
|
Against |
|
|
| |
2AIII |
TO RE-ELECT MR. ROBERTO GUIDETTI
AS AN
EXECUTIVE DIRECTOR |
Management |
|
For |
|
For |
|
|
| |
2.B |
TO DETERMINE THE REMUNERATION
OF THE
DIRECTORS |
Management |
|
For |
|
For |
|
|
| |
3 |
TO APPOINT AUDITORS AND AUTHORISE
THE
DIRECTORS TO FIX THEIR REMUNERATION |
Management |
|
For |
|
For |
|
|
| |
4.A |
TO GRANT A GENERAL MANDATE
TO THE
DIRECTORS TO ISSUE, ALLOT AND DEAL WITH
ADDITIONAL SHARES OF THE COMPANY, NOT
EXCEEDING 10% OF THE NUMBER OF ISSUED
SHARES OF THE COMPANY AS AT THE DATE OF
THIS RESOLUTION |
Management |
|
Against |
|
Against |
|
|
| |
4.B |
TO GRANT A GENERAL MANDATE
TO THE
DIRECTORS TO BUY-BACK SHARES OF THE
COMPANY, NOT EXCEEDING 10% OF THE NUMBER
OF ISSUED SHARES OF THE COMPANY AS AT THE
DATE OF THIS RESOLUTION |
Management |
|
For |
|
For |
|
|
| |
4.C |
TO ADD THE NUMBER OF SHARES
BOUGHT-BACK
PURSUANT TO RESOLUTION 4B TO THE NUMBER
OF SHARES AVAILABLE PURSUANT TO
RESOLUTION 4A |
Management |
|
Against |
|
Against |
|
|
| |
4.D |
TO APPROVE AND ADOPT THE NEW
SHARE OPTION
SCHEME |
Management |
|
Against |
|
Against |
|
|
| |
PATTERSON
COMPANIES, INC. |
|
|
| |
Security |
703395103 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
PDCO |
|
|
|
Meeting Date |
12-Sep-2022 |
|
| |
ISIN |
US7033951036 |
|
|
|
Agenda |
935691471 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director to have
terms expiring in 2023: John
D. Buck |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director to have
terms expiring in 2023: Alex
N. Blanco |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director to have
terms expiring in 2023: Jody
H. Feragen |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director to have
terms expiring in 2023:
Robert C. Frenzel |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director to have
terms expiring in 2023: Philip
G. McKoy |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director to have
terms expiring in 2023: Ellen
A. Rudnick |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director to have
terms expiring in 2023: Neil
A. Schrimsher |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director to have
terms expiring in 2023: Mark
S. Walchirk |
Management |
|
For |
|
For |
|
|
| |
2. |
Advisory approval of executive
compensation. |
Management |
|
For |
|
For |
|
|
| |
3. |
To ratify the selection of
Ernst & Young LLP as our
independent registered public accounting firm for the
fiscal year ending April 29, 2023. |
Management |
|
For |
|
For |
|
|
| |
CONAGRA
BRANDS, INC. |
|
|
| |
Security |
205887102 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
CAG |
|
|
|
Meeting Date |
21-Sep-2022 |
|
| |
ISIN |
US2058871029 |
|
|
|
Agenda |
935696736 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Anil
Arora |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Thomas
K. Brown |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Emanuel
Chirico |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Sean
M. Connolly |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: George
Dowdie |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Fran
Horowitz |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Richard
H. Lenny |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Melissa
Lora |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Ruth
Ann Marshall |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Denise
A. Paulonis |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of the appointment
of KPMG LLP as our
independent auditor for fiscal 2023 |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory approval of our named
executive officer
compensation |
Management |
|
For |
|
For |
|
|
| |
4. |
A Board resolution to amend
the Certificate of
Incorporation to allow shareholders to act by written
consent |
Management |
|
For |
|
For |
|
|
| |
5. |
A shareholder proposal regarding
the office of the Chair
and the office of the Chief Executive Officer |
Shareholder |
|
Against |
|
For |
|
|
| |
1LIFE
HEALTHCARE, INC. |
|
|
| |
Security |
68269G107 |
|
|
|
Meeting Type |
Special |
| |
Ticker Symbol |
ONEM |
|
|
|
Meeting Date |
22-Sep-2022 |
|
| |
ISIN |
US68269G1076 |
|
|
|
Agenda |
935704432 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
To
adopt the Agreement and Plan of Merger, dated July
20, 2022 (such agreement, as it may be amended,
modified or supplemented from time to time, the "Merger
Agreement"), by and among 1Life Healthcare, Inc.
("1Life"), a Delaware corporation, Amazon.com, Inc.
("Amazon"), a Delaware corporation, and Negroni Merger
Sub, Inc. ("Merger Sub"), a Delaware corporation. Upon
the terms and subject to the conditions of the Merger
Agreement, Amazon will acquire 1Life via a merger of
Merger Sub with and into 1Life, with 1Life continuing as
the surviving corporation. |
Management |
|
For |
|
For |
|
|
| |
2. |
To
approve, on an advisory (non-binding) basis, the
compensation that may be paid or become payable to
1Life's named executive officers that is based on or
otherwise relates to the Merger Agreement and the
transactions contemplated by the Merger Agreement. |
Management |
|
For |
|
For |
|
|
| |
3. |
To
adjourn the special meeting of the 1Life stockholders
(the "Special Meeting") to a later date or dates, if
necessary or appropriate, including to solicit additional
proxies to approve the proposal to adopt the Merger
Agreement if there are insufficient votes to adopt the
Merger Agreement at the time of the Special Meeting. |
Management |
|
For |
|
For |
|
|
| |
GENERAL
MILLS, INC. |
|
|
| |
Security |
370334104 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
GIS |
|
|
|
Meeting Date |
27-Sep-2022 |
|
| |
ISIN |
US3703341046 |
|
|
|
Agenda |
935697877 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: R. Kerry
Clark |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: David
M. Cordani |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: C. Kim
Goodwin |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Jeffrey
L. Harmening |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Maria
G. Henry |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Jo Ann
Jenkins |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Elizabeth
C. Lempres |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Diane
L. Neal |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Steve
Odland |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Maria
A. Sastre |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: Eric
D. Sprunk |
Management |
|
For |
|
For |
|
|
| |
1l. |
Election of Director: Jorge
A. Uribe |
Management |
|
For |
|
For |
|
|
| |
2. |
Approval of the 2022 Stock
Compensation Plan. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory Vote on Executive
Compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
Ratify Appointment of the Independent
Registered Public
Accounting Firm. |
Management |
|
For |
|
For |
|
|
| |
5. |
Shareholder Proposal - Independent
Board Chairman. |
Shareholder |
|
Against |
|
For |
|
|
| |
6. |
Shareholder Proposal Regarding
a Plastic Packaging
Report. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
LAMB
WESTON HOLDINGS, INC. |
|
|
| |
Security |
513272104 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
LW |
|
|
|
Meeting Date |
29-Sep-2022 |
|
| |
ISIN |
US5132721045 |
|
|
|
Agenda |
935697889 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Peter
J. Bensen |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Charles
A. Blixt |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Robert
J. Coviello |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: André
J. Hawaux |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: W.G.
Jurgensen |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Thomas
P. Maurer |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Hala
G. Moddelmog |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Robert
A. Niblock |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Maria
Renna Sharpe |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Thomas
P. Werner |
Management |
|
For |
|
For |
|
|
| |
2. |
Advisory Vote to Approve Executive
Compensation. |
Management |
|
For |
|
For |
|
|
| |
3. |
Ratification of the Selection
of KPMG LLP as
Independent Auditors for Fiscal Year 2023. |
Management |
|
For |
|
For |
|
|
| |
BIOHAVEN
PHARMACEUTICAL HLDG CO LTD |
|
|
| |
Security |
G11196105 |
|
|
|
Meeting Type |
Special |
| |
Ticker Symbol |
BHVN |
|
|
|
Meeting Date |
29-Sep-2022 |
|
| |
ISIN |
VGG111961055 |
|
|
|
Agenda |
935707298 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
To
adopt (i) the Agreement and Plan of Merger, dated as
of May 9, 2022 (the "Merger Agreement"), by and among
Biohaven Pharmaceutical Holding Company Ltd.
("Biohaven"), Pfizer Inc. & Bulldog (BVI) Ltd., (ii) the form
of Plan of Reverse Triangular Merger & form of Plan of
Forward Triangular Merger (together, the "Plan of
Merger") & (iii) Separation & Distribution Agreement,
dated as of May 9, 2022 ("Distribution Agreement"), by
and between Biohaven & Biohaven Research Ltd.
("SpinCo"), in each case, as they may be amended from
time to time. |
Management |
|
For |
|
For |
|
|
| |
2. |
To
approve, by non-binding, advisory vote, certain
compensatory arrangements for Biohaven's named
executive officers in connection with the acquisition by
Pfizer of Biohaven and the distribution to Biohaven's
shareholders of all of the issued and outstanding
common shares of SpinCo. |
Management |
|
For |
|
For |
|
|
| |
3. |
To
adjourn the Special Meeting, if necessary, desirable or
appropriate, to solicit additional proxies if, at the time of
the Special Meeting, there are an insufficient number of
votes to adopt the Merger Agreement, the Plan of Merger
and the Distribution Agreement. |
Management |
|
For |
|
For |
|
|
| |
GLOBAL
BLOOD THERAPEUTICS, INC. |
|
|
| |
Security |
37890U108 |
|
|
|
Meeting Type |
Special |
| |
Ticker Symbol |
GBT |
|
|
|
Meeting Date |
30-Sep-2022 |
|
| |
ISIN |
US37890U1088 |
|
|
|
Agenda |
935705662 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
To adopt the Agreement and
Plan of Merger, dated as of
August 7, 2022, by and among Pfizer Inc., Ribeye
Acquisition Corp. and Global Blood Therapeutics, Inc., as
it may be amended from time to time (the "Merger
Agreement"). |
Management |
|
For |
|
For |
|
|
| |
2. |
To
approve, on an advisory (nonbinding) basis, the
compensation that may be paid or become payable to
Global Blood Therapeutics, Inc.'s named executive
officers that is based on or otherwise related to the
Merger Agreement and the transactions contemplated by
the Merger Agreement. |
Management |
|
For |
|
For |
|
|
| |
3. |
To
adjourn the special meeting of stockholders of Global
Blood Therapeutics, Inc. (the "Special Meeting"), if
necessary or appropriate, to solicit additional proxies if
there are insufficient votes to adopt the Merger
Agreement at the time of the Special Meeting. |
Management |
|
For |
|
For |
|
|
| |
NEOGEN
CORPORATION |
|
|
| |
Security |
640491106 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
NEOG |
|
|
|
Meeting Date |
06-Oct-2022 |
|
| |
ISIN |
US6404911066 |
|
|
|
Agenda |
935707628 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
JOHN E. ADENT |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
WILLIAM T. BOEHM, PH.D. |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
JAMES P. TOBIN |
|
|
|
For |
|
For |
|
|
| |
2. |
TO APPROVE, BY NON-BINDING
ADVISORY VOTE,
THE COMPENSATION OF EXECUTIVES. |
Management |
|
For |
|
For |
|
|
| |
3. |
RATIFICATION OF APPOINTMENT
OF BDO USA LLP
AS THE COMPANY'S INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM. |
Management |
|
For |
|
For |
|
|
| |
MERIDIAN
BIOSCIENCE, INC. |
|
|
| |
Security |
589584101 |
|
|
|
Meeting Type |
Special |
| |
Ticker Symbol |
VIVO |
|
|
|
Meeting Date |
10-Oct-2022 |
|
| |
ISIN |
US5895841014 |
|
|
|
Agenda |
935710702 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
Adoption
of the Agreement and Plan of Merger, (as may
be amended from time to time, the "merger agreement"),
by and among Meridian Bioscience, Inc. ("Meridian"), SD
Biosensor, Inc., Columbus Holding Company ("Columbus
Holding") and Madeira Acquisition Corp., a directly wholly
owned subsidiary of Columbus Holding ("Merger Sub").
The merger agreement provides for acquisition of
Meridian by Columbus Holding through a merger of
Merger Sub with and into Meridian, with Meridian
surviving merger as a wholly owned subsidiary of
Columbus Holding. |
Management |
|
For |
|
For |
|
|
| |
2. |
Approval,
on an advisory (non-binding) basis, of the
compensation that may be paid or become payable to
Meridian's named executive officers that is based on or
otherwise relates to the merger agreement and the
transactions contemplated by the merger agreement. |
Management |
|
For |
|
For |
|
|
| |
3. |
Approval of the adjournment
of the special meeting to a
later date or dates if necessary or appropriate to solicit
additional proxies if there are insufficient votes to adopt
the merger agreement at the time of the special meeting. |
Management |
|
For |
|
For |
|
|
| |
THE
PROCTER & GAMBLE COMPANY |
|
|
| |
Security |
742718109 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
PG |
|
|
|
Meeting Date |
11-Oct-2022 |
|
| |
ISIN |
US7427181091 |
|
|
|
Agenda |
935703149 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
ELECTION OF DIRECTOR: B. Marc
Allen |
Management |
|
For |
|
For |
|
|
| |
1b. |
ELECTION OF DIRECTOR: Angela
F. Braly |
Management |
|
For |
|
For |
|
|
| |
1c. |
ELECTION OF DIRECTOR: Amy L.
Chang |
Management |
|
For |
|
For |
|
|
| |
1d. |
ELECTION OF DIRECTOR: Joseph
Jimenez |
Management |
|
For |
|
For |
|
|
| |
1e. |
ELECTION OF DIRECTOR: Christopher
Kempczinski |
Management |
|
For |
|
For |
|
|
| |
1f. |
ELECTION OF DIRECTOR: Debra
L. Lee |
Management |
|
For |
|
For |
|
|
| |
1g. |
ELECTION OF DIRECTOR: Terry
J. Lundgren |
Management |
|
For |
|
For |
|
|
| |
1h. |
ELECTION OF DIRECTOR: Christine
M. McCarthy |
Management |
|
For |
|
For |
|
|
| |
1i. |
ELECTION OF DIRECTOR: Jon R.
Moeller |
Management |
|
For |
|
For |
|
|
| |
1j. |
ELECTION OF DIRECTOR: Rajesh
Subramaniam |
Management |
|
For |
|
For |
|
|
| |
1k. |
ELECTION OF DIRECTOR: Patricia
A. Woertz |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratify Appointment of the Independent
Registered Public
Accounting Firm |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory Vote to Approve the
Company's Executive
Compensation (the "Say on Pay" vote) |
Management |
|
For |
|
For |
|
|
| |
EARGO,
INC. |
|
|
| |
Security |
270087109 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
EAR |
|
|
|
Meeting Date |
12-Oct-2022 |
|
| |
ISIN |
US2700871096 |
|
|
|
Agenda |
935711754 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Class II Director
to hold office until the 2025
annual meeting of stockholder: A. Brooke Seawell |
Management |
|
For |
|
For |
|
|
| |
2. |
To ratify the appointment of
Deloitte & Touche LLP as the
Company's independent registered public accounting firm
for the fiscal year ending December 31, 2022. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve, on a non-binding,
advisory basis, the
frequency of future advisory votes on the compensation
of the Company's named executive officers. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
To
adopt an amendment to the Company's Amended and
Restated Certificate of Incorporation to effect a reverse
stock split of the Company's common stock, at a ratio in
the range of 1-for-5 to 1-for-50, such ratio to be
determined by the Board of Directors and included in a
public announcement. |
Management |
|
For |
|
For |
|
|
| |
5. |
To adopt an amendment to the
Company's Amended and
Restated Certificate of Incorporation to increase the
number of authorized shares of common stock of the
Company from 300,000,000 to 450,000,000. |
Management |
|
For |
|
For |
|
|
| |
6. |
To approve, for purposes of
complying with Nasdaq
Listing Rule 5635, the issuance of shares of the
Company's common stock issuable upon conversion of
the Company's 2022 senior secured convertible notes. |
Management |
|
For |
|
For |
|
|
| |
SEMLER
SCIENTIFIC, INC. |
|
|
| |
Security |
81684M104 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
SMLR |
|
|
|
Meeting Date |
20-Oct-2022 |
|
| |
ISIN |
US81684M1045 |
|
|
|
Agenda |
935710928 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1.1 |
Election of Class l Director:
Wayne T. Pan, M.D., Ph.D. |
Management |
|
For |
|
For |
|
|
| |
2. |
Approve, on an advisory basis,
the compensation of the
Company's named executive officers as disclosed in the
proxy statement. |
Management |
|
For |
|
For |
|
|
| |
3. |
To ratify the selection by
the Audit Committee of the
board of directors of BDO USA, LLP as the independent
registered public accounting firm of the Company for its
year ending December 31, 2022. |
Management |
|
For |
|
For |
|
|
| |
CONFORMIS,
INC. |
|
|
| |
Security |
20717E101 |
|
|
|
Meeting Type |
Special |
| |
Ticker Symbol |
CFMS |
|
|
|
Meeting Date |
26-Oct-2022 |
|
| |
ISIN |
US20717E1010 |
|
|
|
Agenda |
935710663 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
Updated
Reverse Stock Split Proposal: To approve and
adopt an amendment to the Company's restated
certificate of incorporation to effect a reverse stock split of
our common stock and adjust the number of shares
authorized by the restated certificate of incorporation. |
Management |
|
For |
|
For |
|
|
| |
2. |
Adjournment
Proposal: To approve one or more
adjournments of the Special Meeting, if necessary or
appropriate, to solicit additional proxies in favor of the
Updated Reverse Stock Split Proposal if there are not
sufficient votes at the Special Meeting to approve and
adopt the Updated Reverse Stock Split Proposal. |
Management |
|
For |
|
For |
|
|
| |
CATALENT,
INC. |
|
|
| |
Security |
148806102 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
CTLT |
|
|
|
Meeting Date |
27-Oct-2022 |
|
| |
ISIN |
US1488061029 |
|
|
|
Agenda |
935709975 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Madhavan
Balachandran |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Michael
J. Barber |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: J. Martin
Carroll |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: John
Chiminski |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Rolf
Classon |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Rosemary
A. Crane |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Karen
Flynn |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: John
J. Greisch |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Christa
Kreuzburg |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Gregory
T. Lucier |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: Donald
E. Morel, Jr. |
Management |
|
For |
|
For |
|
|
| |
1l. |
Election of Director: Alessandro
Maselli |
Management |
|
For |
|
For |
|
|
| |
1m. |
Election of Director: Jack
Stahl |
Management |
|
For |
|
For |
|
|
| |
1n. |
Election of Director: Peter
Zippelius |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of Appointment
of Ernst & Young LLP as
Independent Auditor for Fiscal 2023 |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory Vote to Approve Our
Executive Compensation
(Say-on-Pay) |
Management |
|
For |
|
For |
|
|
| |
CARDIOVASCULAR
SYSTEMS, INC. |
|
|
| |
Security |
141619106 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
CSII |
|
|
|
Meeting Date |
08-Nov-2022 |
|
| |
ISIN |
US1416191062 |
|
|
|
Agenda |
935713708 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Class II Director
to hold office until the 2025
Annual Meeting: Scott R. Ward |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Class II Director
to hold office until the 2025
Annual Meeting: Kelvin Womack |
Management |
|
For |
|
For |
|
|
| |
2. |
To ratify the appointment of
PricewaterhouseCoopers
LLP as the independent registered public accounting firm
of the Company for its fiscal year ending June 30, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve, on an advisory
basis, the compensation paid
to our named executive officers as disclosed in the proxy
statement. |
Management |
|
For |
|
For |
|
|
| |
ELECTROMED,
INC. |
|
|
| |
Security |
285409108 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
ELMD |
|
|
|
Meeting Date |
11-Nov-2022 |
|
| |
ISIN |
US2854091087 |
|
|
|
Agenda |
935713152 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Stan K. Erickson |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Gregory J. Fluet |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Joseph L. Galatowitsch |
|
|
|
For |
|
For |
|
|
| |
|
|
4 |
Lee A. Jones |
|
|
|
For |
|
For |
|
|
| |
|
|
5 |
Kathleen S. Skarvan |
|
|
|
For |
|
For |
|
|
| |
|
|
6 |
Andrew J. Summers |
|
|
|
For |
|
For |
|
|
| |
|
|
7 |
Kathleen A. Tune |
|
|
|
For |
|
For |
|
|
| |
|
|
8 |
Andrea M. Walsh |
|
|
|
For |
|
For |
|
|
| |
2. |
To ratify appointment of RSM
US LLP as our
independent registered public accounting firm. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve, on a non-binding
and advisory basis, our
executive compensation. |
Management |
|
For |
|
For |
|
|
| |
BARK,
INC. |
|
|
| |
Security |
68622E104 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
BARK |
|
|
|
Meeting Date |
15-Nov-2022 |
|
| |
ISIN |
US68622E1047 |
|
|
|
Agenda |
935717516 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Class A Director:
Betsy McLaughlin |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Class A Director:
Henrik Werdelin |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratify the appointment of Deloitte
& Touche LLP as the
company's independent registered public accounting firm
for the fiscal year ending March 31, 2023 |
Management |
|
For |
|
For |
|
|
| |
3. |
Approve, on an advisory basis,
the frequency with which
future advisory votes to approve the compensation of the
company's named executive officers should be held |
Management |
|
1 Year |
|
For |
|
|
| |
THE
HAIN CELESTIAL GROUP, INC. |
|
|
| |
Security |
405217100 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
HAIN |
|
|
|
Meeting Date |
17-Nov-2022 |
|
| |
ISIN |
US4052171000 |
|
|
|
Agenda |
935716261 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Richard
A. Beck |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Celeste
A. Clark |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Dean
Hollis |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Shervin
J. Korangy |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Mark
L. Schiller |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Michael
B. Sims |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Carlyn
R. Taylor |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Dawn
M. Zier |
Management |
|
For |
|
For |
|
|
| |
2. |
Proposal to approve, on an
advisory basis, named
executive officer compensation. |
Management |
|
For |
|
For |
|
|
| |
3. |
Proposal to ratify the appointment
of Ernst & Young LLP
to act as registered independent accountants of the
Company for the fiscal year ending June 30, 2023. |
Management |
|
For |
|
For |
|
|
| |
4. |
Proposal to approve the 2022
Long Term Incentive and
Stock Award Plan. |
Management |
|
Against |
|
Against |
|
|
| |
CHR.
HANSEN HOLDING A/S |
|
|
| |
Security |
K1830B107 |
|
|
|
Meeting Type |
Annual General Meeting |
| |
Ticker Symbol |
CHYHY |
|
|
|
Meeting Date |
23-Nov-2022 |
|
| |
ISIN |
DK0060227585 |
|
|
|
Agenda |
716293129 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
CMMT |
VOTING
INSTRUCTIONS FOR MOST MEETINGS ARE
CAST BY THE REGISTRAR IN ACCORDANCE-WITH
YOUR VOTING INSTRUCTIONS. FOR THE SMALL
NUMBER OF MEETINGS WHERE THERE-IS NO
REGISTRAR, YOUR VOTING INSTRUCTIONS WILL BE
CAST BY THE CHAIRMAN OF THE-BOARD (OR A
BOARD MEMBER) AS PROXY. THE CHAIRMAN (OR A
BOARD MEMBER) MAY-CHOOSE TO ONLY CAST
PRO-MANAGEMENT VOTING INSTRUCTIONS. TO
GUARANTEE YOUR-VOTING INSTRUCTIONS
AGAINST MANAGEMENT ARE CAST, YOU MAY
SUBMIT A REQUEST TO-ATTEND THE MEETING IN
PERSON. THE SUB CUSTODIAN BANKS OFFER
REPRESENTATION-SERVICES FOR AN ADDED FEE,
IF REQUESTED |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
SPLIT AND PARTIAL VOTING IS
NOT AUTHORIZED
FOR A BENEFICIAL OWNER IN THE-DANISH MARKET |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
VOTING MUST BE LODGED WITH
SHAREHOLDER
DETAILS AS PROVIDED BY YOUR CUSTODIAN-
BANK. IF NO SHAREHOLDER DETAILS ARE
PROVIDED, YOUR INSTRUCTIONS MAY BE-
REJECTED |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
PLEASE NOTE THAT SHAREHOLDERS
ARE
ALLOWED TO VOTE 'IN FAVOR' OR 'ABSTAIN'-ONLY
FOR RESOLUTION NUMBERS 7.A.A, 7.B.A TO 7.B.E
AND 8.A. THANK YOU |
Non-Voting |
|
|
|
|
|
|
| |
1 |
REPORT ON THE COMPANY'S ACTIVITIES |
Non-Voting |
|
|
|
|
|
|
| |
2 |
APPROVAL OF THE 2021/22 ANNUAL
REPORT |
Management |
|
No Action |
|
|
|
|
| |
3 |
RESOLUTION ON THE APPROPRIATION
OF PROFIT |
Management |
|
No Action |
|
|
|
|
| |
4 |
PRESENTATION OF THE COMPANY'S
2021/22
REMUNERATION REPORT FOR AN ADVISORY VOTE |
Management |
|
No Action |
|
|
|
|
| |
5 |
RESOLUTION ON REMUNERATION
OF MEMBERS OF
THE BOARD OF DIRECTORS |
Management |
|
No Action |
|
|
|
|
| |
6.A |
PROPOSALS FROM THE BOARD OF
DIRECTORS:
AUTHORIZATION TO THE BOARD OF DIRECTORS TO
INCREASE THE COMPANY'S SHARE CAPITAL WITH
OR WITHOUT PRE-EMPTIVE SUBSCRIPTION RIGHTS
FOR THE EXISTING SHAREHOLDERS |
Management |
|
No Action |
|
|
|
|
| |
6.B |
PROPOSALS FROM THE BOARD OF
DIRECTORS:
AUTHORIZATION TO THE BOARD OF DIRECTORS
FOR THE COMPANY TO ACQUIRE OWN SHARES |
Management |
|
No Action |
|
|
|
|
| |
6.C |
PROPOSALS FROM THE BOARD OF
DIRECTORS:
PROPOSED AMENDMENTS TO THE COMPANY'S
ARTICLES OF ASSOCIATION (USE OF BOTH MALE
AND FEMALE PRONOUNS) |
Management |
|
No Action |
|
|
|
|
| |
7.A.A |
ELECTION OF A CHAIR OF THE
BOARD OF
DIRECTORS: DOMINIQUE REINICHE (RE-ELECTION) |
Management |
|
No Action |
|
|
|
|
| |
7.B.A |
ELECTION OF OTHER MEMBER TO
THE BOARD OF
DIRECTORS: JESPER BRANDGAARD (RE-ELECTION) |
Management |
|
No Action |
|
|
|
|
| |
7.B.B |
ELECTION OF OTHER MEMBER TO
THE BOARD OF
DIRECTORS: LUIS CANTARELL (RE-ELECTION) |
Management |
|
No Action |
|
|
|
|
| |
7.B.C |
ELECTION OF OTHER MEMBER TO
THE BOARD OF
DIRECTORS: LISE KAAE (RE-ELECTION) |
Management |
|
No Action |
|
|
|
|
| |
7.B.D |
ELECTION OF OTHER MEMBER TO
THE BOARD OF
DIRECTORS: HEIDI KLEINBACH-SAUTER (RE-
ELECTION) |
Management |
|
No Action |
|
|
|
|
| |
7.B.E |
ELECTION OF OTHER MEMBER TO
THE BOARD OF
DIRECTORS: KEVIN LANE (RE-ELECTION) |
Management |
|
No Action |
|
|
|
|
| |
8.A |
ELECTION OF A COMPANY AUDITOR:
RE-ELECTION
OF PWC STATSAUTORISERET
REVISIONSPARTNERSELSKAB |
Management |
|
No Action |
|
|
|
|
| |
9 |
AUTHORISATION OF THE CHAIR
OF THE ANNUAL
GENERAL MEETING |
Management |
|
No Action |
|
|
|
|
| |
CMMT |
INTERMEDIARY
CLIENTS ONLY - PLEASE NOTE
THAT IF YOU ARE CLASSIFIED AS AN-
INTERMEDIARY CLIENT UNDER THE SHAREHOLDER
RIGHTS DIRECTIVE II, YOU SHOULD BE-PROVIDING
THE UNDERLYING SHAREHOLDER INFORMATION
AT THE VOTE INSTRUCTION-LEVEL. IF YOU ARE
UNSURE ON HOW TO PROVIDE THIS LEVEL OF
DATA TO BROADRIDGE-OUTSIDE OF PROXYEDGE,
PLEASE SPEAK TO YOUR DEDICATED CLIENT
SERVICE-REPRESENTATIVE FOR ASSISTANCE |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
PLEASE
NOTE THAT IF YOU HOLD CREST
DEPOSITORY INTERESTS (CDIS) AND-PARTICIPATE
AT THIS MEETING, YOU (OR YOUR CREST
SPONSORED MEMBER/CUSTODIAN)-WILL BE
REQUIRED TO INSTRUCT A TRANSFER OF THE
RELEVANT CDIS TO THE ESCROW-ACCOUNT
SPECIFIED IN THE ASSOCIATED CORPORATE
EVENT IN THE CREST SYSTEM. THIS-TRANSFER
WILL NEED TO BE COMPLETED BY THE SPECIFIED
CREST SYSTEM DEADLINE.-ONCE THIS TRANSFER
HAS SETTLED, THE CDIS WILL BE BLOCKED IN THE
CREST SYSTEM.-THE CDIS WILL TYPICALLY BE
RELEASED FROM ESCROW AS SOON AS
PRACTICABLE ON-RECORD DATE +1 DAY (OR ON
MEETING DATE +1 DAY IF NO RECORD DATE
APPLIES)-UNLESS OTHERWISE SPECIFIED, AND
ONLY AFTER THE AGENT HAS CONFIRMED-
AVAILABILITY OF THE POSITION. IN ORDER FOR A
VOTE TO BE ACCEPTED, THE VOTED-POSITION
MUST BE BLOCKED IN THE REQUIRED ESCROW
ACCOUNT IN THE CREST SYSTEM.-BY VOTING ON |
Non-Voting |
|
|
|
|
|
|
| |
|
THIS
MEETING, YOUR CREST SPONSORED
MEMBER/CUSTODIAN MAY USE YOUR-VOTE
INSTRUCTION AS THE AUTHORIZATION TO TAKE
THE NECESSARY ACTION WHICH WILL-INCLUDE
TRANSFERRING YOUR INSTRUCTED POSITION TO
ESCROW. PLEASE CONTACT YOUR-CREST
SPONSORED MEMBER/CUSTODIAN DIRECTLY FOR
FURTHER INFORMATION ON THE-CUSTODY
PROCESS AND WHETHER OR NOT THEY REQUIRE
SEPARATE INSTRUCTIONS FROM-YOU |
|
|
|
|
|
|
|
|
|
| |
CMMT |
PLEASE NOTE SHARE BLOCKING
WILL APPLY FOR
ANY VOTED POSITIONS SETTLING-THROUGH
EUROCLEAR BANK. |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
02 NOV 2022: PLEASE NOTE THAT
THIS IS A
REVISION DUE TO MODIFICATION OF THE-TEXT OF
RESOLUTION 6.C. IF YOU HAVE ALREADY SENT IN
YOUR VOTES, PLEASE DO NOT-VOTE AGAIN
UNLESS YOU DECIDE TO AMEND YOUR ORIGINAL
INSTRUCTIONS. THANK YOU |
Non-Voting |
|
|
|
|
|
|
| |
CAMPBELL
SOUP COMPANY |
|
|
| |
Security |
134429109 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
CPB |
|
|
|
Meeting Date |
30-Nov-2022 |
|
| |
ISIN |
US1344291091 |
|
|
|
Agenda |
935719130 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Fabiola R. Arredondo |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Howard M. Averill |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: John P. (JP) Bilbrey |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Mark A. Clouse |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Bennett Dorrance, Jr. |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Maria Teresa (Tessa) Hilado |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Grant H. Hill |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Sarah Hofstetter |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Marc B. Lautenbach |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Mary Alice D. Malone |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Keith R. McLoughlin |
Management |
|
For |
|
For |
|
|
| |
1l. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Kurt T. Schmidt |
Management |
|
For |
|
For |
|
|
| |
1m. |
Election of Director for a
one-year term expiring at the
2023 Annual Meeting: Archbold D. van Beuren |
Management |
|
For |
|
For |
|
|
| |
2. |
To ratify the appointment of
PricewaterhouseCoopers
LLP as our independent registered public accounting firm
for fiscal 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
To vote on an advisory resolution
to approve the fiscal
2022 compensation of our named executive officers,
commonly referred to as a "say on pay" vote. |
Management |
|
For |
|
For |
|
|
| |
4. |
To approve the Campbell Soup
Company 2022 Long-
Term Incentive Plan. |
Management |
|
For |
|
For |
|
|
| |
5. |
To vote on a shareholder proposal
regarding a report on
certain supply chain practices. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
6. |
To vote on a shareholder proposal
regarding a report on
how the company's 401(k) retirement fund investments
contribute to climate change. |
Shareholder |
|
Against |
|
For |
|
|
| |
ELECTROCORE,
INC |
|
|
| |
Security |
28531P103 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
ECOR |
|
|
|
Meeting Date |
02-Dec-2022 |
|
| |
ISIN |
US28531P1030 |
|
|
|
Agenda |
935722884 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director until
the 2025 Annual Meeting: Daniel
S. Goldberger |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director until
the 2025 Annual Meeting: Julie
A. Goldstein |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director until
the 2025 Annual Meeting:
Patricia Wilber |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of appointment
of Marcum LLP as the
Company's independent registered public accounting firm
for the fiscal year ending December 31, 2022. |
Management |
|
For |
|
For |
|
|
| |
3. |
Approval
of an amendment to the Company's Certificate
of Incorporation to effect a reverse stock split of the
outstanding shares of common stock of the Company by
a ratio within a range of one-for-5 to one-for-50 (or any
whole number in between), the implementation and
timing of which shall be subject to the discretion of the
Board of Directors. |
Management |
|
For |
|
For |
|
|
| |
MEDTRONIC
PLC |
|
|
| |
Security |
G5960L103 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
MDT |
|
|
|
Meeting Date |
08-Dec-2022 |
|
| |
ISIN |
IE00BTN1Y115 |
|
|
|
Agenda |
935723610 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director to hold
office until the 2023 Annual
General Meeting: Richard H. Anderson |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director to hold
office until the 2023 Annual
General Meeting: Craig Arnold |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director to hold
office until the 2023 Annual
General Meeting: Scott C. Donnelly |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director to hold
office until the 2023 Annual
General Meeting: Lidia L. Fonseca |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director to hold
office until the 2023 Annual
General Meeting: Andrea J. Goldsmith, Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director to hold
office until the 2023 Annual
General Meeting: Randall J. Hogan, III |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director to hold
office until the 2023 Annual
General Meeting: Kevin E. Lofton |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director to hold
office until the 2023 Annual
General Meeting: Geoffrey S. Martha |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director to hold
office until the 2023 Annual
General Meeting: Elizabeth G. Nabel, M.D. |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director to hold
office until the 2023 Annual
General Meeting: Denise M. O'Leary |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director to hold
office until the 2023 Annual
General Meeting: Kendall J. Powell |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratifying,
in a non-binding vote, the appointment of
PricewaterhouseCoopers LLP as the Company's
independent auditor for fiscal year 2023 and authorizing,
in a binding vote, the Board of Directors, acting through
the Audit Committee, to set the auditor's remuneration. |
Management |
|
For |
|
For |
|
|
| |
3. |
Approving, on an advisory basis,
the Company's
executive compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
Renewing the Board of Directors'
authority to issue
shares under Irish law. |
Management |
|
For |
|
For |
|
|
| |
5. |
Renewing the Board of Directors'
authority to opt out of
pre-emption rights under Irish law. |
Management |
|
Against |
|
Against |
|
|
| |
6. |
Authorizing the Company and
any subsidiary of the
Company to make overseas market purchases of
Medtronic ordinary shares. |
Management |
|
For |
|
For |
|
|
| |
VIATRIS
INC. |
|
|
| |
Security |
92556V106 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
VTRS |
|
|
|
Meeting Date |
09-Dec-2022 |
|
| |
ISIN |
US92556V1061 |
|
|
|
Agenda |
935725880 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1A. |
Election of Class II Director
to hold office until the 2023
annual meeting: W. Don Cornwell |
Management |
|
For |
|
For |
|
|
| |
1B. |
Election of Class II Director
to hold office until the 2023
annual meeting: Harry A. Korman |
Management |
|
For |
|
For |
|
|
| |
1C. |
Election of Class II Director
to hold office until the 2023
annual meeting: Rajiv Malik |
Management |
|
For |
|
For |
|
|
| |
1D. |
Election of Class II Director
to hold office until the 2023
annual meeting: Richard A. Mark, C.P.A. |
Management |
|
For |
|
For |
|
|
| |
2. |
Approval of, on a non-binding
advisory basis, the 2021
compensation of the named executive officers of the
Company. |
Management |
|
For |
|
For |
|
|
| |
3. |
Ratification of the selection
of Deloitte & Touche LLP as
the Company's independent registered public accounting
firm for the fiscal year ending December 31, 2022. |
Management |
|
For |
|
For |
|
|
| |
4. |
Shareholder proposal regarding
independent board
chairman. |
Shareholder |
|
Against |
|
For |
|
|
| |
ORTHOFIX
MEDICAL INC. |
|
|
| |
Security |
68752M108 |
|
|
|
Meeting Type |
Special |
| |
Ticker Symbol |
OFIX |
|
|
|
Meeting Date |
04-Jan-2023 |
|
| |
ISIN |
US68752M1080 |
|
|
|
Agenda |
935744397 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
To
approve the issuance of Orthofix common stock, par
value $0.10 per share, to SeaSpine stockholders in
connection with the merger contemplated by the
Agreement and Plan of Merger, dated as of October 10,
2022, by and among Orthofix Medical Inc., Orca Merger
Sub Inc. and SeaSpine Holdings Corporation (the
"Orthofix share issuance proposal"). |
Management |
|
For |
|
For |
|
|
| |
2. |
To
approve the adjournment of the Orthofix special
meeting to a later date or dates, if necessary or
appropriate, to solicit additional proxies in the event there
are not sufficient votes at the time of the Orthofix special
meeting to approve the Orthofix share issuance proposal. |
Management |
|
For |
|
For |
|
|
| |
UNITED
NATURAL FOODS, INC. |
|
|
| |
Security |
911163103 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
UNFI |
|
|
|
Meeting Date |
10-Jan-2023 |
|
| |
ISIN |
US9111631035 |
|
|
|
Agenda |
935739574 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Eric
F. Artz |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Ann Torre
Bates |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Gloria
R. Boyland |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Denise
M. Clark |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: J. Alexander
Douglas |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Daphne
J. Dufresne |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Michael
S. Funk |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Shamim
Mohammad |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: James
L. Muehlbauer |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Peter
A. Roy |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: Jack
Stahl |
Management |
|
For |
|
For |
|
|
| |
2. |
The ratification of the selection
of KPMG LLP as our
independent registered public accounting firm for the
fiscal year ending July 29, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve, on an advisory
basis, our executive
compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
The approval of the Second
Amended and Restated
2020 Equity Incentive Plan. |
Management |
|
Against |
|
Against |
|
|
| |
BECTON,
DICKINSON AND COMPANY |
|
|
| |
Security |
075887109 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
BDX |
|
|
|
Meeting Date |
24-Jan-2023 |
|
| |
ISIN |
US0758871091 |
|
|
|
Agenda |
935749789 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1A. |
Election of Director: William
M. Brown |
Management |
|
For |
|
For |
|
|
| |
1B. |
Election of Director: Catherine
M. Burzik |
Management |
|
For |
|
For |
|
|
| |
1C. |
Election of Director: Carrie
L. Byington |
Management |
|
For |
|
For |
|
|
| |
1D. |
Election of Director: R Andrew
Eckert |
Management |
|
For |
|
For |
|
|
| |
1E. |
Election of Director: Claire
M. Fraser |
Management |
|
For |
|
For |
|
|
| |
1F. |
Election of Director: Jeffrey
W. Henderson |
Management |
|
For |
|
For |
|
|
| |
1G. |
Election of Director: Christopher
Jones |
Management |
|
For |
|
For |
|
|
| |
1H. |
Election of Director: Marshall
O. Larsen |
Management |
|
For |
|
For |
|
|
| |
1I. |
Election of Director: Thomas
E. Polen |
Management |
|
For |
|
For |
|
|
| |
1J. |
Election of Director: Timothy
M. Ring |
Management |
|
For |
|
For |
|
|
| |
1K. |
Election of Director: Bertram
L. Scott |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of the selection
of the independent registered
public accounting firm. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory vote to approve named
executive officer
compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
Advisory vote to approve the
frequency of named
executive officer compensation advisory votes. |
Management |
|
1 Year |
|
For |
|
|
| |
5. |
Approval of amendments to the
2004 Employee and
Director Equity-Based Compensation Plan. |
Management |
|
For |
|
For |
|
|
| |
6. |
A shareholder proposal to require
prior shareholder
approval of certain termination payments, if properly
presented at the meeting. |
Shareholder |
|
Against |
|
For |
|
|
| |
POST
HOLDINGS, INC. |
|
|
| |
Security |
737446104 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
POST |
|
|
|
Meeting Date |
26-Jan-2023 |
|
| |
ISIN |
US7374461041 |
|
|
|
Agenda |
935742711 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1.1 |
Election of Director: Dorothy
M. Burwell |
Management |
|
For |
|
For |
|
|
| |
1.2 |
Election of Director: Robert
E. Grote |
Management |
|
For |
|
For |
|
|
| |
1.3 |
Election of Director: David
W. Kemper |
Management |
|
For |
|
For |
|
|
| |
1.4 |
Election of Director: Robert
V. Vitale |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of PricewaterhouseCoopers
LLP as the
Company's Independent Registered Public Accounting
Firm for the fiscal year ending September 30, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory approval of the Company's
executive
compensation. |
Management |
|
For |
|
For |
|
|
| |
WALGREENS
BOOTS ALLIANCE, INC. |
|
|
| |
Security |
931427108 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
WBA |
|
|
|
Meeting Date |
26-Jan-2023 |
|
| |
ISIN |
US9314271084 |
|
|
|
Agenda |
935747280 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Janice
M. Babiak |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Inderpal
S. Bhandari |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Rosalind
G. Brewer |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Ginger
L. Graham |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Bryan
C. Hanson |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Valerie
B. Jarrett |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: John
A. Lederer |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Dominic
P. Murphy |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Stefano
Pessina |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Nancy
M. Schlichting |
Management |
|
For |
|
For |
|
|
| |
2. |
Advisory vote to approve named
executive officer
compensation. |
Management |
|
For |
|
For |
|
|
| |
3. |
Ratification of the appointment
of Deloitte & Touche LLP
as the independent registered public accounting firm for
fiscal year 2023. |
Management |
|
For |
|
For |
|
|
| |
4. |
Stockholder proposal requesting
report on public health
costs due to tobacco product sales and the impact on
overall market returns. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
5. |
Stockholder proposal requesting
an independent board
chairman. |
Shareholder |
|
Against |
|
For |
|
|
| |
EDGEWELL
PERSONAL CARE COMPANY |
|
|
| |
Security |
28035Q102 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
EPC |
|
|
|
Meeting Date |
03-Feb-2023 |
|
| |
ISIN |
US28035Q1022 |
|
|
|
Agenda |
935748989 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Robert
W. Black |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: George
R. Corbin |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Carla
C. Hendra |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: John
C. Hunter, III |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: James
C. Johnson |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Rod R.
Little |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Joseph
D. O'Leary |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Rakesh
Sachdev |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Swan
Sit |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Gary
K. Waring |
Management |
|
For |
|
For |
|
|
| |
2. |
To ratify the appointment of
PricewaterhouseCoopers
LLP as the independent registered public accounting firm
for fiscal 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
To cast a non-binding advisory
vote on executive
compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
Approval of the Company's 2nd
Amended and Restated
2018 Stock Incentive Plan. |
Management |
|
Abstain |
|
Against |
|
|
| |
BELLRING
BRANDS, INC. |
|
|
| |
Security |
07831C103 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
BRBR |
|
|
|
Meeting Date |
06-Feb-2023 |
|
| |
ISIN |
US07831C1036 |
|
|
|
Agenda |
935751924 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1.1 |
Election of Director: Darcy
H. Davenport |
Management |
|
For |
|
For |
|
|
| |
1.2 |
Election of Director: Elliot
H. Stein, Jr. |
Management |
|
For |
|
For |
|
|
| |
2. |
The ratification of the appointment
of
PricewaterhouseCoopers LLP as our independent
registered public accounting firm for the fiscal year
ending September 30, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
To consider and vote upon a
proposal to increase the
number of authorized shares under the Company's 2019
Long-Term Incentive Plan by 6,000,000 shares from
2,000,000 shares to 8,000,000 shares. |
Management |
|
For |
|
For |
|
|
| |
4. |
To
consider and vote, on an advisory basis, for the
adoption of a resolution approving the compensation of
our named executive officers, as such compensation is
described under the "Compensation Discussion and
Analysis" and "Executive Compensation" sections of this
proxy statement. |
Management |
|
For |
|
For |
|
|
| |
SURMODICS,
INC. |
|
|
| |
Security |
868873100 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
SRDX |
|
|
|
Meeting Date |
09-Feb-2023 |
|
| |
ISIN |
US8688731004 |
|
|
|
Agenda |
935751227 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Susan E. Knight |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
José H. Bedoya |
|
|
|
For |
|
For |
|
|
| |
2. |
Set the number of directors
at six (6). |
Management |
|
For |
|
For |
|
|
| |
3. |
Ratify the appointment of Deloitte
& Touche LLP as
Surmodics' independent registered public accounting firm
for fiscal year 2023. |
Management |
|
For |
|
For |
|
|
| |
4. |
Approve, in a non-binding advisory
vote, the Company's
executive compensation. |
Management |
|
For |
|
For |
|
|
| |
5. |
Approve, in a non-binding advisory
vote, the frequency of
the non-binding shareholder advisory vote on executive
compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
6. |
Approve an amendment to the
Surmodics, Inc. 2019
Equity Incentive Plan. |
Management |
|
Against |
|
Against |
|
|
| |
EMBECTA
CORP |
|
|
| |
Security |
29082K105 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
EMBC |
|
|
|
Meeting Date |
09-Feb-2023 |
|
| |
ISIN |
US29082K1051 |
|
|
|
Agenda |
935752673 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Mr. David
J. Albritton |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Ms. Carrie
L. Anderson |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Mr. Christopher
R. Reidy |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of selection of
independent registered public
accounting firm. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory vote to approve named
executive officer
compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
Advisory vote on the frequency
of future advisory votes to
approve named executive officer compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
INGLES
MARKETS, INCORPORATED |
|
|
| |
Security |
457030104 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
IMKTA |
|
|
|
Meeting Date |
14-Feb-2023 |
|
| |
ISIN |
US4570301048 |
|
|
|
Agenda |
935754449 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Ernest E. Ferguson |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
John R. Lowden |
|
|
|
For |
|
For |
|
|
| |
2. |
To approve, by non-binding
vote, executive
compensation, as disclosed in the Proxy Statement. |
Management |
|
For |
|
For |
|
|
| |
3. |
Stockholder proposal concerning
equal voting rights for
each share. |
Shareholder |
|
Against |
|
For |
|
|
| |
HOLOGIC,
INC. |
|
|
| |
Security |
436440101 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
HOLX |
|
|
|
Meeting Date |
09-Mar-2023 |
|
| |
ISIN |
US4364401012 |
|
|
|
Agenda |
935758132 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Stephen
P. MacMillan |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Sally
W. Crawford |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Charles
J. Dockendorff |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Scott
T. Garrett |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Ludwig
N. Hantson |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Namal
Nawana |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Christiana
Stamoulis |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Stacey
D. Stewart |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Amy M.
Wendell |
Management |
|
For |
|
For |
|
|
| |
2. |
A non-binding advisory resolution
to approve executive
compensation. |
Management |
|
For |
|
For |
|
|
| |
3. |
A non-binding advisory vote
on the frequency of future
advisory votes to approve executive compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Approval of the Hologic, Inc.
Amended and Restated
2008 Equity Incentive Plan. |
Management |
|
For |
|
For |
|
|
| |
5. |
Approval of the Hologic, Inc.
Amended and Restated
2012 Employee Stock Purchase Plan. |
Management |
|
For |
|
For |
|
|
| |
6. |
Ratification of the appointment
of Ernst & Young LLP as
our independent registered public accounting firm for
fiscal 2023. |
Management |
|
For |
|
For |
|
|
| |
DLH
HOLDINGS CORP. |
|
|
| |
Security |
23335Q100 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
DLHC |
|
|
|
Meeting Date |
09-Mar-2023 |
|
| |
ISIN |
US23335Q1004 |
|
|
|
Agenda |
935760187 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Judith L. Bjornaas |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Martin J. Delaney |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Dr. Elder Granger |
|
|
|
For |
|
For |
|
|
| |
|
|
4 |
Dr. Frances M. Murphy |
|
|
|
For |
|
For |
|
|
| |
|
|
5 |
Zachary C. Parker |
|
|
|
For |
|
For |
|
|
| |
|
|
6 |
Frederick G. Wasserman |
|
|
|
For |
|
For |
|
|
| |
|
|
7 |
Austin J. Yerks III |
|
|
|
For |
|
For |
|
|
| |
|
|
8 |
Stephen J. Zelkowicz |
|
|
|
For |
|
For |
|
|
| |
2. |
An Advisory Vote regarding
the approval of
compensation paid to our named Executive Officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
Ratification of Independent
Registered Public Accounting
Firm. |
Management |
|
For |
|
For |
|
|
| |
AMERISOURCEBERGEN
CORPORATION |
|
|
| |
Security |
03073E105 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
ABC |
|
|
|
Meeting Date |
09-Mar-2023 |
|
| |
ISIN |
US03073E1055 |
|
|
|
Agenda |
935761242 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Ornella
Barra |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Steven
H. Collis |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: D. Mark
Durcan |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Richard
W. Gochnauer |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Lon R.
Greenberg |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Kathleen
W. Hyle |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Lorence
H. Kim, M.D. |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Henry
W. McGee |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Redonda
G. Miller, M.D. |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Dennis
M. Nally |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of Ernst &
Young LLP as the Company's
independent registered public accounting firm for fiscal
year 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory vote to approve the
compensation of the
Company's named executive officers. |
Management |
|
For |
|
For |
|
|
| |
4. |
Advisory vote on the frequency
of a shareholder vote on
the compensation of the Company's named executive
officers. |
Management |
|
1 Year |
|
For |
|
|
| |
5. |
Shareholder proposal regarding
shareholder ratification
of termination pay. |
Shareholder |
|
Against |
|
For |
|
|
| |
AGILENT
TECHNOLOGIES, INC. |
|
|
| |
Security |
00846U101 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
A |
|
|
|
Meeting Date |
15-Mar-2023 |
|
| |
ISIN |
US00846U1016 |
|
|
|
Agenda |
935762218 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1.1 |
Election of Director for a
three-year term: Heidi K. Kunz |
Management |
|
For |
|
For |
|
|
| |
1.2 |
Election of Director for a
three-year term: Susan H. Rataj |
Management |
|
For |
|
For |
|
|
| |
1.3 |
Election of Director for a
three-year term: George A.
Scangos, Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1.4 |
Election of Director for a
three-year term: Dow R. Wilson |
Management |
|
For |
|
For |
|
|
| |
2. |
To approve, on a non-binding
advisory basis, the
compensation of our named executive officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
To ratify the Audit and Finance
Committee's appointment
of PricewaterhouseCoopers LLP as our independent
registered public accounting firm. |
Management |
|
For |
|
For |
|
|
| |
4. |
To approve amendments to the
Certificate of
Incorporation to create a new stockholder right to call a
special meeting. |
Management |
|
For |
|
For |
|
|
| |
5. |
An advisory vote on the frequency
of the stockholder vote
to approve the compensation of our named executive
officers. |
Management |
|
1 Year |
|
For |
|
|
| |
THE
COOPER COMPANIES, INC. |
|
|
| |
Security |
216648402 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
COO |
|
|
|
Meeting Date |
15-Mar-2023 |
|
| |
ISIN |
US2166484020 |
|
|
|
Agenda |
935764010 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Colleen
E. Jay |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: William
A. Kozy |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Cynthia
L. Lucchese |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Teresa
S. Madden |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Gary
S. Petersmeyer |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Maria
Rivas, M.D. |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Robert
S. Weiss |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Albert
G. White III |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of the appointment
of KPMG LLP as the
independent registered public accounting firm for The
Cooper Companies, Inc. for the fiscal year ending
October 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Approval of the 2023 Long Term
Incentive Plan for
Employees. |
Management |
|
For |
|
For |
|
|
| |
4. |
An advisory vote on the compensation
of our named
executive officers as presented in the Proxy Statement. |
Management |
|
For |
|
For |
|
|
| |
5. |
Advisory vote on the frequency
with which executive
compensation will be subject to a stockholder advisory
vote. |
Management |
|
1 Year |
|
For |
|
|
| |
PHENOMEX
INC. |
|
|
| |
Security |
084310101 |
|
|
|
Meeting Type |
Special |
| |
Ticker Symbol |
BLI |
|
|
|
Meeting Date |
16-Mar-2023 |
|
| |
ISIN |
US0843101017 |
|
|
|
Agenda |
935768133 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
Approve
the issuance of shares of common stock of
Berkeley Lights, Inc. ("Berkeley Lights") to the
stockholders of IsoPlexis Corporation ("IsoPlexis") in
connection with the merger contemplated by the
Agreement and Plan of Merger, dated as of December
21, 2022, by and among Berkeley Lights, Iceland Merger
Sub Inc. and IsoPlexis (the "share issuance proposal"). |
Management |
|
For |
|
For |
|
|
| |
2. |
Approve the adjournment of
the special meeting, if
necessary or appropriate, to solicit additional proxies if
there are insufficient votes at the time of the Berkeley
Lights special meeting to approve the share issuance
proposal. |
Management |
|
For |
|
For |
|
|
| |
SUNTORY
BEVERAGE & FOOD LIMITED |
|
|
| |
Security |
J78186103 |
|
|
|
Meeting Type |
Annual General Meeting |
| |
Ticker Symbol |
|
|
|
|
Meeting Date |
24-Mar-2023 |
|
| |
ISIN |
JP3336560002 |
|
|
|
Agenda |
716729908 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
|
Please reference meeting materials. |
Non-Voting |
|
|
|
|
|
|
| |
1 |
Approve Appropriation of Surplus |
Management |
|
For |
|
For |
|
|
| |
2.1 |
Appoint a Director who is not
Audit and Supervisory
Committee Member Ono, Makiko |
Management |
|
For |
|
For |
|
|
| |
2.2 |
Appoint a Director who is not
Audit and Supervisory
Committee Member Shekhar Mundlay |
Management |
|
For |
|
For |
|
|
| |
2.3 |
Appoint a Director who is not
Audit and Supervisory
Committee Member Naiki, Hachiro |
Management |
|
For |
|
For |
|
|
| |
2.4 |
Appoint a Director who is not
Audit and Supervisory
Committee Member Peter Harding |
Management |
|
For |
|
For |
|
|
| |
2.5 |
Appoint a Director who is not
Audit and Supervisory
Committee Member Miyamori, Hiroshi |
Management |
|
Against |
|
Against |
|
|
| |
2.6 |
Appoint a Director who is not
Audit and Supervisory
Committee Member Inoue, Yukari |
Management |
|
For |
|
For |
|
|
| |
3.1 |
Appoint a Director who is Audit
and Supervisory
Committee Member Yamazaki, Yuji |
Management |
|
Against |
|
Against |
|
|
| |
3.2 |
Appoint a Director who is Audit
and Supervisory
Committee Member Masuyama, Mika |
Management |
|
For |
|
For |
|
|
| |
3.3 |
Appoint a Director who is Audit
and Supervisory
Committee Member Mimura, Mariko |
Management |
|
For |
|
For |
|
|
| |
4 |
Appoint a Substitute Director
who is Audit and
Supervisory Committee Member Amitani, Mitsuhiro |
Management |
|
For |
|
For |
|
|
| |
CHR.
HANSEN HOLDING A/S |
|
|
| |
Security |
K1830B107 |
|
|
|
Meeting Type |
ExtraOrdinary General Meeting |
| |
Ticker Symbol |
CHYHY |
|
|
|
Meeting Date |
30-Mar-2023 |
|
| |
ISIN |
DK0060227585 |
|
|
|
Agenda |
716757820 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
CMMT |
VOTING
INSTRUCTIONS FOR MOST MEETINGS ARE
CAST BY THE REGISTRAR IN ACCORDANCE-WITH
YOUR VOTING INSTRUCTIONS. FOR THE SMALL
NUMBER OF MEETINGS WHERE THERE-IS NO
REGISTRAR, YOUR VOTING INSTRUCTIONS WILL BE
CAST BY THE CHAIRMAN OF THE-BOARD (OR A
BOARD MEMBER) AS PROXY. THE CHAIRMAN (OR A
BOARD MEMBER) MAY-CHOOSE TO ONLY CAST
PRO-MANAGEMENT VOTING INSTRUCTIONS. TO
GUARANTEE YOUR-VOTING INSTRUCTIONS
AGAINST MANAGEMENT ARE CAST, YOU MAY
SUBMIT A REQUEST TO-ATTEND THE MEETING IN
PERSON. THE SUB CUSTODIAN BANKS OFFER
REPRESENTATION-SERVICES FOR AN ADDED FEE,
IF REQUESTED. |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
SPLIT AND PARTIAL VOTING IS
NOT AUTHORIZED
FOR A BENEFICIAL OWNER IN THE-DANISH
MARKET. |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
VOTING MUST BE LODGED WITH
SHAREHOLDER
DETAILS AS PROVIDED BY YOUR CUSTODIAN-
BANK. IF NO SHAREHOLDER DETAILS ARE
PROVIDED, YOUR INSTRUCTIONS MAY BE-
REJECTED. |
Non-Voting |
|
|
|
|
|
|
| |
1 |
RESOLUTION TO ADOPT THE IMPLEMENTATION
OF
A STATUTORY MERGER OF CHR. HANSEN AND
NOVOZYMES A/S IN ACCORDANCE WITH THE
MERGER PLAN OF DECEMBER 12, 2022 |
Management |
|
No Action |
|
|
|
|
| |
2 |
RESOLUTION TO APPROVE TRANSACTION
SPECIFIC INDEMNIFICATION OF MANAGEMENT AND
RELEVANT EMPLOYEES |
Management |
|
No Action |
|
|
|
|
| |
3 |
CHANGE OF THE FINANCIAL YEAR
OF CHR.
HANSEN |
Management |
|
No Action |
|
|
|
|
| |
4 |
ADJUSTMENT OF BOARD REMUNERATION
DUE TO
PROPOSED MERGER AND CHANGE OF THE
FINANCIAL YEAR |
Management |
|
No Action |
|
|
|
|
| |
5 |
AUTHORISATION TO THE CHAIR
OF THE
EXTRAORDINARY GENERAL MEETING |
Management |
|
No Action |
|
|
|
|
| |
CMMT |
PLEASE
NOTE THAT IF YOU HOLD CREST
DEPOSITORY INTERESTS (CDIS) AND-PARTICIPATE
AT THIS MEETING, YOU (OR YOUR CREST
SPONSORED MEMBER/CUSTODIAN)-WILL BE
REQUIRED TO INSTRUCT A TRANSFER OF THE
RELEVANT CDIS TO THE ESCROW-ACCOUNT
SPECIFIED IN THE ASSOCIATED CORPORATE |
Non-Voting |
|
|
|
|
|
|
| |
|
EVENT
IN THE CREST SYSTEM. THIS-TRANSFER
WILL NEED TO BE COMPLETED BY THE SPECIFIED
CREST SYSTEM DEADLINE.-ONCE THIS TRANSFER
HAS SETTLED, THE CDIS WILL BE BLOCKED IN THE
CREST SYSTEM.-THE CDIS WILL TYPICALLY BE
RELEASED FROM ESCROW AS SOON AS
PRACTICABLE ON-RECORD DATE +1 DAY (OR ON
MEETING DATE +1 DAY IF NO RECORD DATE
APPLIES)-UNLESS OTHERWISE SPECIFIED, AND
ONLY AFTER THE AGENT HAS CONFIRMED-
AVAILABILITY OF THE POSITION. IN ORDER FOR A
VOTE TO BE ACCEPTED, THE VOTED-POSITION
MUST BE BLOCKED IN THE REQUIRED ESCROW
ACCOUNT IN THE CREST SYSTEM.-BY VOTING ON
THIS MEETING, YOUR CREST SPONSORED
MEMBER/CUSTODIAN MAY USE YOUR-VOTE
INSTRUCTION AS THE AUTHORIZATION TO TAKE
THE NECESSARY ACTION WHICH WILL-INCLUDE
TRANSFERRING YOUR INSTRUCTED POSITION TO
ESCROW. PLEASE CONTACT YOUR-CREST
SPONSORED MEMBER/CUSTODIAN DIRECTLY FOR
FURTHER INFORMATION ON THE-CUSTODY
PROCESS AND WHETHER OR NOT THEY REQUIRE
SEPARATE INSTRUCTIONS FROM-YOU |
|
|
|
|
|
|
|
|
|
| |
CMMT |
PLEASE NOTE SHARE BLOCKING
WILL APPLY FOR
ANY VOTED POSITIONS SETTLING-THROUGH
EUROCLEAR BANK. |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
09 MAR 2023: PLEASE NOTE THAT
THIS IS A
REVISION DUE TO ADDITION OF COMMENT.-IF YOU
HAVE ALREADY SENT IN YOUR VOTES, PLEASE DO
NOT VOTE AGAIN UNLESS YOU-DECIDE TO AMEND
YOUR ORIGINAL INSTRUCTIONS. THANK YOU |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
09
MAR 2023: INTERMEDIARY CLIENTS ONLY -
PLEASE NOTE THAT IF YOU ARE-CLASSIFIED AS AN
INTERMEDIARY CLIENT UNDER THE SHAREHOLDER
RIGHTS DIRECTIVE-II, YOU SHOULD BE PROVIDING
THE UNDERLYING SHAREHOLDER INFORMATION
AT THE-VOTE INSTRUCTION LEVEL. IF YOU ARE
UNSURE ON HOW TO PROVIDE THIS LEVEL OF-
DATA TO BROADRIDGE OUTSIDE OF PROXYEDGE,
PLEASE SPEAK TO YOUR DEDICATED-CLIENT
SERVICE REPRESENTATIVE FOR ASSISTANCE |
Non-Voting |
|
|
|
|
|
|
| |
IQVIA
HOLDINGS INC. |
|
|
| |
Security |
46266C105 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
IQV |
|
|
|
Meeting Date |
18-Apr-2023 |
|
| |
ISIN |
US46266C1053 |
|
|
|
Agenda |
935769628 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Carol
J. Burt |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Colleen
A. Goggins |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Sheila
A. Stamps |
Management |
|
For |
|
For |
|
|
| |
2. |
Approve an advisory (non-binding)
resolution to approve
IQVIA's executive compensation (say-on-pay). |
Management |
|
For |
|
For |
|
|
| |
3. |
Approve a Company proposal
to amend IQVIA's
Certificate of Incorporation to adopt a stockholders' right
to request a special stockholders' meeting. |
Management |
|
For |
|
For |
|
|
| |
4. |
If properly presented, a stockholder
proposal concerning
special stockholder meetings. |
Shareholder |
|
Against |
|
For |
|
|
| |
5. |
If properly presented, a stockholder
proposal for separate
Chairman and Chief Executive Officer roles. |
Shareholder |
|
Against |
|
For |
|
|
| |
6. |
Ratification of the appointment
of
PricewaterhouseCoopers LLP as IQVIA's independent
registered public accounting firm for 2023. |
Management |
|
For |
|
For |
|
|
| |
HCA
HEALTHCARE, INC. |
|
|
| |
Security |
40412C101 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
HCA |
|
|
|
Meeting Date |
19-Apr-2023 |
|
| |
ISIN |
US40412C1018 |
|
|
|
Agenda |
935776902 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Thomas
F. Frist III |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Samuel
N. Hazen |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Meg G.
Crofton |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Robert
J. Dennis |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Nancy-Ann
DeParle |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: William
R. Frist |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Hugh
F. Johnston |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Michael
W. Michelson |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Wayne
J. Riley, M.D. |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Andrea
B. Smith |
Management |
|
For |
|
For |
|
|
| |
2. |
To ratify the appointment of
Ernst & Young LLP as our
independent registered public accounting firm for the year
ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve the HCA Healthcare,
Inc. 2023 Employee
Stock Purchase Plan. |
Management |
|
For |
|
For |
|
|
| |
4. |
Advisory vote to approve named
executive officer
compensation. |
Management |
|
For |
|
For |
|
|
| |
5. |
Stockholder proposal, if properly
presented at the
meeting, regarding political spending disclosure. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
6. |
Stockholder proposal, if properly
presented at the
meeting, regarding amendment to Patient Safety and
Quality of Care Committee charter. |
Shareholder |
|
Against |
|
For |
|
|
| |
NESTLE
S.A. |
|
|
| |
Security |
H57312649 |
|
|
|
Meeting Type |
Annual General Meeting |
| |
Ticker Symbol |
NSRGY |
|
|
|
Meeting Date |
20-Apr-2023 |
|
| |
ISIN |
CH0038863350 |
|
|
|
Agenda |
716817068 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
CMMT |
VOTING MUST BE LODGED WITH
BENEFICIAL
OWNER DETAILS AS PROVIDED BY YOUR-
CUSTODIAN BANK. IF NO BENEFICIAL OWNER
DETAILS ARE PROVIDED, YOUR INSTRUCTION-MAY
BE REJECTED |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
PART
2 OF THIS MEETING IS FOR VOTING ON
AGENDA AND MEETING ATTENDANCE-REQUESTS
ONLY. PLEASE ENSURE THAT YOU HAVE FIRST
VOTED IN FAVOUR OF THE-REGISTRATION OF
SHARES IN PART 1 OF THE MEETING. IT IS A
MARKET REQUIREMENT-FOR MEETINGS OF THIS
TYPE THAT THE SHARES ARE REGISTERED AND
MOVED TO A-REGISTERED LOCATION AT THE CSD,
AND SPECIFIC POLICIES AT THE INDIVIDUAL-SUB-
CUSTODIANS MAY VARY. UPON RECEIPT OF THE
VOTE INSTRUCTION, IT IS POSSIBLE-THAT A
MARKER MAY BE PLACED ON YOUR SHARES TO
ALLOW FOR RECONCILIATION AND-RE-
REGISTRATION FOLLOWING A TRADE.THEREFORE
WHILST THIS DOES NOT PREVENT THE-TRADING
OF SHARES, ANY THAT ARE REGISTERED MUST BE
FIRST DEREGISTERED IF-REQUIRED FOR
SETTLEMENT. DEREGISTRATION CAN AFFECT THE
VOTING RIGHTS OF THOSE-SHARES. IF YOU HAVE
CONCERNS REGARDING YOUR ACCOUNTS,
PLEASE CONTACT YOUR-CLIENT
REPRESENTATIVE. |
Non-Voting |
|
|
|
|
|
|
| |
1.1 |
APPROVAL OF THE ANNUAL REVIEW,
THE
FINANCIAL STATEMENTS OF NESTLE S.A. AND THE
CONSOLIDATED FINANCIAL STATEMENTS OF THE
NESTLE GROUP FOR 2022 |
Management |
|
No Action |
|
|
|
|
| |
1.2 |
ACCEPTANCE OF THE COMPENSATION
REPORT
2022 (ADVISORY VOTE) |
Management |
|
No Action |
|
|
|
|
| |
2 |
DISCHARGE TO THE MEMBERS OF
THE BOARD OF
DIRECTORS AND OF THE MANAGEMENT FOR 2022 |
Management |
|
No Action |
|
|
|
|
| |
3 |
APPROPRIATION OF PROFIT RESULTING
FROM THE
BALANCE SHEET OF NESTLE S.A. (PROPOSED
DIVIDEND) FOR THE FINANCIAL YEAR 2022 |
Management |
|
No Action |
|
|
|
|
| |
4.1.1 |
RE-ELECTION AS MEMBER AND CHAIRMAN
OF THE
BOARD OF DIRECTORS: PAUL BULCKE |
Management |
|
No Action |
|
|
|
|
| |
4.1.2 |
RE-ELECTION AS MEMBER OF THE
BOARD OF
DIRECTORS: ULF MARK SCHNEIDER |
Management |
|
No Action |
|
|
|
|
| |
4.1.3 |
RE-ELECTION AS MEMBER OF THE
BOARD OF
DIRECTORS: HENRI DE CASTRIES |
Management |
|
No Action |
|
|
|
|
| |
4.1.4 |
RE-ELECTION AS MEMBER OF THE
BOARD OF
DIRECTORS: RENATO FASSBIND |
Management |
|
No Action |
|
|
|
|
| |
4.1.5 |
RE-ELECTION AS MEMBER OF THE
BOARD OF
DIRECTORS: PABLO ISLA |
Management |
|
No Action |
|
|
|
|
| |
4.1.6 |
RE-ELECTION AS MEMBER OF THE
BOARD OF
DIRECTORS: PATRICK AEBISCHER |
Management |
|
No Action |
|
|
|
|
| |
4.1.7 |
RE-ELECTION AS MEMBER OF THE
BOARD OF
DIRECTORS: KIMBERLY A. ROSS |
Management |
|
No Action |
|
|
|
|
| |
4.1.8 |
RE-ELECTION AS MEMBER OF THE
BOARD OF
DIRECTORS: DICK BOER |
Management |
|
No Action |
|
|
|
|
| |
4.1.9 |
RE-ELECTION AS MEMBER OF THE
BOARD OF
DIRECTORS: DINESH PALIWAL |
Management |
|
No Action |
|
|
|
|
| |
4.110 |
RE-ELECTION AS MEMBER OF THE
BOARD OF
DIRECTORS: HANNE JIMENEZ DE MORA |
Management |
|
No Action |
|
|
|
|
| |
4.111 |
RE-ELECTION AS MEMBER OF THE
BOARD OF
DIRECTORS: LINDIWE MAJELE SIBANDA |
Management |
|
No Action |
|
|
|
|
| |
4.112 |
RE-ELECTION AS MEMBER OF THE
BOARD OF
DIRECTORS: CHRIS LEONG |
Management |
|
No Action |
|
|
|
|
| |
4.113 |
RE-ELECTION AS MEMBER OF THE
BOARD OF
DIRECTORS: LUCA MAESTRI |
Management |
|
No Action |
|
|
|
|
| |
4.2.1 |
ELECTION TO THE BOARD OF DIRECTORS:
RAINER
BLAIR |
Management |
|
No Action |
|
|
|
|
| |
4.2.2 |
ELECTION TO THE BOARD OF DIRECTORS:
MARIE-
GABRIELLE INEICHEN-FLEISCH |
Management |
|
No Action |
|
|
|
|
| |
4.3.1 |
ELECTION AS MEMBER OF THE COMPENSATION
COMMITTEE: PABLO ISLA |
Management |
|
No Action |
|
|
|
|
| |
4.3.2 |
ELECTION AS MEMBER OF THE COMPENSATION
COMMITTEE: PATRICK AEBISCHER |
Management |
|
No Action |
|
|
|
|
| |
4.3.3 |
ELECTION AS MEMBER OF THE COMPENSATION
COMMITTEE: DICK BOER |
Management |
|
No Action |
|
|
|
|
| |
4.3.4 |
ELECTION AS MEMBER OF THE COMPENSATION
COMMITTEE: DINESH PALIWAL |
Management |
|
No Action |
|
|
|
|
| |
4.4 |
ELECTION OF THE STATUTORY AUDITORS:
ERNST
AND YOUNG LTD, LAUSANNE BRANCH |
Management |
|
No Action |
|
|
|
|
| |
4.5 |
ELECTION OF THE INDEPENDENT
REPRESENTATIVE: HARTMANN DREYER,
ATTORNEYS-AT-LAW |
Management |
|
No Action |
|
|
|
|
| |
5.1 |
APPROVAL OF THE COMPENSATION
OF THE BOARD
OF DIRECTORS |
Management |
|
No Action |
|
|
|
|
| |
5.2 |
APPROVAL OF THE COMPENSATION
OF THE
EXECUTIVE BOARD |
Management |
|
No Action |
|
|
|
|
| |
6 |
CAPITAL REDUCTION (BY CANCELLATION
OF
SHARES) |
Management |
|
No Action |
|
|
|
|
| |
7.1 |
AMENDMENTS OF PROVISIONS OF
THE ARTICLES
OF ASSOCIATION PERTAINING TO THE GENERAL
MEETING |
Management |
|
No Action |
|
|
|
|
| |
7.2 |
AMENDMENTS OF PROVISIONS OF
THE ARTICLES
OF ASSOCIATION PERTAINING TO THE BOARD OF
DIRECTORS, COMPENSATION, CONTRACTS AND
MANDATES AND MISCELLANEOUS PROVISIONS |
Management |
|
No Action |
|
|
|
|
| |
8 |
IN
THE EVENT OF ANY YET UNKNOWN NEW OR
MODIFIED PROPOSAL BY A SHAREHOLDER DURING
THE GENERAL MEETING, I INSTRUCT THE
INDEPENDENT REPRESENTATIVE TO VOTE AS
FOLLOWS: (YES = VOTE IN FAVOR OF ANY SUCH
YET UNKNOWN PROPOSAL, NO = VOTE AGAINST
ANY SUCH YET UNKNOWN PROPOSAL, ABSTAIN =
ABSTAIN FROM VOTING) - THE BOARD OF
DIRECTORS RECOMMENDS TO VOTE NO ON ANY
SUCH YET UNKNOWN PROPOSAL |
Shareholder |
|
No Action |
|
|
|
|
| |
BAUSCH
+ LOMB CORPORATION |
|
|
| |
Security |
071705107 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
BLCO |
|
|
|
Meeting Date |
24-Apr-2023 |
|
| |
ISIN |
CA0717051076 |
|
|
|
Agenda |
935776510 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Nathalie
Bernier |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Richard
U. De Schutter |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Gary
Hu |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Brett
Icahn |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Sarah
B. Kavanagh |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: John
A. Paulson |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Russel
C. Robertson |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Thomas
W. Ross, Sr. |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Brenton
L. Saunders |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Andrew
C. von Eschenbach |
Management |
|
For |
|
For |
|
|
| |
2. |
The approval, in an advisory
vote, of the compensation of
our Named Executive Officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
The approval, in an advisory
vote, of the frequency of
future advisory votes on named executive officer
compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
The approval of an amendment
and restatement of the
Bausch + Lomb Corporation 2022 Omnibus Incentive
Plan. |
Management |
|
Against |
|
Against |
|
|
| |
5. |
The appointment of PricewaterhouseCoopers
LLP to
serve as the Company's auditor until the close of the
2024 Annual Meeting of Shareholders and to authorize
the Board to fix the auditor's remuneration. |
Management |
|
For |
|
For |
|
|
| |
PERKINELMER,
INC. |
|
|
| |
Security |
714046109 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
PKI |
|
|
|
Meeting Date |
25-Apr-2023 |
|
| |
ISIN |
US7140461093 |
|
|
|
Agenda |
935776623 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director for a
term of one year: Peter Barrett,
PhD |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director for a
term of one year: Samuel R.
Chapin |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director for a
term of one year: Sylvie
Grégoire, PharmD |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director for a
term of one year: Michelle
McMurry-Heath, MD, PhD |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director for a
term of one year: Alexis P.
Michas |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director for a
term of one year: Prahlad R.
Singh, PhD |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director for a
term of one year: Michel
Vounatsos |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director for a
term of one year: Frank Witney,
PhD |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director for a
term of one year: Pascale Witz |
Management |
|
For |
|
For |
|
|
| |
2. |
To ratify the selection of
Deloitte & Touche LLP as
PerkinElmer's independent registered public accounting
firm for the current fiscal year. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve, by non-binding
advisory vote, our executive
compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
To recommend, by non-binding
advisory vote, the
frequency of future executive compensation advisory
votes. |
Management |
|
1 Year |
|
For |
|
|
| |
5. |
To approve the amendment of
the company's restated
articles of organization, as amended, to change the name
of the Company from PerkinElmer, Inc. to Revvity, Inc. |
Management |
|
For |
|
For |
|
|
| |
GALAPAGOS
N V |
|
|
| |
Security |
36315X101 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
GLPG |
|
|
|
Meeting Date |
25-Apr-2023 |
|
| |
ISIN |
US36315X1019 |
|
|
|
Agenda |
935800866 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
2. |
Acknowledgement and approval
of the non-consolidated
annual accounts of the Company for the financial year
ended on 31 December 2022, and approval of the
allocation of the annual result as proposed by the Board
of Directors. |
Management |
|
For |
|
For |
|
|
| |
5. |
Acknowledgement and approval
of the remuneration
report. |
Management |
|
Against |
|
Against |
|
|
| |
6. |
Release from liability to be
granted to the members of the
Board of Directors, the members of the former
Supervisory Board, and the statutory auditor for the
performance of their respective mandates during the
financial year ended on 31 December 2022. |
Management |
|
For |
|
For |
|
|
| |
7. |
Remuneration of the statutory
auditor for the financial
year ended on 31 December 2022. |
Management |
|
For |
|
For |
|
|
| |
8. |
Appointment of statutory auditor. |
Management |
|
For |
|
For |
|
|
| |
9. |
Re-appointment of Mr. Peter
Guenter as independent
director. |
Management |
|
For |
|
For |
|
|
| |
10. |
Re-appointment of Mr. Daniel
O'Day as director. |
Management |
|
For |
|
For |
|
|
| |
11. |
Re-appointment of Dr. Linda
Higgins as director. |
Management |
|
For |
|
For |
|
|
| |
BIO-RAD
LABORATORIES, INC. |
|
|
| |
Security |
090572207 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
BIO |
|
|
|
Meeting Date |
25-Apr-2023 |
|
| |
ISIN |
US0905722072 |
|
|
|
Agenda |
935806224 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1.1 |
Election of Director: Melinda
Litherland |
Management |
|
For |
|
For |
|
|
| |
1.2 |
Election of Director: Arnold
A. Pinkston |
Management |
|
For |
|
For |
|
|
| |
2. |
Proposal to ratify the selection
of KPMG LLP to serve as
the Company's independent auditors. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory vote to approve executive
compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
Advisory vote on the frequency
of future advisory votes to
approve executive compensation. |
Management |
|
3 Years |
|
For |
|
|
| |
5. |
Stockholder proposal regarding
political disclosure. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
GALAPAGOS
N V |
|
|
| |
Security |
36315X101 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
GLPG |
|
|
|
Meeting Date |
25-Apr-2023 |
|
| |
ISIN |
US36315X1019 |
|
|
|
Agenda |
935830631 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
2. |
Acknowledgement and approval
of the non-consolidated
annual accounts of the Company for the financial year
ended on 31 December 2022, and approval of the
allocation of the annual result as proposed by the Board
of Directors. |
Management |
|
For |
|
For |
|
|
| |
5. |
Acknowledgement and approval
of the remuneration
report. |
Management |
|
Against |
|
Against |
|
|
| |
6. |
Release from liability to be
granted to the members of the
Board of Directors, the members of the former
Supervisory Board, and the statutory auditor for the
performance of their respective mandates during the
financial year ended on 31 December 2022. |
Management |
|
For |
|
For |
|
|
| |
7. |
Remuneration of the statutory
auditor for the financial
year ended on 31 December 2022. |
Management |
|
For |
|
For |
|
|
| |
8. |
Appointment of statutory auditor. |
Management |
|
For |
|
For |
|
|
| |
9. |
Re-appointment of Mr. Peter
Guenter as independent
director. |
Management |
|
For |
|
For |
|
|
| |
10. |
Re-appointment of Mr. Daniel
O'Day as director. |
Management |
|
For |
|
For |
|
|
| |
11. |
Re-appointment of Dr. Linda
Higgins as director. |
Management |
|
For |
|
For |
|
|
| |
CALAVO
GROWERS, INC. |
|
|
| |
Security |
128246105 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
CVGW |
|
|
|
Meeting Date |
26-Apr-2023 |
|
| |
ISIN |
US1282461052 |
|
|
|
Agenda |
935772928 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Farha Aslam |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Marc L. Brown |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Michael A. DiGregorio |
|
|
|
For |
|
For |
|
|
| |
|
|
4 |
James D. Helin |
|
|
|
For |
|
For |
|
|
| |
|
|
5 |
Steven Hollister |
|
|
|
For |
|
For |
|
|
| |
|
|
6 |
Kathleen M. Holmgren |
|
|
|
For |
|
For |
|
|
| |
|
|
7 |
Brian Kocher |
|
|
|
Withheld |
|
Against |
|
|
| |
|
|
8 |
J. Link Leavens |
|
|
|
For |
|
For |
|
|
| |
|
|
9 |
Adriana G. Mendizabal |
|
|
|
For |
|
For |
|
|
| |
2. |
RATIFICATION OF APPOINTMENT
OF DELOITTE &
TOUCHE LLP AS INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM OF CALAVO GROWERS,
INC. FOR THE YEAR ENDING OCTOBER 31, 2023 |
Management |
|
For |
|
For |
|
|
| |
3. |
ADVISORY VOTE APPROVING THE
EXECUTIVE
COMPENSATION DISCLOSED IN THE
ACCOMPANYING PROXY STATEMENT |
Management |
|
For |
|
For |
|
|
| |
SMITH
& NEPHEW PLC |
|
|
| |
Security |
83175M205 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
SNN |
|
|
|
Meeting Date |
26-Apr-2023 |
|
| |
ISIN |
US83175M2052 |
|
|
|
Agenda |
935775063 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
O1 |
To receive the audited accounts
for the financial year
ended 31 December 2022. |
Management |
|
For |
|
For |
|
|
| |
O2 |
To approve the Directors' Remuneration
Policy. |
Management |
|
For |
|
For |
|
|
| |
O3 |
To approve the Directors' Remuneration
Report. |
Management |
|
For |
|
For |
|
|
| |
O4 |
To declare a final dividend. |
Management |
|
For |
|
For |
|
|
| |
O5 |
ELECTION OF DIRECTOR: Rupert
Soames OBE |
Management |
|
For |
|
For |
|
|
| |
O6 |
ELECTION OF DIRECTOR: Erik
Engstrom |
Management |
|
For |
|
For |
|
|
| |
O7 |
ELECTION OF DIRECTOR: Jo Hallas |
Management |
|
For |
|
For |
|
|
| |
O8 |
ELECTION OF DIRECTOR: John
Ma |
Management |
|
For |
|
For |
|
|
| |
O9 |
ELECTION OF DIRECTOR: Katarzyna
Mazur-Hofsaess |
Management |
|
For |
|
For |
|
|
| |
O10 |
ELECTION OF DIRECTOR: Rick
Medlock |
Management |
|
For |
|
For |
|
|
| |
O11 |
ELECTION OF DIRECTOR: Deepak
Nath |
Management |
|
For |
|
For |
|
|
| |
O12 |
ELECTION OF DIRECTOR: Anne-Françoise
Nesmes |
Management |
|
For |
|
For |
|
|
| |
O13 |
ELECTION OF DIRECTOR: Marc
Owen |
Management |
|
For |
|
For |
|
|
| |
O14 |
ELECTION OF DIRECTOR: Roberto
Quarta |
Management |
|
For |
|
For |
|
|
| |
O15 |
ELECTION OF DIRECTOR: Angie
Risley |
Management |
|
For |
|
For |
|
|
| |
O16 |
ELECTION OF DIRECTOR: Bob White |
Management |
|
For |
|
For |
|
|
| |
O17 |
To re-appoint KPMG LLP as the
Auditor. |
Management |
|
For |
|
For |
|
|
| |
O18 |
To authorise the Directors
to determine the remuneration
of the Auditor. |
Management |
|
For |
|
For |
|
|
| |
O19 |
To renew the authorisation
of the Directors to allot
shares. |
Management |
|
For |
|
For |
|
|
| |
S20 |
Directors given power to allot
equity securities in the
Company for cash through the sale of treasury shares. |
Management |
|
For |
|
For |
|
|
| |
S21 |
Directors given power to allot
equity securities in the
Company for cash through the sale of ordinary shares
held by the Company as treasury shares. |
Management |
|
For |
|
For |
|
|
| |
S22 |
That the Company be generally
and unconditionally
authorised to make market purchases of the Company's
own shares. |
Management |
|
For |
|
For |
|
|
| |
S23 |
To authorise general meetings
to be held on 14 clear
days' notice. |
Management |
|
For |
|
For |
|
|
| |
THE
CIGNA GROUP |
|
|
| |
Security |
125523100 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
CI |
|
|
|
Meeting Date |
26-Apr-2023 |
|
| |
ISIN |
US1255231003 |
|
|
|
Agenda |
935779073 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: David
M. Cordani |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: William
J. DeLaney |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Eric
J. Foss |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Retired
Maj. Gen. Elder Granger,
M.D. |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Neesha
Hathi |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: George
Kurian |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Kathleen
M. Mazzarella |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Mark
B. McClellan, M.D., Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Kimberly
A. Ross |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Eric
C. Wiseman |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: Donna
F. Zarcone |
Management |
|
For |
|
For |
|
|
| |
2. |
Advisory approval of The Cigna
Group's executive
compensation |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory approval of the frequency
of future advisory
votes on executive compensation |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Ratification of the appointment
of
PricewaterhouseCoopers LLP as The Cigna Group's
independent registered public accounting firm for 2023 |
Management |
|
For |
|
For |
|
|
| |
5. |
Approval of an amendment to
our Restated Certificate of
Incorporation to limit the liability of certain officers of the
Company as permitted pursuant to recent amendments
to the Delaware General Corporation Law |
Management |
|
For |
|
For |
|
|
| |
6. |
Shareholder proposal - Special
shareholder meeting
improvement |
Shareholder |
|
Against |
|
For |
|
|
| |
7. |
Shareholder proposal - Political
contributions report |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
KERRY
GROUP PLC |
|
|
| |
Security |
G52416107 |
|
|
|
Meeting Type |
Annual General Meeting |
| |
Ticker Symbol |
|
|
|
|
Meeting Date |
27-Apr-2023 |
|
| |
ISIN |
IE0004906560 |
|
|
|
Agenda |
716822918 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
CMMT |
VOTING MUST BE LODGED WITH
SHAREHOLDER
DETAILS AS PROVIDED BY YOUR CUSTODIAN-
BANK. IF NO SHAREHOLDER DETAILS ARE
PROVIDED, YOUR INSTRUCTIONS MAY BE-
REJECTED |
Non-Voting |
|
|
|
|
|
|
| |
1 |
TO REVIEW THE COMPANY'S AFFAIRS
AND TO
RECEIVE AND CONSIDER THE FINANCIAL
STATEMENTS FOR THE YEAR ENDED 31 DECEMBER
2022, TOGETHER WITH THE REPORTS OF THE
DIRECTORS AND THE AUDITORS THEREON |
Management |
|
No Action |
|
|
|
|
| |
2 |
TO
DECLARE A FINAL DIVIDEND: THIS IS A
RESOLUTION TO DECLARE A FINAL DIVIDEND OF
73.4 CENT PER A ORDINARY SHARE FOR THE YEAR
ENDED 31 DECEMBER 2022. IF APPROVED, THE
FINAL DIVIDEND WILL BE PAID ON 12 MAY 2023 TO
SHAREHOLDERS REGISTERED ON THE RECORD
DATE 14 APRIL 2023. THIS DIVIDEND IS IN ADDITION
TO THE INTERIM DIVIDEND OF 31.4 CENT PER
SHARE PAID TO SHAREHOLDERS ON 11 NOVEMBER
2022. |
Management |
|
No Action |
|
|
|
|
| |
3.A |
TO ELECT THE FOLLOWING DIRECTOR:
MR
PATRICK ROHAN |
Management |
|
No Action |
|
|
|
|
| |
4.A |
TO RE-ELECT THE FOLLOWING DIRECTOR:
MR
GERRY BEHAN |
Management |
|
No Action |
|
|
|
|
| |
4.B |
TO RE-ELECT THE FOLLOWING DIRECTOR:
DR
HUGH BRADY |
Management |
|
No Action |
|
|
|
|
| |
4.C |
TO RE-ELECT THE FOLLOWING DIRECTOR:
MS
FIONA DAWSON |
Management |
|
No Action |
|
|
|
|
| |
4.D |
TO RE-ELECT THE FOLLOWING DIRECTOR:
DR
KARIN DORREPAAL |
Management |
|
No Action |
|
|
|
|
| |
4.E |
TO RE-ELECT THE FOLLOWING DIRECTOR:
MS
EMER GILVARRY |
Management |
|
No Action |
|
|
|
|
| |
4.F |
TO RE-ELECT THE FOLLOWING DIRECTOR:
MR
MICHAEL KERR |
Management |
|
No Action |
|
|
|
|
| |
4.G |
TO RE-ELECT THE FOLLOWING DIRECTOR:
MS
MARGUERITE LARKIN |
Management |
|
No Action |
|
|
|
|
| |
4.H |
TO RE-ELECT THE FOLLOWING DIRECTOR:
MR TOM
MORAN |
Management |
|
No Action |
|
|
|
|
| |
4.I |
TO RE-ELECT THE FOLLOWING DIRECTOR:
MR
CHRISTOPHER ROGERS |
Management |
|
No Action |
|
|
|
|
| |
4.J |
TO RE-ELECT THE FOLLOWING DIRECTOR:
MR
EDMOND SCANLON |
Management |
|
No Action |
|
|
|
|
| |
4.K |
TO RE-ELECT THE FOLLOWING DIRECTOR:
MR
JINLONG WANG |
Management |
|
No Action |
|
|
|
|
| |
5 |
AUTHORITY TO DETERMINE THE
AUDITORS
REMUNERATION |
Management |
|
No Action |
|
|
|
|
| |
6 |
AUTHORITY TO CONVENE AN EXTRAORDINARY
GENERAL MEETING ON 14 DAYS NOTICE FOR THE
PASSING OF AN ORDINARY RESOLUTION |
Management |
|
No Action |
|
|
|
|
| |
7 |
TO RECEIVE AND CONSIDER THE
DIRECTORS'
REMUNERATION REPORT (EXCLUDING SECTION C) |
Management |
|
No Action |
|
|
|
|
| |
8 |
AUTHORITY TO ISSUE ORDINARY
SHARES |
Management |
|
No Action |
|
|
|
|
| |
9 |
AUTHORITY TO DISAPPLY PRE-EMPTION
RIGHTS |
Management |
|
No Action |
|
|
|
|
| |
10 |
AUTHORITY TO DISAPPLY PRE-EMPTION
RIGHTS
FOR AN ADDITIONAL 5 PERCENT FOR SPECIFIED
TRANSACTIONS |
Management |
|
No Action |
|
|
|
|
| |
11 |
AUTHORITY TO MAKE MARKET PURCHASES
OF THE
COMPANY'S OWN SHARES |
Management |
|
No Action |
|
|
|
|
| |
12 |
TO APPROVE THE KERRY GLOBAL
EMPLOYEE
SHARE PLAN |
Management |
|
No Action |
|
|
|
|
| |
CMMT |
29
MAR 2023: INTERMEDIARY CLIENTS ONLY -
PLEASE NOTE THAT IF YOU ARE-CLASSIFIED AS AN
INTERMEDIARY CLIENT UNDER THE SHAREHOLDER
RIGHTS DIRECTIVE-II, YOU SHOULD BE PROVIDING
THE UNDERLYING SHAREHOLDER INFORMATION
AT THE-VOTE INSTRUCTION LEVEL. IF YOU ARE
UNSURE ON HOW TO PROVIDE THIS LEVEL OF-
DATA TO BROADRIDGE OUTSIDE OF PROXYEDGE,
PLEASE SPEAK TO YOUR DEDICATED-CLIENT
SERVICE REPRESENTATIVE FOR ASSISTANCE |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
14 APR 2023: PLEASE NOTE THAT
THIS IS A
REVISION DUE TO ADDITION OF COMMENT-AND
CHANGE IN NUMBERING OF RESOLUTION 3.A . IF
YOU HAVE ALREADY SENT IN YOUR-VOTES,
PLEASE DO NOT VOTE AGAIN UNLESS YOU DECIDE
TO AMEND YOUR ORIGINAL-INSTRUCTIONS. THANK
YOU |
Non-Voting |
|
|
|
|
|
|
| |
DANONE
SA |
|
|
| |
Security |
F12033134 |
|
|
|
Meeting Type |
MIX |
| |
Ticker Symbol |
DANGY |
|
|
|
Meeting Date |
27-Apr-2023 |
|
| |
ISIN |
FR0000120644 |
|
|
|
Agenda |
716928532 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
CMMT |
FOR
SHAREHOLDERS NOT HOLDING SHARES
DIRECTLY WITH A FRENCH CUSTODIAN, VOTING-
INSTRUCTIONS WILL BE FORWARDED TO YOUR
GLOBAL CUSTODIAN ON VOTE DEADLINE-DATE.
THE GLOBAL CUSTODIAN AS THE REGISTERED
INTERMEDIARY WILL SIGN THE PROXY-CARD AND
FORWARD TO THE LOCAL CUSTODIAN FOR
LODGMENT. |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
FOR
FRENCH MEETINGS 'ABSTAIN' IS A VALID
VOTING OPTION. FOR ANY ADDITIONAL-
RESOLUTIONS RAISED AT THE MEETING THE
VOTING INSTRUCTION WILL DEFAULT TO-'AGAINST.'
IF YOUR CUSTODIAN IS COMPLETING THE PROXY
CARD, THE VOTING-INSTRUCTION WILL DEFAULT
TO THE PREFERENCE OF YOUR CUSTODIAN. |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
VOTING MUST BE LODGED WITH
SHAREHOLDER
DETAILS AS PROVIDED BY YOUR CUSTODIAN-
BANK. IF NO SHAREHOLDER DETAILS ARE
PROVIDED, YOUR INSTRUCTIONS MAY BE-
REJECTED. |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
FOR
SHAREHOLDERS HOLDING SHARES DIRECTLY
REGISTERED IN THEIR OWN NAME ON THE-
COMPANY SHARE REGISTER, YOU SHOULD
RECEIVE A PROXY CARD/VOTING FORM DIRECTLY-
FROM THE ISSUER. PLEASE SUBMIT YOUR VOTE
DIRECTLY BACK TO THE ISSUER VIA THE-PROXY
CARD/VOTING FORM, DO NOT SUBMIT YOUR VOTE
VIA BROADRIDGE-SYSTEMS/PLATFORMS OR YOUR
INSTRUCTIONS MAY BE REJECTED. |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
INTERMEDIARY
CLIENTS ONLY - PLEASE NOTE
THAT IF YOU ARE CLASSIFIED AS AN-
INTERMEDIARY CLIENT UNDER THE SHAREHOLDER
RIGHTS DIRECTIVE II, YOU SHOULD BE-PROVIDING
THE UNDERLYING SHAREHOLDER INFORMATION
AT THE VOTE INSTRUCTION-LEVEL. IF YOU ARE
UNSURE ON HOW TO PROVIDE THIS LEVEL OF
DATA TO BROADRIDGE-OUTSIDE OF PROXYEDGE,
PLEASE SPEAK TO YOUR DEDICATED CLIENT
SERVICE-REPRESENTATIVE FOR ASSISTANCE |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
PLEASE NOTE THAT IMPORTANT
ADDITIONAL
MEETING INFORMATION IS AVAILABLE BY-CLICKING
ON THE MATERIAL URL LINK:-https://www.journal-
officiel.gouv.fr/telechargements/BALO/pdf/2023/0405/202
304-052300677.pdf |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
PLEASE NOTE THAT THIS IS AN
AMENDMENT TO
MEETING ID 880519 DUE TO RECEIPT OF-UPDATED
AGENDA. ALL VOTES RECEIVED ON THE PREVIOUS
MEETING WILL BE-DISREGARDED AND YOU WILL
NEED TO REINSTRUCT ON THIS MEETING NOTICE.
THANK YOU |
Non-Voting |
|
|
|
|
|
|
| |
1 |
APPROVAL OF THE CORPORATE FINANCIAL
STATEMENTS FOR THE FINANCIAL YEAR ENDED 31
DECEMBER 2022 |
Management |
|
No Action |
|
|
|
|
| |
2 |
APPROVAL OF THE CONSOLIDATED
FINANCIAL
STATEMENTS FOR THE FINANCIAL YEAR ENDED 31
DECEMBER 2022 |
Management |
|
No Action |
|
|
|
|
| |
3 |
ALLOCATION OF INCOME FOR THE
FINANCIAL YEAR
ENDED 31 DECEMBER 2022 AND SETTING OF THE
DIVIDEND AT 2.00 EUROS PER SHARE |
Management |
|
No Action |
|
|
|
|
| |
4 |
RENEWAL OF THE TERM OF OFFICE
OF VALERIE
CHAPOULAUD-FLOQUET AS DIRECTOR |
Management |
|
No Action |
|
|
|
|
| |
5 |
RENEWAL OF THE TERM OF OFFICE
OF GILLES
SCHNEPP AS DIRECTOR |
Management |
|
No Action |
|
|
|
|
| |
6 |
RATIFICATION OF THE CO-OPTION
OF GILBERT
GHOSTINE AS DIRECTOR, AS A REPLACEMENT FOR
GUIDO BARILLA WHO RESIGNED |
Management |
|
No Action |
|
|
|
|
| |
7 |
RATIFICATION OF THE CO-OPTION
OF LISE KINGO
AS DIRECTOR, AS A REPLACEMENT FOR CECILE
CABANIS WHO RESIGNED |
Management |
|
No Action |
|
|
|
|
| |
8 |
APPROVAL OF THE INFORMATION
RELATING TO
THE REMUNERATION OF CORPORATE OFFICERS
MENTIONED IN SECTION I OF ARTICLE L.22-10-9 OF
THE FRENCH COMMERCIAL CODE FOR THE
FINANCIAL YEAR 2022 |
Management |
|
No Action |
|
|
|
|
| |
9 |
APPROVAL OF THE COMPENSATION
ELEMENTS
PAID DURING OR AWARDED FOR THE FINANCIAL
YEAR ENDED 31 DECEMBER 2022 TO ANTOINE DE
SAINT-AFFRIQUE, CHIEF EXECUTIVE OFFICER |
Management |
|
No Action |
|
|
|
|
| |
10 |
APPROVAL OF THE COMPENSATION
ELEMENTS
PAID DURING OR AWARDED FOR THE FINANCIAL
YEAR ENDED 31 DECEMBER 2022 TO GILLES
SCHNEPP, CHAIRMAN OF THE BOARD OF
DIRECTORS |
Management |
|
No Action |
|
|
|
|
| |
11 |
APPROVAL OF THE REMUNERATION
POLICY FOR
EXECUTIVE CORPORATE OFFICERS FOR THE
FINANCIAL YEAR 2023 |
Management |
|
No Action |
|
|
|
|
| |
12 |
APPROVAL OF THE REMUNERATION
POLICY FOR
THE CHAIRMAN OF THE BOARD OF DIRECTORS
FOR THE FINANCIAL YEAR 2023 |
Management |
|
No Action |
|
|
|
|
| |
13 |
APPROVAL OF THE REMUNERATION
POLICY FOR
DIRECTORS FOR THE FINANCIAL YEAR 2023 |
Management |
|
No Action |
|
|
|
|
| |
14 |
AUTHORISATION TO BE GRANTED
TO THE BOARD
OF DIRECTORS IN ORDER TO PURCHASE, HOLD OR
TRANSFER THE COMPANYS SHARES |
Management |
|
No Action |
|
|
|
|
| |
15 |
DELEGATION OF AUTHORITY TO
THE BOARD OF
DIRECTORS TO ISSUE COMMON SHARES AND
TRANSFERABLE SECURITIES, WITH RETENTION OF
THE SHAREHOLDERS PRE-EMPTIVE SUBSCRIPTION
RIGHT |
Management |
|
No Action |
|
|
|
|
| |
16 |
DELEGATION OF AUTHORITY TO
THE BOARD OF
DIRECTORS TO ISSUE COMMON SHARES AND
TRANSFERABLE SECURITIES, WITH CANCELLATION
OF THE SHAREHOLDERS PRE-EMPTIVE
SUBSCRIPTION RIGHT, BUT WITH AN OBLIGATION
TO GRANT A PRIORITY RIGHT |
Management |
|
No Action |
|
|
|
|
| |
17 |
DELEGATION OF AUTHORITY TO
THE BOARD OF
DIRECTORS IN THE EVENT OF A CAPITAL INCREASE
WITH CANCELLATION OF THE SHAREHOLDERS
PRE-EMPTIVE SUBSCRIPTION RIGHT, TO INCREASE
THE NUMBER OF SECURITIES TO BE ISSUED |
Management |
|
No Action |
|
|
|
|
| |
18 |
DELEGATION OF AUTHORITY TO
THE BOARD OF
DIRECTORS TO ISSUE COMMON SHARES AND
TRANSFERABLE SECURITIES, WITHOUT THE
SHAREHOLDERS PRE-EMPTIVE SUBSCRIPTION
RIGHT, IN THE EVENT OF A PUBLIC EXCHANGE
OFFER INITIATED BY THE COMPANY |
Management |
|
No Action |
|
|
|
|
| |
19 |
DELEGATION
OF POWERS TO THE BOARD OF
DIRECTORS FOR THE PURPOSE OF ISSUING
COMMON SHARES AND TRANSFERABLE
SECURITIES, WITHOUT THE SHAREHOLDERS PRE-
EMPTIVE SUBSCRIPTION RIGHT, IN ORDER TO
REMUNERATE CONTRIBUTIONS IN KIND GRANTED
TO THE COMPANY AND CONSISTING OF EQUITY
SECURITIES OR TRANSFERABLE SECURITIES
GRANTING ACCESS TO THE CAPITAL |
Management |
|
No Action |
|
|
|
|
| |
20 |
DELEGATION OF AUTHORITY TO
THE BOARD OF
DIRECTORS TO INCREASE THE COMPANYS
CAPITAL BY INCORPORATION OF RESERVES,
PROFITS, PREMIUMS OR OTHER AMOUNTS WHOSE
CAPITALIZATION WOULD BE ALLOWED |
Management |
|
No Action |
|
|
|
|
| |
21 |
DELEGATION
OF AUTHORITY TO THE BOARD OF
DIRECTORS TO ISSUE COMMON SHARES AND
TRANSFERABLE SECURITIES RESERVED FOR
EMPLOYEES WHO ARE MEMBERS OF A COMPANY
SAVINGS PLAN AND/OR THE TRANSFER OF
RESERVED SECURITIES, WITHOUT THE
SHAREHOLDERS PRE-EMPTIVE SUBSCRIPTION
RIGHT |
Management |
|
No Action |
|
|
|
|
| |
22 |
DELEGATION
OF AUTHORITY TO THE BOARD OF
DIRECTORS TO ISSUE COMMON SHARES AND
TRANSFERABLE SECURITIES GRANTING ACCESS
TO THE CAPITAL, WITH CANCELLATION OF THE
PRE-EMPTIVE SUBSCRIPTION RIGHT, RESERVED
FOR CATEGORIES OF BENEFICIARIES CONSISTING
OF EMPLOYEES WORKING IN FOREIGN COMPANIES
OF THE DANONE GROUP, OR IN A SITUATION OF
INTERNATIONAL MOBILITY, IN THE CONTEXT OF
EMPLOYEE SHAREHOLDING OPERATIONS |
Management |
|
No Action |
|
|
|
|
| |
23 |
AUTHORIZATION GRANTED TO THE
BOARD OF
DIRECTORS TO PROCEED WITH ALLOCATIONS OF
EXISTING OR FUTURE PERFORMANCE SHARES OF
THE COMPANY, WITHOUT THE SHAREHOLDERS
PRE-EMPTIVE SUBSCRIPTION RIGHT |
Management |
|
No Action |
|
|
|
|
| |
24 |
AUTHORIZATION GRANTED TO THE
BOARD OF
DIRECTORS TO REDUCE THE CAPITAL BY
CANCELLING SHARES |
Management |
|
No Action |
|
|
|
|
| |
25 |
POWERS TO CARRY OUT FORMALITIES |
Management |
|
No Action |
|
|
|
|
| |
26 |
APPOINTMENT OF SANJIV MEHTA
AS DIRECTOR |
Management |
|
No Action |
|
|
|
|
| |
CMMT |
11
APR 2023: PLEASE NOTE THAT IF YOU HOLD
CREST DEPOSITORY INTERESTS (CDIS)-AND
PARTICIPATE AT THIS MEETING, YOU (OR YOUR
CREST SPONSORED-MEMBER/CUSTODIAN) WILL BE
REQUIRED TO INSTRUCT A TRANSFER OF THE
RELEVANT-CDIS TO THE ESCROW ACCOUNT
SPECIFIED IN THE ASSOCIATED CORPORATE
EVENT IN THE-CREST SYSTEM. THIS TRANSFER
WILL NEED TO BE COMPLETED BY THE SPECIFIED
CREST-SYSTEM DEADLINE. ONCE THIS TRANSFER
HAS SETTLED, THE CDIS WILL BE BLOCKED IN-THE
CREST SYSTEM. THE CDIS WILL TYPICALLY BE
RELEASED FROM ESCROW AS SOON AS-
PRACTICABLE ON RECORD DATE +1 DAY (OR ON
MEETING DATE +1 DAY IF NO RECORD-DATE
APPLIES) UNLESS OTHERWISE SPECIFIED, AND
ONLY AFTER THE AGENT HAS-CONFIRMED
AVAILABILITY OF THE POSITION. IN ORDER FOR A
VOTE TO BE ACCEPTED,-THE VOTED POSITION
MUST BE BLOCKED IN THE REQUIRED ESCROW
ACCOUNT IN THE-CREST SYSTEM. BY VOTING ON
THIS MEETING, YOUR CREST SPONSORED-
MEMBER/CUSTODIAN MAY USE YOUR VOTE
INSTRUCTION AS THE AUTHORIZATION TO TAKE-
THE NECESSARY ACTION WHICH WILL INCLUDE
TRANSFERRING YOUR INSTRUCTED POSITION-TO
ESCROW. PLEASE CONTACT YOUR CREST
SPONSORED MEMBER/CUSTODIAN DIRECTLY FOR-
FURTHER INFORMATION ON THE CUSTODY
PROCESS AND WHETHER OR NOT THEY REQUIRE-
SEPARATE INSTRUCTIONS FROM YOU |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
11 APR 2023: PLEASE NOTE SHARE
BLOCKING WILL
APPLY FOR ANY VOTED POSITIONS-SETTLING
THROUGH EUROCLEAR BANK. |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
11 APR 2023: PLEASE NOTE THAT
THIS IS A
REVISION DUE TO ADDITION OF COMMENTS.-IF
YOU HAVE ALREADY SENT IN YOUR VOTES,
PLEASE DO NOT VOTE AGAIN UNLESS YOU-DECIDE
TO AMEND YOUR ORIGINAL INSTRUCTIONS. THANK
YOU |
Non-Voting |
|
|
|
|
|
|
| |
TREEHOUSE
FOODS, INC. |
|
|
| |
Security |
89469A104 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
THS |
|
|
|
Meeting Date |
27-Apr-2023 |
|
| |
ISIN |
US89469A1043 |
|
|
|
Agenda |
935775544 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Scott
D. Ostfeld |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Jean
E. Spence |
Management |
|
For |
|
For |
|
|
| |
2. |
Advisory vote to approve the
Company's executive
compensation. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory vote to approve the
frequency of future advisory
votes on the Company's executive compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Ratification of the selection
of Deloitte & Touche LLP as
the Company's independent registered public accounting
firm for fiscal year 2023. |
Management |
|
For |
|
For |
|
|
| |
5. |
Approval of amendments to the
Company's Certificate of
Incorporation to declassify the Board of Directors and
phase-in annual director elections. |
Management |
|
For |
|
For |
|
|
| |
6. |
Approval of the amendment and
restatement of the
TreeHouse Foods, Inc. Equity and Incentive Plan,
including an increase in the number of shares subject to
the plan. |
Management |
|
Against |
|
Against |
|
|
| |
JOHNSON
& JOHNSON |
|
|
| |
Security |
478160104 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
JNJ |
|
|
|
Meeting Date |
27-Apr-2023 |
|
| |
ISIN |
US4781601046 |
|
|
|
Agenda |
935776813 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Darius
Adamczyk |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Mary
C. Beckerle |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: D. Scott
Davis |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Jennifer
A. Doudna |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Joaquin
Duato |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Marillyn
A. Hewson |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Paula
A. Johnson |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Hubert
Joly |
Management |
|
For |
|
For |
|
|
| |
1I. |
Election of Director: Mark
B. McClellan |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Anne
M. Mulcahy |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: Mark
A. Weinberger |
Management |
|
For |
|
For |
|
|
| |
1l. |
Election of Director: Nadja
Y. West |
Management |
|
For |
|
For |
|
|
| |
2. |
Advisory Vote to Approve Named
Executive Officer
Compensation |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory Vote on the Frequency
of Voting to Approve
Named Executive Officer Compensation |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Ratification of Appointment
of PricewaterhouseCoopers
LLP as the Independent Registered Public Accounting
Firm |
Management |
|
For |
|
For |
|
|
| |
5. |
Proposal Withdrawn (Federal
Securities Laws Mandatory
Arbitration Bylaw) |
Shareholder |
|
Abstain |
|
|
|
|
| |
6. |
Vaccine Pricing Report |
Shareholder |
|
Against |
|
For |
|
|
| |
7. |
Executive Compensation Adjustment
Policy |
Shareholder |
|
Against |
|
For |
|
|
| |
8. |
Impact of Extended Patent Exclusivities
on Product
Access |
Shareholder |
|
Against |
|
For |
|
|
| |
PFIZER
INC. |
|
|
| |
Security |
717081103 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
PFE |
|
|
|
Meeting Date |
27-Apr-2023 |
|
| |
ISIN |
US7170811035 |
|
|
|
Agenda |
935778451 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Ronald
E. Blaylock |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Albert
Bourla |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Susan
Desmond-Hellmann |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Joseph
J. Echevarria |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Scott
Gottlieb |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Helen
H. Hobbs |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Susan
Hockfield |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Dan R.
Littman |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Shantanu
Narayen |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Suzanne
Nora Johnson |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: James
Quincey |
Management |
|
For |
|
For |
|
|
| |
1l. |
Election of Director: James
C. Smith |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratify the selection of KPMG
LLP as independent
registered public accounting firm for 2023 |
Management |
|
For |
|
For |
|
|
| |
3. |
2023 advisory approval of executive
compensation |
Management |
|
For |
|
For |
|
|
| |
4. |
Advisory vote on frequency
of future advisory votes to
approve executive compensation |
Management |
|
1 Year |
|
For |
|
|
| |
5. |
Shareholder proposal regarding
ratification of termination
pay |
Shareholder |
|
Against |
|
For |
|
|
| |
6. |
Shareholder proposal regarding
independent board
chairman policy |
Shareholder |
|
Against |
|
For |
|
|
| |
7. |
Shareholder proposal regarding
transfer of intellectual
property to potential COVID-19 manufacturers feasibility
report |
Shareholder |
|
Against |
|
For |
|
|
| |
8. |
Shareholder proposal regarding
impact of extended
patent exclusivities on product access report |
Shareholder |
|
Against |
|
For |
|
|
| |
9. |
Shareholder proposal regarding
political contributions
congruency report |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
LANTHEUS
HOLDINGS, INC. |
|
|
| |
Security |
516544103 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
LNTH |
|
|
|
Meeting Date |
27-Apr-2023 |
|
| |
ISIN |
US5165441032 |
|
|
|
Agenda |
935779403 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1.1 |
Election of Class II Director:
Ms. Minnie Baylor-Henry |
Management |
|
For |
|
For |
|
|
| |
1.2 |
Election of Class II Director:
Mr. Heinz Mäusli |
Management |
|
For |
|
For |
|
|
| |
1.3 |
Election of Class II Director:
Ms. Julie McHugh |
Management |
|
For |
|
For |
|
|
| |
2. |
The approval, on an advisory
basis, of the compensation
paid to our named executive officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
The approval of the Lantheus
Holdings, Inc. 2023
Employee Stock Purchase Plan. |
Management |
|
For |
|
For |
|
|
| |
4. |
The ratification of the appointment
of Deloitte & Touche
LLP as our independent registered public accounting firm
for the fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
INTUITIVE
SURGICAL, INC. |
|
|
| |
Security |
46120E602 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
ISRG |
|
|
|
Meeting Date |
27-Apr-2023 |
|
| |
ISIN |
US46120E6023 |
|
|
|
Agenda |
935779744 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Craig
H. Barratt, Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Joseph
C. Beery |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Gary
S. Guthart, Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Amal
M. Johnson |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Don R.
Kania, Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Amy L.
Ladd, M.D. |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Keith
R. Leonard, Jr. |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Alan
J. Levy, Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Jami
Dover Nachtsheim |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Monica
P. Reed, M.D. |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: Mark
J. Rubash |
Management |
|
For |
|
For |
|
|
| |
2. |
To approve, by advisory vote,
the compensation of the
Company's Named Executive Officers |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve, by advisory vote,
the frequency of the
advisory vote on the compensation of the Company's
Named Executive Officers. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
The ratification of appointment
of
PricewaterhouseCoopers LLP as the Company's
independent registered public accounting firm for the
fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
5. |
The stockholder proposal regarding
pay equity
disclosure. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
CHURCH
& DWIGHT CO., INC. |
|
|
| |
Security |
171340102 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
CHD |
|
|
|
Meeting Date |
27-Apr-2023 |
|
| |
ISIN |
US1713401024 |
|
|
|
Agenda |
935780622 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director for a
term of one year: Bradlen S.
Cashaw |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director for a
term of one year: Matthew T.
Farrell |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director for a
term of one year: Bradley C.
Irwin |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director for a
term of one year: Penry W. Price |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director for a
term of one year: Susan G.
Saideman |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director for a
term of one year: Ravichandra
K. Saligram |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director for a
term of one year: Robert K.
Shearer |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director for a
term of one year: Janet S.
Vergis |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director for a
term of one year: Arthur B.
Winkleblack |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director for a
term of one year: Laurie J. Yoler |
Management |
|
For |
|
For |
|
|
| |
2. |
An advisory vote to approve
compensation of our named
executive officers; |
Management |
|
For |
|
For |
|
|
| |
3. |
An advisory vote to approve
the preferred frequency of
the advisory vote on compensation of our named
executive officers. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Ratification of the appointment
of Deloitte & Touche LLP
as our independent registered public accounting firm for
2023. |
Management |
|
For |
|
For |
|
|
| |
5. |
Approval of the Church &
Dwight Co., Inc. Employee
Stock Purchase Plan. |
Management |
|
For |
|
For |
|
|
| |
6. |
Stockholder Proposal - Independent
Board Chairman. |
Shareholder |
|
Against |
|
For |
|
|
| |
ASTRAZENECA
PLC |
|
|
| |
Security |
046353108 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
AZN |
|
|
|
Meeting Date |
27-Apr-2023 |
|
| |
ISIN |
US0463531089 |
|
|
|
Agenda |
935796841 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
To receive the Company's Accounts,
the Reports of the
Directors and Auditor and the Strategic Report for the
year ended 31 December 2022 |
Management |
|
For |
|
For |
|
|
| |
2. |
To confirm dividends |
Management |
|
For |
|
For |
|
|
| |
3. |
To reappoint PricewaterhouseCoopers
LLP as Auditor |
Management |
|
For |
|
For |
|
|
| |
4. |
To authorise the Directors
to agree the remuneration of
the Auditor |
Management |
|
For |
|
For |
|
|
| |
5a. |
Re-election of Director: Michel
Demaré |
Management |
|
For |
|
For |
|
|
| |
5b. |
Re-election of Director: Pascal
Soriot |
Management |
|
For |
|
For |
|
|
| |
5c. |
Re-election of Director: Aradhana
Sarin |
Management |
|
For |
|
For |
|
|
| |
5d. |
Re-election of Director: Philip
Broadley |
Management |
|
For |
|
For |
|
|
| |
5e. |
Re-election of Director: Euan
Ashley |
Management |
|
For |
|
For |
|
|
| |
5f. |
Re-election of Director: Deborah
DiSanzo |
Management |
|
For |
|
For |
|
|
| |
5g. |
Re-election of Director: Diana
Layfield |
Management |
|
For |
|
For |
|
|
| |
5h. |
Re-election of Director: Sheri
McCoy |
Management |
|
For |
|
For |
|
|
| |
5i. |
Re-election of Director: Tony
Mok |
Management |
|
For |
|
For |
|
|
| |
5j. |
Re-election of Director: Nazneen
Rahman |
Management |
|
For |
|
For |
|
|
| |
5k. |
Re-election of Director: Andreas
Rummelt |
Management |
|
For |
|
For |
|
|
| |
5l. |
Re-election of Director: Marcus
Wallenberg |
Management |
|
For |
|
For |
|
|
| |
6. |
To approve the Annual Report
on Remuneration for the
year ended 31 December 2022 |
Management |
|
For |
|
For |
|
|
| |
7. |
To authorise limited political
donations |
Management |
|
For |
|
For |
|
|
| |
8. |
To authorise the Directors
to allot shares |
Management |
|
For |
|
For |
|
|
| |
9. |
To authorise the Directors
to disapply pre-emption rights
(Special Resolution) |
Management |
|
Abstain |
|
Against |
|
|
| |
10. |
To authorise the Directors
to further disapply pre-emption
rights for acquisitions and specified capital investments
(Special Resolution) |
Management |
|
For |
|
For |
|
|
| |
11. |
To authorise the Company to
purchase its own shares
(Special Resolution) |
Management |
|
For |
|
For |
|
|
| |
12. |
To reduce the notice period
for general meetings (Special
Resolution) |
Management |
|
For |
|
For |
|
|
| |
13. |
To adopt new Articles of Association
(Special Resolution) |
Management |
|
For |
|
For |
|
|
| |
CARDIOVASCULAR
SYSTEMS, INC. |
|
|
| |
Security |
141619106 |
|
|
|
Meeting Type |
Special |
| |
Ticker Symbol |
CSII |
|
|
|
Meeting Date |
27-Apr-2023 |
|
| |
ISIN |
US1416191062 |
|
|
|
Agenda |
935800880 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
To
adopt the Agreement and Plan of Merger, dated
February 8, 2023 (such agreement, as it may be
amended, modified or supplemented from time to time,
the "Merger Agreement"), by and among Cardiovascular
Systems, Inc. ("CSI"), Abbott Laboratories ("Abbott"), and
Cobra Acquisition Co. ("Merger Sub"). Upon the terms
and subject to the conditions of the Merger Agreement,
Abbott will acquire CSI via a merger of Merger Sub with
and into CSI, with CSI continuing as the surviving
corporation and a wholly owned subsidiary of Abbott (the
"Merger"). |
Management |
|
For |
|
For |
|
|
| |
2. |
To
approve, on an advisory (non-binding) basis, the
compensation that may be paid or become payable to
CSI's named executive officers that is based on or
otherwise relates to the Merger Agreement, the Merger,
and the other transactions contemplated by the Merger
Agreement. |
Management |
|
For |
|
For |
|
|
| |
3. |
To
adjourn the Special Meeting to a later date or dates, if
necessary or appropriate, including to solicit additional
proxies to approve the proposal to adopt the Merger
Agreement if there are insufficient votes to adopt the
Merger Agreement at the time of the Special Meeting. |
Management |
|
For |
|
For |
|
|
| |
NUVASIVE,
INC. |
|
|
| |
Security |
670704105 |
|
|
|
Meeting Type |
Special |
| |
Ticker Symbol |
NUVA |
|
|
|
Meeting Date |
27-Apr-2023 |
|
| |
ISIN |
US6707041058 |
|
|
|
Agenda |
935811352 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
To
adopt the Agreement and Plan of Merger, dated
February 8, 2023 (which agreement is referred to as the
"Merger Agreement"), by and among Globus Medical,
Inc., Zebra Merger Sub, Inc., and NuVasive, Inc.
("NuVasive"), as it may be amended from time to time
(which proposal is referred to as the "NuVasive Merger
Proposal"). |
Management |
|
For |
|
For |
|
|
| |
2. |
To approve, on a non-binding
advisory basis, the
compensation that may be paid or become payable to
NuVasive named executive officers that is based on or
otherwise relates to the transactions contemplated by the
Merger Agreement. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve the adjournment
of the NuVasive special
meeting, if necessary or appropriate, to solicit additional
proxies if there are insufficient votes at the time of the
NuVasive special meeting to approve the NuVasive
Merger Proposal. |
Management |
|
For |
|
For |
|
|
| |
GLOBUS
MEDICAL, INC. |
|
|
| |
Security |
379577208 |
|
|
|
Meeting Type |
Special |
| |
Ticker Symbol |
GMED |
|
|
|
Meeting Date |
27-Apr-2023 |
|
| |
ISIN |
US3795772082 |
|
|
|
Agenda |
935813964 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
To
approve the issuance of shares of Class A common
stock, par value $0.001 per share, of Globus Medical,
Inc. ("Globus") in connection with the merger
contemplated by the Agreement and Plan of Merger,
dated as of February 8, 2023, by and among Globus,
NuVasive, Inc. and Zebra Merger Sub, Inc. (the "Globus
Share Issuance Proposal"). |
Management |
|
For |
|
For |
|
|
| |
2. |
To
approve adjournments of the special meeting from
time to time, if necessary or appropriate, including to
solicit additional proxies in favor of the Globus Share
Issuance Proposal if there are insufficient votes at the
time of such adjournment to approve such proposal. |
Management |
|
For |
|
For |
|
|
| |
ASTRAZENECA
PLC |
|
|
| |
Security |
046353108 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
AZN |
|
|
|
Meeting Date |
27-Apr-2023 |
|
| |
ISIN |
US0463531089 |
|
|
|
Agenda |
935820793 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
To receive the Company's Accounts,
the Reports of the
Directors and Auditor and the Strategic Report for the
year ended 31 December 2022 |
Management |
|
For |
|
For |
|
|
| |
2. |
To confirm dividends |
Management |
|
For |
|
For |
|
|
| |
3. |
To reappoint PricewaterhouseCoopers
LLP as Auditor |
Management |
|
For |
|
For |
|
|
| |
4. |
To authorise the Directors
to agree the remuneration of
the Auditor |
Management |
|
For |
|
For |
|
|
| |
5a. |
Re-election of Director: Michel
Demaré |
Management |
|
For |
|
For |
|
|
| |
5b. |
Re-election of Director: Pascal
Soriot |
Management |
|
For |
|
For |
|
|
| |
5c. |
Re-election of Director: Aradhana
Sarin |
Management |
|
For |
|
For |
|
|
| |
5d. |
Re-election of Director: Philip
Broadley |
Management |
|
For |
|
For |
|
|
| |
5e. |
Re-election of Director: Euan
Ashley |
Management |
|
For |
|
For |
|
|
| |
5f. |
Re-election of Director: Deborah
DiSanzo |
Management |
|
For |
|
For |
|
|
| |
5g. |
Re-election of Director: Diana
Layfield |
Management |
|
For |
|
For |
|
|
| |
5h. |
Re-election of Director: Sheri
McCoy |
Management |
|
For |
|
For |
|
|
| |
5i. |
Re-election of Director: Tony
Mok |
Management |
|
For |
|
For |
|
|
| |
5j. |
Re-election of Director: Nazneen
Rahman |
Management |
|
For |
|
For |
|
|
| |
5k. |
Re-election of Director: Andreas
Rummelt |
Management |
|
For |
|
For |
|
|
| |
5l. |
Re-election of Director: Marcus
Wallenberg |
Management |
|
For |
|
For |
|
|
| |
6. |
To approve the Annual Report
on Remuneration for the
year ended 31 December 2022 |
Management |
|
For |
|
For |
|
|
| |
7. |
To authorise limited political
donations |
Management |
|
For |
|
For |
|
|
| |
8. |
To authorise the Directors
to allot shares |
Management |
|
For |
|
For |
|
|
| |
9. |
To authorise the Directors
to disapply pre-emption rights
(Special Resolution) |
Management |
|
Abstain |
|
Against |
|
|
| |
10. |
To authorise the Directors
to further disapply pre-emption
rights for acquisitions and specified capital investments
(Special Resolution) |
Management |
|
For |
|
For |
|
|
| |
11. |
To authorise the Company to
purchase its own shares
(Special Resolution) |
Management |
|
For |
|
For |
|
|
| |
12. |
To reduce the notice period
for general meetings (Special
Resolution) |
Management |
|
For |
|
For |
|
|
| |
13. |
To adopt new Articles of Association
(Special Resolution) |
Management |
|
For |
|
For |
|
|
| |
KELLOGG
COMPANY |
|
|
| |
Security |
487836108 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
K |
|
|
|
Meeting Date |
28-Apr-2023 |
|
| |
ISIN |
US4878361082 |
|
|
|
Agenda |
935773540 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director (term
expires 2026): Stephanie Burns |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director (term
expires 2026): Steve Cahillane |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director (term
expires 2026): La June
Montgomery Tabron |
Management |
|
For |
|
For |
|
|
| |
2. |
Advisory resolution to approve
executive compensation. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory vote on the frequency
of holding an advisory
vote on executive compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Ratification of the appointment
of
PricewaterhouseCoopers LLP as Kellogg's independent
registered public accounting firm for fiscal year 2023. |
Management |
|
For |
|
For |
|
|
| |
5. |
Shareowner proposal requesting
a civil rights,
nondiscrimination and return to merits audit, if properly
presented at the meeting. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
6. |
Shareowner proposal requesting
additional reporting on
pay equity disclosure, if properly presented at the
meeting. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
ABBOTT
LABORATORIES |
|
|
| |
Security |
002824100 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
ABT |
|
|
|
Meeting Date |
28-Apr-2023 |
|
| |
ISIN |
US0028241000 |
|
|
|
Agenda |
935777865 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: R. J.
Alpern |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: C. Babineaux-Fontenot |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: S. E.
Blount |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: R. B.
Ford |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: P. Gonzalez |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: M. A.
Kumbier |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: D. W.
McDew |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: N. McKinstry |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: M. G.
O'Grady |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: M. F.
Roman |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: D. J.
Starks |
Management |
|
For |
|
For |
|
|
| |
1l. |
Election of Director: J. G.
Stratton |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of Ernst &
Young LLP As Auditors |
Management |
|
For |
|
For |
|
|
| |
3. |
Say on Pay - An Advisory Vote
on the Approval of
Executive Compensation |
Management |
|
For |
|
For |
|
|
| |
4. |
Say When on Pay - An Advisory
Vote on the Approval of
the Frequency of Shareholder Votes on Executive
Compensation |
Management |
|
1 Year |
|
For |
|
|
| |
5. |
Shareholder Proposal - Special
Shareholder Meeting
Threshold |
Shareholder |
|
Against |
|
For |
|
|
| |
6. |
Shareholder Proposal - Independent
Board Chairman |
Shareholder |
|
Against |
|
For |
|
|
| |
7. |
Shareholder Proposal - Lobbying
Disclosure |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
8. |
Shareholder Proposal - Incentive
Compensation |
Shareholder |
|
Against |
|
For |
|
|
| |
BAXTER
INTERNATIONAL INC. |
|
|
| |
Security |
071813109 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
BAX |
|
|
|
Meeting Date |
02-May-2023 |
|
| |
ISIN |
US0718131099 |
|
|
|
Agenda |
935786218 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: José
(Joe) Almeida |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Michael
F. Mahoney |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Patricia
B. Morrison |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Stephen
N. Oesterle |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Nancy
M. Schlichting |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Brent
Shafer |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Cathy
R. Smith |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Amy A.
Wendell |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: David
S. Wilkes |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Peter
M. Wilver |
Management |
|
For |
|
For |
|
|
| |
2. |
Advisory Vote to Approve Named
Executive Officer
Compensation. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory Vote on the Frequency
of Executive
Compensation Advisory Votes. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Ratification of Appointment
of Independent Registered
Public Accounting Firm. |
Management |
|
For |
|
For |
|
|
| |
5. |
Stockholder Proposal - Shareholder
Ratification of
Excessive Termination Pay. |
Shareholder |
|
Against |
|
For |
|
|
| |
6. |
Stockholder Proposal - Executives
to Retain Significant
Stock. |
Shareholder |
|
Against |
|
For |
|
|
| |
BRISTOL-MYERS
SQUIBB COMPANY |
|
|
| |
Security |
110122108 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
BMY |
|
|
|
Meeting Date |
02-May-2023 |
|
| |
ISIN |
US1101221083 |
|
|
|
Agenda |
935788286 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1A. |
Election of Director: Peter
J. Arduini |
Management |
|
For |
|
For |
|
|
| |
1B. |
Election of Director: Deepak
L. Bhatt, M.D., M.P.H. |
Management |
|
For |
|
For |
|
|
| |
1C. |
Election of Director: Giovanni
Caforio, M.D. |
Management |
|
For |
|
For |
|
|
| |
1D. |
Election of Director: Julia
A. Haller, M.D. |
Management |
|
For |
|
For |
|
|
| |
1E. |
Election of Director: Manuel
Hidalgo Medina, M.D., Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1F. |
Election of Director: Paula
A. Price |
Management |
|
For |
|
For |
|
|
| |
1G. |
Election of Director: Derica
W. Rice |
Management |
|
For |
|
For |
|
|
| |
1H. |
Election of Director: Theodore
R. Samuels |
Management |
|
For |
|
For |
|
|
| |
1I. |
Election of Director: Gerald
L. Storch |
Management |
|
For |
|
For |
|
|
| |
1J. |
Election of Director: Karen
H. Vousden, Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1K. |
Election of Director: Phyllis
R. Yale |
Management |
|
For |
|
For |
|
|
| |
2. |
Advisory Vote to Approve the
Compensation of our
Named Executive Officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory Vote on the Frequency
of the Advisory Vote on
the Compensation of our Named Executive Officers. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Ratification of the Appointment
of an Independent
Registered Public Accounting Firm. |
Management |
|
For |
|
For |
|
|
| |
5. |
Shareholder Proposal on the
Adoption of a Board Policy
that the Chairperson of the Board be an Independent
Director. |
Shareholder |
|
Against |
|
For |
|
|
| |
6. |
Shareholder Proposal on Workplace
Non-Discrimination
Audit. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
7. |
Shareholder Proposal on Special
Shareholder Meeting
Improvement. |
Shareholder |
|
Against |
|
For |
|
|
| |
PEPSICO,
INC. |
|
|
| |
Security |
713448108 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
PEP |
|
|
|
Meeting Date |
03-May-2023 |
|
| |
ISIN |
US7134481081 |
|
|
|
Agenda |
935784795 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Segun
Agbaje |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Jennifer
Bailey |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Cesar
Conde |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Ian Cook |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Edith
W. Cooper |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Susan
M. Diamond |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Dina
Dublon |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Michelle
Gass |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Ramon
L. Laguarta |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Dave
J. Lewis |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: David
C. Page |
Management |
|
For |
|
For |
|
|
| |
1l. |
Election of Director: Robert
C. Pohlad |
Management |
|
For |
|
For |
|
|
| |
1m. |
Election of Director: Daniel
Vasella |
Management |
|
For |
|
For |
|
|
| |
1n. |
Election of Director: Darren
Walker |
Management |
|
For |
|
For |
|
|
| |
1o. |
Election of Director: Alberto
Weisser |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of the appointment
of KPMG LLP as the
Company's independent registered public accounting firm
for fiscal year 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory approval of the Company's
executive
compensation |
Management |
|
For |
|
For |
|
|
| |
4. |
Advisory vote on frequency
of future shareholder
advisory approval of the Company's executive
compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
5. |
Shareholder Proposal - Independent
Board Chair. |
Shareholder |
|
Against |
|
For |
|
|
| |
6. |
Shareholder Proposal - Global
Transparency Report. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
7. |
Shareholder Proposal - Report
on Impacts of
Reproductive Healthcare Legislation |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
8. |
Shareholder Proposal - Congruency
Report on Net-Zero
Emissions Policies. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
INTERNATIONAL
FLAVORS & FRAGRANCES INC. |
|
|
| |
Security |
459506101 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
IFF |
|
|
|
Meeting Date |
03-May-2023 |
|
| |
ISIN |
US4595061015 |
|
|
|
Agenda |
935785470 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director for a
one-year term expiring at the
2024 Annual Meeting of Shareholders: Kathryn J. Boor |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director for a
one-year term expiring at the
2024 Annual Meeting of Shareholders: Barry A. Bruno |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director for a
one-year term expiring at the
2024 Annual Meeting of Shareholders: Frank K. Clyburn,
Jr. |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director for a
one-year term expiring at the
2024 Annual Meeting of Shareholders: Mark J. Costa |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director for a
one-year term expiring at the
2024 Annual Meeting of Shareholders: Carol Anthony
(John) Davidson |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director for a
one-year term expiring at the
2024 Annual Meeting of Shareholders: Roger W.
Ferguson, Jr. |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director for a
one-year term expiring at the
2024 Annual Meeting of Shareholders: John F. Ferraro |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director for a
one-year term expiring at the
2024 Annual Meeting of Shareholders: Christina Gold |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director for a
one-year term expiring at the
2024 Annual Meeting of Shareholders: Gary Hu |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director for a
one-year term expiring at the
2024 Annual Meeting of Shareholders: Kevin O'Byrne |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director for a
one-year term expiring at the
2024 Annual Meeting of Shareholders: Dawn C.
Willoughby |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratify the selection of PricewaterhouseCoopers
LLP as
our independent registered public accounting firm for the
2023 fiscal year. |
Management |
|
For |
|
For |
|
|
| |
3. |
Approve, on an advisory basis,
the compensation of our
named executive officers in 2022. |
Management |
|
For |
|
For |
|
|
| |
4. |
Vote, on an advisory basis,
on the frequency of votes on
executive compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
VERICEL
CORPORATION |
|
|
| |
Security |
92346J108 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
VCEL |
|
|
|
Meeting Date |
03-May-2023 |
|
| |
ISIN |
US92346J1088 |
|
|
|
Agenda |
935786674 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Robert L. Zerbe |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Alan L. Rubino |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Heidi Hagen |
|
|
|
For |
|
For |
|
|
| |
|
|
4 |
Steven C. Gilman |
|
|
|
For |
|
For |
|
|
| |
|
|
5 |
Kevin F. McLaughlin |
|
|
|
For |
|
For |
|
|
| |
|
|
6 |
Paul K. Wotton |
|
|
|
For |
|
For |
|
|
| |
|
|
7 |
Dominick C. Colangelo |
|
|
|
For |
|
For |
|
|
| |
|
|
8 |
Lisa Wright |
|
|
|
For |
|
For |
|
|
| |
2. |
To approve, on an advisory
basis, the compensation of
Vericel Corporation's named executive officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
To ratify the appointment of
PricewaterhouseCoopers
LLP as Vericel Corporation's independent registered
public accounting firm for the fiscal year ending
December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
UNILEVER
PLC |
|
|
| |
Security |
904767704 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
UL |
|
|
|
Meeting Date |
03-May-2023 |
|
| |
ISIN |
US9047677045 |
|
|
|
Agenda |
935793124 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
To receive the Report and Accounts
for the year ended
31 December 2022. |
Management |
|
For |
|
For |
|
|
| |
2. |
To approve the Directors' Remuneration
Report. |
Management |
|
Against |
|
Against |
|
|
| |
3. |
To re-elect Nils Andersen as
a Director. |
Management |
|
For |
|
For |
|
|
| |
4. |
To re-elect Judith Hartmann
as a Director. |
Management |
|
For |
|
For |
|
|
| |
5. |
To re-elect Adrian Hennah as
a Director. |
Management |
|
For |
|
For |
|
|
| |
6. |
To re-elect Alan Jope as a
Director. |
Management |
|
For |
|
For |
|
|
| |
7. |
To re-elect Andrea Jung as
a Director. |
Management |
|
For |
|
For |
|
|
| |
8. |
To re-elect Susan Kilsby as
a Director. |
Management |
|
For |
|
For |
|
|
| |
9. |
To re-elect Ruby Lu as a Director. |
Management |
|
For |
|
For |
|
|
| |
10. |
To re-elect Strive Masiyiwa
as a Director. |
Management |
|
For |
|
For |
|
|
| |
11. |
To re-elect Youngme Moon as
a Director. |
Management |
|
For |
|
For |
|
|
| |
12. |
To re-elect Graeme Pitkethly
as a Director. |
Management |
|
For |
|
For |
|
|
| |
13. |
To re-elect Feike Sijbesma
as a Director. |
Management |
|
For |
|
For |
|
|
| |
14. |
To elect Nelson Peltz as a
Director. |
Management |
|
For |
|
For |
|
|
| |
15. |
To elect Hein Schumacher as
a Director. |
Management |
|
For |
|
For |
|
|
| |
16. |
To reappoint KPMG LLP as Auditor
of the Company. |
Management |
|
For |
|
For |
|
|
| |
17. |
To authorise the Directors
to fix the remuneration of the
Auditor. |
Management |
|
For |
|
For |
|
|
| |
18. |
To authorise Political Donations
and expenditure. |
Management |
|
For |
|
For |
|
|
| |
19. |
To renew the authority to Directors
to issue shares. |
Management |
|
For |
|
For |
|
|
| |
20. |
To renew the authority to Directors
to disapply pre-
emption rights. |
Management |
|
Abstain |
|
Against |
|
|
| |
21. |
To renew the authority to Directors
to disapply pre-
emption rights for the purposes of acquisitions or capital
investments. |
Management |
|
For |
|
For |
|
|
| |
22. |
To renew the authority to the
Company to purchase its
own shares. |
Management |
|
For |
|
For |
|
|
| |
23. |
To shorten the notice period
for General Meetings to 14
clear days' notice. |
Management |
|
For |
|
For |
|
|
| |
IDORSIA
LTD |
|
|
| |
Security |
H3879B109 |
|
|
|
Meeting Type |
Annual General Meeting |
| |
Ticker Symbol |
|
|
|
|
Meeting Date |
04-May-2023 |
|
| |
ISIN |
CH0363463438 |
|
|
|
Agenda |
716957064 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
CMMT |
VOTING MUST BE LODGED WITH
BENEFICIAL
OWNER DETAILS AS PROVIDED BY YOUR-
CUSTODIAN BANK. IF NO BENEFICIAL OWNER
DETAILS ARE PROVIDED, YOUR INSTRUCTION-MAY
BE REJECTED. |
Non-Voting |
|
|
|
|
|
|
| |
1.1 |
ACCEPT FINANCIAL STATEMENTS
AND STATUTORY
REPORTS |
Management |
|
No Action |
|
|
|
|
| |
1.2 |
APPROVE REMUNERATION REPORT
(NON-BINDING) |
Management |
|
No Action |
|
|
|
|
| |
2 |
APPROVE TREATMENT OF NET LOSS |
Management |
|
No Action |
|
|
|
|
| |
3 |
APPROVE DISCHARGE OF BOARD
AND SENIOR
MANAGEMENT |
Management |
|
No Action |
|
|
|
|
| |
4.1.1 |
REELECT MATHIEU SIMON AS DIRECTOR |
Management |
|
No Action |
|
|
|
|
| |
4.1.2 |
REELECT JOERN ALDAG AS DIRECTOR |
Management |
|
No Action |
|
|
|
|
| |
4.1.3 |
REELECT JEAN-PAUL CLOZEL AS
DIRECTOR |
Management |
|
No Action |
|
|
|
|
| |
4.1.4 |
REELECT FELIX EHRAT AS DIRECTOR |
Management |
|
No Action |
|
|
|
|
| |
4.1.5 |
REELECT SRISHTI GUPTA AS DIRECTOR |
Management |
|
No Action |
|
|
|
|
| |
4.1.6 |
REELECT PETER KELLOGG AS DIRECTOR |
Management |
|
No Action |
|
|
|
|
| |
4.1.7 |
REELECT SANDY MAHATME AS DIRECTOR |
Management |
|
No Action |
|
|
|
|
| |
4.1.8 |
ELECT SOPHIE KORNOWSKI AS DIRECTOR |
Management |
|
No Action |
|
|
|
|
| |
4.2 |
REELECT MATHIEU SIMON AS BOARD
CHAIR |
Management |
|
No Action |
|
|
|
|
| |
4.3.1 |
REAPPOINT FELIX EHRAT AS CHAIRMAN
OF THE
NOMINATION, COMPENSATION AND GOVERNANCE
COMMITTEE |
Management |
|
No Action |
|
|
|
|
| |
4.3.2 |
REAPPOINT SRISHTI GUPTA AS
MEMBER OF THE
NOMINATION, COMPENSATION AND GOVERNANCE
COMMITTEE |
Management |
|
No Action |
|
|
|
|
| |
4.3.3 |
REAPPOINT MATHIEU SIMON AS
MEMBER OF THE
NOMINATION, COMPENSATION AND GOVERNANCE
COMMITTEE |
Management |
|
No Action |
|
|
|
|
| |
4.3.4 |
APPOINT SOPHIE KORNOWSKI AS
MEMBER OF THE
NOMINATION, COMPENSATION AND GOVERNANCE
COMMITTEE |
Management |
|
No Action |
|
|
|
|
| |
5.1 |
APPROVE REMUNERATION OF DIRECTORS
IN THE
AMOUNT OF CHF 1.5 MILLION |
Management |
|
No Action |
|
|
|
|
| |
5.2 |
APPROVE REMUNERATION OF EXECUTIVE
COMMITTEE IN THE AMOUNT OF CHF 17.2 MILLION |
Management |
|
No Action |
|
|
|
|
| |
6 |
DESIGNATE BACHMANNPARTNER AG
AS
INDEPENDENT PROXY |
Management |
|
No Action |
|
|
|
|
| |
7 |
RATIFY ERNST & YOUNG AG
AS AUDITORS |
Management |
|
No Action |
|
|
|
|
| |
8.1 |
AMEND CORPORATE PURPOSE |
Management |
|
No Action |
|
|
|
|
| |
8.2 |
APPROVE CREATION OF CHF 1.3
MILLION POOL OF
CONDITIONAL CAPITAL FOR EMPLOYEE EQUITY
PARTICIPATION |
Management |
|
No Action |
|
|
|
|
| |
8.3 |
APPROVE CREATION OF CAPITAL
BAND WITHIN
THE UPPER LIMIT OF CHF 14.1 MILLION AND THE
LOWER LIMIT OF CHF 4.7 MILLION WITH OR
WITHOUT EXCLUSION OF PREEMPTIVE RIGHTS |
Management |
|
No Action |
|
|
|
|
| |
8.4 |
AMEND ARTICLES RE: SHARES AND
SHARE
REGISTER |
Management |
|
No Action |
|
|
|
|
| |
8.5 |
AMEND ARTICLES OF ASSOCIATION
(INCL.
APPROVAL OF VIRTUAL-ONLY OR HYBRID
SHAREHOLDER MEETINGS) |
Management |
|
No Action |
|
|
|
|
| |
8.6 |
AMEND ARTICLES RE: BOARD OF
DIRECTORS;
COMPENSATION; EXTERNAL MANDATES FOR
MEMBERS OF THE BOARD OF DIRECTORS AND
EXECUTIVE COMMITTEE |
Management |
|
No Action |
|
|
|
|
| |
CMMT |
PART
2 OF THIS MEETING IS FOR VOTING ON
AGENDA AND MEETING ATTENDANCE-REQUESTS
ONLY. PLEASE ENSURE THAT YOU HAVE FIRST
VOTED IN FAVOUR OF THE-REGISTRATION OF
SHARES IN PART 1 OF THE MEETING. IT IS A
MARKET REQUIREMENT-FOR MEETINGS OF THIS
TYPE THAT THE SHARES ARE REGISTERED AND
MOVED TO A-REGISTERED LOCATION AT THE CSD,
AND SPECIFIC POLICIES AT THE INDIVIDUAL-SUB-
CUSTODIANS MAY VARY. UPON RECEIPT OF THE
VOTE INSTRUCTION, IT IS POSSIBLE-THAT A
MARKER MAY BE PLACED ON YOUR SHARES TO
ALLOW FOR RECONCILIATION AND-RE-
REGISTRATION FOLLOWING A TRADE. THEREFORE
WHILST THIS DOES NOT PREVENT THE-TRADING
OF SHARES, ANY THAT ARE REGISTERED MUST BE
FIRST DEREGISTERED IF-REQUIRED FOR
SETTLEMENT. DEREGISTRATION CAN AFFECT THE
VOTING RIGHTS OF THOSE-SHARES. IF YOU HAVE
CONCERNS REGARDING YOUR ACCOUNTS,
PLEASE CONTACT YOUR-CLIENT REPRESENTATIVE |
Non-Voting |
|
|
|
|
|
|
| |
THE
KRAFT HEINZ COMPANY |
|
|
| |
Security |
500754106 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
KHC |
|
|
|
Meeting Date |
04-May-2023 |
|
| |
ISIN |
US5007541064 |
|
|
|
Agenda |
935780557 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Gregory
E. Abel |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Humberto
P. Alfonso |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: John
T. Cahill |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Lori
Dickerson Fouché |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Diane
Gherson |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Timothy
Kenesey |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Alicia
Knapp |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Elio
Leoni Sceti |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Susan
Mulder |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: James
Park |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: Miguel
Patricio |
Management |
|
For |
|
For |
|
|
| |
1l. |
Election of Director: John
C. Pope |
Management |
|
For |
|
For |
|
|
| |
2. |
Advisory vote to approve executive
compensation. |
Management |
|
For |
|
For |
|
|
| |
3. |
Ratification of the selection
of PricewaterhouseCoopers
LLP as our independent auditors for 2023. |
Management |
|
For |
|
For |
|
|
| |
4. |
Stockholder Proposal - Simple
majority vote, if properly
presented. |
Shareholder |
|
Against |
|
For |
|
|
| |
5. |
Stockholder Proposal - Report
on water risk, if properly
presented. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
6. |
Stockholder Proposal - Civil
rights audit, if properly
presented. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
BOSTON
SCIENTIFIC CORPORATION |
|
|
| |
Security |
101137107 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
BSX |
|
|
|
Meeting Date |
04-May-2023 |
|
| |
ISIN |
US1011371077 |
|
|
|
Agenda |
935784860 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Nelda
J. Connors |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Charles
J. Dockendorff |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Yoshiaki
Fujimori |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Edward
J. Ludwig |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Michael
F. Mahoney |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: David
J. Roux |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: John
E. Sununu |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: David
S. Wichmann |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Ellen
M. Zane |
Management |
|
For |
|
For |
|
|
| |
2. |
To approve, on a non-binding,
advisory basis, the
compensation of our named executive officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve, on a non-binding,
advisory basis, the
frequency of future advisory votes on the compensation
of our named executive officers. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
To ratify the appointment of
Ernst & Young LLP as our
independent registered public accounting firm for the
2023 fiscal year. |
Management |
|
For |
|
For |
|
|
| |
PERRIGO
COMPANY PLC |
|
|
| |
Security |
G97822103 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
PRGO |
|
|
|
Meeting Date |
04-May-2023 |
|
| |
ISIN |
IE00BGH1M568 |
|
|
|
Agenda |
935788464 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1A. |
Election of Director to hold
office until the 2024 Annual
General Meeting: Bradley A. Alford |
Management |
|
For |
|
For |
|
|
| |
1B. |
Election of Director to hold
office until the 2024 Annual
General Meeting: Orlando D. Ashford |
Management |
|
For |
|
For |
|
|
| |
1C. |
Election of Director to hold
office until the 2024 Annual
General Meeting: Katherine C. Doyle |
Management |
|
For |
|
For |
|
|
| |
1D. |
Election of Director to hold
office until the 2024 Annual
General Meeting: Adriana Karaboutis |
Management |
|
For |
|
For |
|
|
| |
1E. |
Election of Director to hold
office until the 2024 Annual
General Meeting: Murray S. Kessler |
Management |
|
For |
|
For |
|
|
| |
1F. |
Election of Director to hold
office until the 2024 Annual
General Meeting: Jeffrey B. Kindler |
Management |
|
For |
|
For |
|
|
| |
1G. |
Election of Director to hold
office until the 2024 Annual
General Meeting: Erica L. Mann |
Management |
|
For |
|
For |
|
|
| |
1H. |
Election of Director to hold
office until the 2024 Annual
General Meeting: Albert A. Manzone |
Management |
|
For |
|
For |
|
|
| |
1I. |
Election of Director to hold
office until the 2024 Annual
General Meeting: Donal O'Connor |
Management |
|
For |
|
For |
|
|
| |
1J. |
Election of Director to hold
office until the 2024 Annual
General Meeting: Geoffrey M. Parker |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratify, in a non-binding advisory
vote, the appointment of
Ernst & Young LLP as the Company's independent
auditor, and authorize, in a binding vote, the Board of
Directors, acting through the Audit Committee, to fix the
remuneration of the auditor |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory vote on executive
compensation |
Management |
|
For |
|
For |
|
|
| |
4. |
Advisory vote on the frequency
of future advisory votes
on executive compensation |
Management |
|
1 Year |
|
For |
|
|
| |
5. |
Renew the Board's authority
to issue shares under Irish
law |
Management |
|
For |
|
For |
|
|
| |
6. |
Renew the Board's authority
to opt-out of statutory pre-
emption rights under Irish law |
Management |
|
Against |
|
Against |
|
|
| |
7. |
Approve the creation of distributable
reserves by
reducing some or all of the Company's share premium |
Management |
|
For |
|
For |
|
|
| |
HALOZYME
THERAPEUTICS, INC. |
|
|
| |
Security |
40637H109 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
HALO |
|
|
|
Meeting Date |
05-May-2023 |
|
| |
ISIN |
US40637H1095 |
|
|
|
Agenda |
935782121 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1A. |
Election of Class I Director:
Bernadette Connaughton |
Management |
|
For |
|
For |
|
|
| |
1B. |
Election of Class I Director:
Moni Miyashita |
Management |
|
For |
|
For |
|
|
| |
1C. |
Election of Class I Director:
Matthew L. Posard |
Management |
|
For |
|
For |
|
|
| |
2. |
To approve, by a non-binding
advisory vote, the
compensation of the Company's named executive
officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
To recommend, by non-binding
vote, the frequency of
executive compensation votes. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
To ratify the selection of
Ernst & Young LLP as the
Company's independent registered public accounting firm
for the fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
ABBVIE
INC. |
|
|
| |
Security |
00287Y109 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
ABBV |
|
|
|
Meeting Date |
05-May-2023 |
|
| |
ISIN |
US00287Y1091 |
|
|
|
Agenda |
935786484 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Class II Director:
Robert J. Alpern |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Class II Director:
Melody B. Meyer |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Class II Director:
Frederick H. Waddell |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of Ernst &
Young LLP as AbbVie's
independent registered public accounting firm for 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Say on Pay - An advisory vote
on the approval of
executive compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
Approval of a management proposal
regarding
amendment of the certificate of incorporation to eliminate
supermajority voting. |
Management |
|
For |
|
For |
|
|
| |
5. |
Stockholder Proposal - to Implement
Simple Majority
Vote. |
Shareholder |
|
Against |
|
For |
|
|
| |
6. |
Stockholder Proposal - to Issue
an Annual Report on
Political Spending. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
7. |
Stockholder Proposal - to Issue
an Annual Report on
Lobbying. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
8. |
Stockholder Proposal - to Issue
a Report on Patent
Process. |
Shareholder |
|
Against |
|
For |
|
|
| |
TACTILE
SYSTEMS TECHNOLOGY, INC. |
|
|
| |
Security |
87357P100 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
TCMD |
|
|
|
Meeting Date |
08-May-2023 |
|
| |
ISIN |
US87357P1003 |
|
|
|
Agenda |
935791625 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Valerie Asbury |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Bill Burke |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Sheri Dodd |
|
|
|
For |
|
For |
|
|
| |
|
|
4 |
Raymond Huggenberger |
|
|
|
For |
|
For |
|
|
| |
|
|
5 |
Daniel Reuvers |
|
|
|
For |
|
For |
|
|
| |
|
|
6 |
Brent Shafer |
|
|
|
For |
|
For |
|
|
| |
|
|
7 |
Carmen Volkart |
|
|
|
For |
|
For |
|
|
| |
2. |
Ratify the appointment of Grant
Thornton LLP as our
independent registered public accounting firm for the year
ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Approve, on an advisory basis,
the 2022 compensation of
our named executive officers. |
Management |
|
For |
|
For |
|
|
| |
CHARLES
RIVER LABORATORIES INTL., INC. |
|
|
| |
Security |
159864107 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
CRL |
|
|
|
Meeting Date |
09-May-2023 |
|
| |
ISIN |
US1598641074 |
|
|
|
Agenda |
935808999 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: James
C. Foster |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Nancy
C. Andrews |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Robert
Bertolini |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Deborah
T. Kochevar |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: George
Llado, Sr. |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Martin
W. Mackay |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: George
E. Massaro |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: C. Richard
Reese |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Craig
B. Thompson |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Richard
F. Wallman |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: Virginia
M. Wilson |
Management |
|
For |
|
For |
|
|
| |
2. |
Advisory Approval of 2022 Executive
Officer
Compensation |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory Vote on the Frequency
of Future Advisory Votes
on Executive Compensation |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Ratification of PricewaterhouseCoopers
LLC as
independent registered public accounting firm for 2023 |
Management |
|
For |
|
For |
|
|
| |
5. |
Proposal to publish a report
on non-human primates
imported by Charles River Laboratories International, Inc. |
Management |
|
Abstain |
|
Against |
|
|
| |
STRYKER
CORPORATION |
|
|
| |
Security |
863667101 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
SYK |
|
|
|
Meeting Date |
10-May-2023 |
|
| |
ISIN |
US8636671013 |
|
|
|
Agenda |
935785444 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Mary
K. Brainerd |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Giovanni
Caforio, M.D. |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Srikant
M. Datar, Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Allan
C. Golston |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Kevin
A. Lobo (Chair of the Board,
Chief Executive Officer and President) |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Sherilyn
S. McCoy (Lead
Independent Director) |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Andrew
K. Silvernail |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Lisa
M. Skeete Tatum |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Ronda
E. Stryker |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Rajeev
Suri |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of Appointment
of Ernst & Young LLP as Our
Independent Registered Public Accounting Firm for 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory Vote to Approve Named
Executive Officer
Compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
Advisory Vote on the Frequency
of Future Advisory Votes
on Named Executive Officer Compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
5. |
Shareholder Proposal on Political
Disclosure. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
ELEVANCE
HEALTH, INC. |
|
|
| |
Security |
036752103 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
ELV |
|
|
|
Meeting Date |
10-May-2023 |
|
| |
ISIN |
US0367521038 |
|
|
|
Agenda |
935797502 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Gail
K. Boudreaux |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: R. Kerry
Clark |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Robert
L. Dixon, Jr. |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Deanna
D. Strable |
Management |
|
For |
|
For |
|
|
| |
2. |
Advisory vote to approve the
compensation of our named
executive officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory vote on the frequency
of the advisory vote to
approve the compensation of our named executive
officers. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
To ratify the appointment of
Ernst & Young LLP as the
independent registered public accounting firm for 2023. |
Management |
|
For |
|
For |
|
|
| |
5. |
Shareholder proposal to allow
shareholders owning 10%
or more of our common stock to call a special meeting of
shareholders. |
Shareholder |
|
Against |
|
For |
|
|
| |
6. |
Shareholder proposal requesting
annual reporting from
third parties seeking financial support. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
MAPLE
LEAF FOODS INC |
|
|
| |
Security |
564905107 |
|
|
|
Meeting Type |
Annual General Meeting |
| |
Ticker Symbol |
|
|
|
|
Meeting Date |
11-May-2023 |
|
| |
ISIN |
CA5649051078 |
|
|
|
Agenda |
716848051 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
CMMT |
PLEASE NOTE THAT SHAREHOLDERS
ARE
ALLOWED TO VOTE 'IN FAVOR' OR 'AGAINST'-ONLY
FOR RESOLUTIONS 1.A TO 1.I AND 3 AND 'IN FAVOR'
OR 'ABSTAIN' ONLY FOR-RESOLUTION NUMBER 2.
THANK YOU |
Non-Voting |
|
|
|
|
|
|
| |
1.A |
ELECTION OF DIRECTOR: WILLIAM
E. AZIZ |
Management |
|
For |
|
For |
|
|
| |
1.B |
ELECTION OF DIRECTOR: RONALD
G. CLOSE |
Management |
|
For |
|
For |
|
|
| |
1.C |
ELECTION OF DIRECTOR: THOMAS
P. HAYES |
Management |
|
For |
|
For |
|
|
| |
1.D |
ELECTION OF DIRECTOR: KATHERINE
N. LEMON |
Management |
|
For |
|
For |
|
|
| |
1.E |
ELECTION OF DIRECTOR: ANDREW
G. MACDONALD |
Management |
|
For |
|
For |
|
|
| |
1.F |
ELECTION OF DIRECTOR: LINDA
MANTIA |
Management |
|
For |
|
For |
|
|
| |
1.G |
ELECTION OF DIRECTOR: JONATHAN
W.F. MCCAIN |
Management |
|
For |
|
For |
|
|
| |
1.H |
ELECTION OF DIRECTOR: MICHAEL
H. MCCAIN |
Management |
|
For |
|
For |
|
|
| |
1.I |
ELECTION OF DIRECTOR: BETH
NEWLANDS
CAMPBELL |
Management |
|
For |
|
For |
|
|
| |
2 |
APPOINTMENT OF KPMG LLP, AS
AUDITORS OF
MAPLE LEAF FOODS INC. FOR THE ENSUING YEAR
AND AUTHORIZING THE DIRECTORS TO FIX THEIR
REMUNERATION |
Management |
|
For |
|
For |
|
|
| |
3 |
TO APPROVE, ON AN ADVISORY
AND NON-BINDING
BASIS, MAPLE LEAF FOODS INC.'S APPROACH TO
EXECUTIVECOMPENSATION |
Management |
|
For |
|
For |
|
|
| |
AVANTOR,
INC. |
|
|
| |
Security |
05352A100 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
AVTR |
|
|
|
Meeting Date |
11-May-2023 |
|
| |
ISIN |
US05352A1007 |
|
|
|
Agenda |
935794075 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Juan
Andres |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: John
Carethers |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Lan Kang |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Joseph
Massaro |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Mala
Murthy |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Jonathan
Peacock |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Michael
Severino |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Christi
Shaw |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Michael
Stubblefield |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Gregory
Summe |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of the Appointment
of Deloitte & Touche LLP
as the Company's independent registered accounting firm
for 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Approve, on an Advisory Basis,
Named Executive Officer
Compensation. |
Management |
|
For |
|
For |
|
|
| |
LABORATORY
CORP. OF AMERICA HOLDINGS |
|
|
| |
Security |
50540R409 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
LH |
|
|
|
Meeting Date |
11-May-2023 |
|
| |
ISIN |
US50540R4092 |
|
|
|
Agenda |
935798972 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Kerrii
B. Anderson |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Jean-Luc
Bélingard |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Jeffrey
A. Davis |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: D. Gary
Gilliland, M.D., Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Kirsten
M. Kliphouse |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Garheng
Kong, M.D., Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Peter
M. Neupert |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Richelle
P. Parham |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Adam
H. Schechter |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Kathryn
E. Wengel |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: R. Sanders
Williams, M.D. |
Management |
|
For |
|
For |
|
|
| |
2. |
To approve, by non-binding
vote, executive
compensation. |
Management |
|
For |
|
For |
|
|
| |
3. |
To recommend by non-binding
vote, the frequency of
future non- binding votes on executive compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Ratification of the appointment
of Deloitte and Touche
LLP as Laboratory Corporation of America Holdings'
independent registered public accounting firm for the year
ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
5. |
Shareholder proposal relating
to a policy regarding
separation of the roles of Board Chairman and Chief
Executive Officer. |
Shareholder |
|
Against |
|
For |
|
|
| |
6. |
Shareholder proposal regarding
a Board report on
transport of nonhuman primates within the U.S. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
7. |
Shareholder proposal regarding
a Board report on known
risks of fulfilling information requests and mitigation
strategies. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
ZIMMER
BIOMET HOLDINGS, INC. |
|
|
| |
Security |
98956P102 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
ZBH |
|
|
|
Meeting Date |
12-May-2023 |
|
| |
ISIN |
US98956P1021 |
|
|
|
Agenda |
935784909 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Christopher
B. Begley |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Betsy
J. Bernard |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Michael
J. Farrell |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Robert
A. Hagemann |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Bryan
C. Hanson |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Arthur
J. Higgins |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Maria
Teresa Hilado |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Syed
Jafry |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Sreelakshmi
Kolli |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Michael
W. Michelson |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratify the appointment of PricewaterhouseCoopers
LLP
as our independent registered public accounting firm for
2023 |
Management |
|
For |
|
For |
|
|
| |
3. |
Approve, on a non-binding advisory
basis, named
executive officer compensation ("Say on Pay") |
Management |
|
For |
|
For |
|
|
| |
4. |
Approve, on a non-binding advisory
basis, the frequency
of future Say on Pay votes |
Management |
|
1 Year |
|
For |
|
|
| |
COLGATE-PALMOLIVE
COMPANY |
|
|
| |
Security |
194162103 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
CL |
|
|
|
Meeting Date |
12-May-2023 |
|
| |
ISIN |
US1941621039 |
|
|
|
Agenda |
935795382 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: John
P. Bilbrey |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: John
T. Cahill |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Steve
Cahillane |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Lisa
M. Edwards |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: C. Martin
Harris |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Martina
Hund-Mejean |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Kimberly
A. Nelson |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Lorrie
M. Norrington |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Michael
B. Polk |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Stephen
I. Sadove |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: Noel
R. Wallace |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratify selection of PricewaterhouseCoopers
LLP as
Colgate's independent registered public accounting firm. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory vote on executive
compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
Advisory vote on the frequency
of future advisory votes
on executive compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
5. |
Stockholder proposal on independent
Board Chairman. |
Shareholder |
|
Against |
|
For |
|
|
| |
6. |
Stockholder proposal on executives
to retain significant
stock. |
Shareholder |
|
Against |
|
For |
|
|
| |
ZIMVIE
INC. |
|
|
| |
Security |
98888T107 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
ZIMV |
|
|
|
Meeting Date |
12-May-2023 |
|
| |
ISIN |
US98888T1079 |
|
|
|
Agenda |
935795522 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Vinit
Asar |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Richard
Kuntz, M.D., M.Sc. |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratify the appointment of PricewaterhouseCoopers
LLP
as our independent registered public accounting firm for
2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Approve, on a non-binding advisory
basis, named
executive officer compensation ("Say on Pay"). |
Management |
|
For |
|
For |
|
|
| |
4. |
Approve, on a non-binding advisory
basis, the frequency
of future Say on Pay votes. |
Management |
|
1 Year |
|
For |
|
|
| |
5. |
Approve the amended 2022 Stock
Incentive Plan. |
Management |
|
Against |
|
Against |
|
|
| |
CHEMED
CORPORATION |
|
|
| |
Security |
16359R103 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
CHE |
|
|
|
Meeting Date |
15-May-2023 |
|
| |
ISIN |
US16359R1032 |
|
|
|
Agenda |
935809698 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Kevin
J. McNamara |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Ron DeLyons |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Patrick
P. Grace |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Christopher
J. Heaney |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Thomas
C. Hutton |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Andrea
R. Lindell |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Eileen
P. McCarthy |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: John
M. Mount, Jr. |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Thomas
P. Rice |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: George
J. Walsh III |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of Audit Committee's
selection of
PricewaterhouseCoopers LLP as independent
accountants for 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory vote to approve executive
compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
Advisory vote to determine
the frequency of future
advisory votes on executive compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
5. |
Stockholder proposal requesting
Stockholder Ratification
of Termination Pay. |
Shareholder |
|
Against |
|
For |
|
|
| |
QUIDELORTHO
CORPORATION |
|
|
| |
Security |
219798105 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
QDEL |
|
|
|
Meeting Date |
16-May-2023 |
|
| |
ISIN |
US2197981051 |
|
|
|
Agenda |
935803393 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Douglas C. Bryant |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Kenneth F. Buechler PhD |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Evelyn S. Dilsaver |
|
|
|
For |
|
For |
|
|
| |
|
|
4 |
Edward L. Michael |
|
|
|
For |
|
For |
|
|
| |
|
|
5 |
Mary L Polan MD PhD MPH |
|
|
|
For |
|
For |
|
|
| |
|
|
6 |
Ann D. Rhoads |
|
|
|
For |
|
For |
|
|
| |
|
|
7 |
Robert R. Schmidt |
|
|
|
For |
|
For |
|
|
| |
|
|
8 |
Christopher M. Smith |
|
|
|
For |
|
For |
|
|
| |
|
|
9 |
Matthew W. Strobeck PhD |
|
|
|
For |
|
For |
|
|
| |
|
|
10 |
Kenneth J. Widder, M.D. |
|
|
|
For |
|
For |
|
|
| |
|
|
11 |
Joseph D. Wilkins Jr. |
|
|
|
For |
|
For |
|
|
| |
|
|
12 |
Stephen H. Wise |
|
|
|
For |
|
For |
|
|
| |
2. |
To approve, on an advisory
basis, the compensation of
QuidelOrtho's named executive officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
To hold a non-binding advisory
vote on the frequency of
future advisory votes on the compensation of
QuidelOrtho's named executive officers. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
To ratify the selection of
Ernst & Young LLP as
QuidelOrtho's independent registered public accounting
firm for the fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
STERICYCLE,
INC. |
|
|
| |
Security |
858912108 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
SRCL |
|
|
|
Meeting Date |
16-May-2023 |
|
| |
ISIN |
US8589121081 |
|
|
|
Agenda |
935808468 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Robert
S. Murley |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Cindy
J. Miller |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Brian
P. Anderson |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Lynn
D. Bleil |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Thomas
F. Chen |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Victoria
L. Dolan |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Naren
K. Gursahaney |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: J. Joel
Hackney, Jr. |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Stephen
C. Hooley |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: James
L. Welch |
Management |
|
For |
|
For |
|
|
| |
2. |
Advisory vote to approve executive
compensation ("say-
on-pay vote"). |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory vote on the frequency
of the say-on-pay vote. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Ratification of the appointment
of Ernst & Young LLP as
our independent registered public accounting firm for
2023. |
Management |
|
For |
|
For |
|
|
| |
5. |
Stockholder proposal entitled
Improve Political Spending
Disclosure. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
6. |
Stockholder proposal regarding
a policy on accelerated
vesting of equity awards in the event of a change in
control. |
Shareholder |
|
Against |
|
For |
|
|
| |
BAUSCH
HEALTH COMPANIES, INC. |
|
|
| |
Security |
071734107 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
BHC |
|
|
|
Meeting Date |
16-May-2023 |
|
| |
ISIN |
CA0717341071 |
|
|
|
Agenda |
935808557 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Thomas
J. Appio |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Brett
M. Icahn |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Sarah
B. Kavanagh |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Steven
D. Miller |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Dr. Richard
C. Mulligan |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: John
A. Paulson |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Robert
N. Power |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Russel
C. Robertson |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Thomas
W. Ross, Sr. |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Amy B.
Wechsler, M.D. |
Management |
|
For |
|
For |
|
|
| |
2. |
The approval, in an advisory
vote, of the compensation of
our Named Executive Officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
The approval, in an advisory
vote, of the frequency of
advisory votes on the compensation of our Named
Executive Officers. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
The approval of an amendment
and restatement of the
Company's Amended and Restated 2014 Omnibus
Incentive Plan. |
Management |
|
Withheld |
|
Against |
|
|
| |
5. |
The appointment of PricewaterhouseCoopers
LLP to
serve as the Company's auditor until the close of the
2024 Annual Meeting of Shareholders and to authorize
the Board to fix the auditor's remuneration. |
Management |
|
For |
|
For |
|
|
| |
INFUSYSTEM
HOLDINGS, INC. |
|
|
| |
Security |
45685K102 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
INFU |
|
|
|
Meeting Date |
16-May-2023 |
|
| |
ISIN |
US45685K1025 |
|
|
|
Agenda |
935821872 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1.1 |
Election of Director: Ralph
Boyd |
Management |
|
For |
|
For |
|
|
| |
1.2 |
Election of Director: Richard
Dilorio |
Management |
|
For |
|
For |
|
|
| |
1.3 |
Election of Director: Paul
Gendron |
Management |
|
For |
|
For |
|
|
| |
1.4 |
Election of Director: Carrie
Lachance |
Management |
|
For |
|
For |
|
|
| |
1.5 |
Election of Director: Gregg
Lehman |
Management |
|
For |
|
For |
|
|
| |
1.6 |
Election of Director: R. Rimmy
Malhotra |
Management |
|
For |
|
For |
|
|
| |
1.7 |
Election of Director: Scott
Shuda |
Management |
|
For |
|
For |
|
|
| |
2. |
Approval, on an advisory basis,
of the Company's
Executive Compensation. |
Management |
|
For |
|
For |
|
|
| |
3. |
Approval of an amendment to
the 2021 Equity Incentive
Plan to increase the number of shares under the Plan. |
Management |
|
Against |
|
Against |
|
|
| |
4. |
Approval of the 2023 Employee
Stock Purchase Plan. |
Management |
|
For |
|
For |
|
|
| |
5. |
Ratification of the appointment
of BDO USA, LLP as
independent registered public accounting firm for the
fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
ICU
MEDICAL, INC. |
|
|
| |
Security |
44930G107 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
ICUI |
|
|
|
Meeting Date |
17-May-2023 |
|
| |
ISIN |
US44930G1076 |
|
|
|
Agenda |
935798453 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Vivek Jain |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
George A. Lopez, M.D. |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
David C. Greenberg |
|
|
|
For |
|
For |
|
|
| |
|
|
4 |
Elisha W. Finney |
|
|
|
For |
|
For |
|
|
| |
|
|
5 |
David F. Hoffmeister |
|
|
|
For |
|
For |
|
|
| |
|
|
6 |
Donald M. Abbey |
|
|
|
For |
|
For |
|
|
| |
|
|
7 |
Laurie Hernandez |
|
|
|
For |
|
For |
|
|
| |
|
|
8 |
Kolleen T. Kennedy |
|
|
|
For |
|
For |
|
|
| |
|
|
9 |
William Seeger |
|
|
|
For |
|
For |
|
|
| |
2. |
To approve an amendment to
the Amended and
Restated ICU Medical, Inc. 2011 Stock Incentive Plan. |
Management |
|
Against |
|
Against |
|
|
| |
3. |
To ratify the selection of
Deloitte & Touche LLP as the
independent registered public accounting firm for the
Company for the year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
4. |
To approve named executive
officer compensation on an
advisory basis. |
Management |
|
For |
|
For |
|
|
| |
5. |
Approve, on an advisory basis,
the frequency of future
advisory votes on named executive officer compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
QUEST
DIAGNOSTICS INCORPORATED |
|
|
| |
Security |
74834L100 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
DGX |
|
|
|
Meeting Date |
17-May-2023 |
|
| |
ISIN |
US74834L1008 |
|
|
|
Agenda |
935807137 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: James
E. Davis |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Luis
A. Diaz, Jr., M.D. |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Tracey
C. Doi |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Vicky
B. Gregg |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Wright
L. Lassiter, III |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Timothy
L. Main |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Denise
M. Morrison |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Gary
M. Pfeiffer |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Timothy
M. Ring |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Gail
R. Wilensky, Ph.D. |
Management |
|
For |
|
For |
|
|
| |
2. |
An advisory resolution to approve
the executive officer
compensation disclosed in the Company's 2023 proxy
statement |
Management |
|
For |
|
For |
|
|
| |
3. |
An advisory vote to recommend
the frequency of the
stockholder advisory vote to approve executive officer
compensation |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Ratification of the appointment
of our independent
registered public accounting firm for 2023 |
Management |
|
For |
|
For |
|
|
| |
5. |
Approval of the Amended and
Restated Employee Long-
Term Incentive Plan |
Management |
|
Against |
|
Against |
|
|
| |
6. |
Stockholder proposal regarding
a report on the
Company's greenhouse gas emissions |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
MONDELEZ
INTERNATIONAL, INC. |
|
|
| |
Security |
609207105 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
MDLZ |
|
|
|
Meeting Date |
17-May-2023 |
|
| |
ISIN |
US6092071058 |
|
|
|
Agenda |
935809357 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Lewis
W.K. Booth |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Charles
E. Bunch |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Ertharin
Cousin |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Jorge
S. Mesquita |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Anindita
Mukherjee |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Jane
Hamilton Nielsen |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Patrick
T. Siewert |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Michael
A. Todman |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Dirk
Van de Put |
Management |
|
For |
|
For |
|
|
| |
2. |
Advisory Vote to Approve Executive
Compensation. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory Vote on the Frequency
of Future Votes to
Approve Executive Compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Ratification of the Selection
of PricewaterhouseCoopers
LLP as Independent Registered Public Accountants for
Fiscal Year Ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
5. |
Require Independent Chair of
the Board. |
Shareholder |
|
Against |
|
For |
|
|
| |
6. |
Publish Annual Benchmarks for
Achieving Company's
2025 Cage-Free Egg Goal. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
7. |
Adopt Public Targets to Eradicate
Child Labor in Cocoa
Supply Chain |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
VERTEX
PHARMACEUTICALS INCORPORATED |
|
|
| |
Security |
92532F100 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
VRTX |
|
|
|
Meeting Date |
17-May-2023 |
|
| |
ISIN |
US92532F1003 |
|
|
|
Agenda |
935809852 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1.1 |
Election of Director: Sangeeta
Bhatia |
Management |
|
For |
|
For |
|
|
| |
1.2 |
Election of Director: Lloyd
Carney |
Management |
|
For |
|
For |
|
|
| |
1.3 |
Election of Director: Alan
Garber |
Management |
|
For |
|
For |
|
|
| |
1.4 |
Election of Director: Terrence
Kearney |
Management |
|
For |
|
For |
|
|
| |
1.5 |
Election of Director: Reshma
Kewalramani |
Management |
|
For |
|
For |
|
|
| |
1.6 |
Election of Director: Jeffrey
Leiden |
Management |
|
For |
|
For |
|
|
| |
1.7 |
Election of Director: Diana
McKenzie |
Management |
|
For |
|
For |
|
|
| |
1.8 |
Election of Director: Bruce
Sachs |
Management |
|
For |
|
For |
|
|
| |
1.9 |
Election of Director: Suketu
Upadhyay |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of Ernst &
Young LLP as independent
Registered Public Accounting firm for the year ending
December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory vote to approve named
executive office
compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
Advisory vote on the frequency
of future advisory votes
on executive compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
OPTION
CARE HEALTH, INC. |
|
|
| |
Security |
68404L201 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
OPCH |
|
|
|
Meeting Date |
17-May-2023 |
|
| |
ISIN |
US68404L2016 |
|
|
|
Agenda |
935812758 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
John J. Arlotta |
|
|
|
Withheld |
|
Against |
|
|
| |
|
|
2 |
Elizabeth Q. Betten |
|
|
|
Withheld |
|
Against |
|
|
| |
|
|
3 |
Elizabeth D. Bierbower |
|
|
|
Withheld |
|
Against |
|
|
| |
|
|
4 |
Natasha Deckmann |
|
|
|
Withheld |
|
Against |
|
|
| |
|
|
5 |
David W. Golding |
|
|
|
Withheld |
|
Against |
|
|
| |
|
|
6 |
Harry M. J. Kraemer Jr. |
|
|
|
Withheld |
|
Against |
|
|
| |
|
|
7 |
R. Carter Pate |
|
|
|
Withheld |
|
Against |
|
|
| |
|
|
8 |
John C. Rademacher |
|
|
|
Withheld |
|
Against |
|
|
| |
|
|
9 |
Nitin Sahney |
|
|
|
Withheld |
|
Against |
|
|
| |
|
|
10 |
Timothy P. Sullivan |
|
|
|
Withheld |
|
Against |
|
|
| |
2. |
To ratify the appointment of
KPMG LLP as our
independent registered public accounting firm for the year
ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve, on a non-binding
advisory basis, our
executive compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
To conduct an advisory vote
on the frequency of a
stockholder vote on our executive compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
ZOETIS
INC. |
|
|
| |
Security |
98978V103 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
ZTS |
|
|
|
Meeting Date |
18-May-2023 |
|
| |
ISIN |
US98978V1035 |
|
|
|
Agenda |
935801224 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Paul
M. Bisaro |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Vanessa
Broadhurst |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Frank
A. D'Amelio |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Michael
B. McCallister |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Gregory
Norden |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Louise
M. Parent |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Kristin
C. Peck |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Robert
W. Scully |
Management |
|
For |
|
For |
|
|
| |
2. |
Advisory vote to approve our
executive compensation. |
Management |
|
For |
|
For |
|
|
| |
3. |
Ratification of appointment
of KPMG LLP as our
independent registered public accounting firm for 2023. |
Management |
|
For |
|
For |
|
|
| |
4. |
Approval of an amendment to
our Restated Certificate of
Incorporation to create a right to call a special meeting. |
Management |
|
For |
|
For |
|
|
| |
5. |
Shareholder proposal regarding
ability to call a special
meeting. |
Shareholder |
|
Against |
|
For |
|
|
| |
ELANCO
ANIMAL HEALTH INCORPORATED |
|
|
| |
Security |
28414H103 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
ELAN |
|
|
|
Meeting Date |
18-May-2023 |
|
| |
ISIN |
US28414H1032 |
|
|
|
Agenda |
935803420 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Michael
J. Harrington |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: R. David
Hoover |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Deborah
T. Kochevar |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Kirk
P. McDonald |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of the appointment
of Ernst & Young LLP as
the company's independent registered public accounting
firm for 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory vote on the approval
of executive
compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
Approval of the Amended and
Restated Elanco Animal
Health Incorporated Employee Stock Purchase Plan. |
Management |
|
For |
|
For |
|
|
| |
5. |
Approval of the Amended and
Restated 2018 Elanco
Animal Health Incorporated Stock Plan. |
Management |
|
For |
|
For |
|
|
| |
MERIT
MEDICAL SYSTEMS, INC. |
|
|
| |
Security |
589889104 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
MMSI |
|
|
|
Meeting Date |
18-May-2023 |
|
| |
ISIN |
US5898891040 |
|
|
|
Agenda |
935806200 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director for a
three year term: Lonny J.
Carpenter |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director for a
three year term: David K. Floyd |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director for a
three year term: Lynne N. Ward |
Management |
|
For |
|
For |
|
|
| |
2. |
Approval of a non-binding,
advisory resolution approving
the compensation of the Company's named executive
officers as described in the Merit Medical Systems, Inc.
Proxy Statement. |
Management |
|
For |
|
For |
|
|
| |
3. |
Approval of a non-binding advisory
resolution to
determine whether, during the next six years, the
Company's shareholders will be asked to approve the
compensation of the Company's named executive
officers every one, two or three years. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Ratification of the Audit Committee's
appointment of
Deloitte & Touche LLP to serve as the independent
registered public accounting firm of the Company for the
year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
CVS
HEALTH CORPORATION |
|
|
| |
Security |
126650100 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
CVS |
|
|
|
Meeting Date |
18-May-2023 |
|
| |
ISIN |
US1266501006 |
|
|
|
Agenda |
935806375 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Fernando
Aguirre |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Jeffrey
R. Balser, M.D., Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: C. David
Brown II |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Alecia
A. DeCoudreaux |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Nancy-Ann
M. DeParle |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Roger
N. Farah |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Anne
M. Finucane |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Edward
J. Ludwig |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Karen
S. Lynch |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Jean-Pierre
Millon |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: Mary
L. Schapiro |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of the Appointment
of Our Independent
Registered Public Accounting Firm for 2023 |
Management |
|
For |
|
For |
|
|
| |
3. |
Say on Pay, a Proposal to Approve,
on an Advisory
Basis, the Company's Executive Compensation |
Management |
|
For |
|
For |
|
|
| |
4. |
Proposal to Recommend, on an
Advisory Basis, the
Frequency of Advisory Votes on Executive Compensation
Votes |
Management |
|
1 Year |
|
For |
|
|
| |
5. |
Stockholder Proposal Requesting
Paid Sick Leave for All
Employees |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
6. |
Stockholder Proposal for Reducing
our Ownership
Threshold to Request a Special Stockholder Meeting |
Shareholder |
|
Against |
|
For |
|
|
| |
7. |
Stockholder Proposal Regarding
"Fair Elections" and
Requiring Stockholder Approval of Certain Types of By-
law Amendments |
Shareholder |
|
Against |
|
For |
|
|
| |
8. |
Stockholder Proposal Requesting
a Report on a "Worker
Rights Assessment" |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
9. |
Stockholder Proposal to Prevent
Company Directors from
Simultaneously Sitting on the Boards of Directors of Any
Other Company |
Shareholder |
|
Against |
|
For |
|
|
| |
MEDPACE
HOLDINGS, INC. |
|
|
| |
Security |
58506Q109 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
MEDP |
|
|
|
Meeting Date |
19-May-2023 |
|
| |
ISIN |
US58506Q1094 |
|
|
|
Agenda |
935806680 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Brian T. Carley |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
F. H. Gwadry-Sridhar |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Robert O. Kraft |
|
|
|
For |
|
For |
|
|
| |
2. |
To ratify the appointment of
Deloitte & Touche LLP as our
independent registered public accounting firm for the
fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve, on an advisory
basis, the compensation of
our named executive officers as disclosed in the proxy
statement for the 2023 Annual Meeting. |
Management |
|
For |
|
For |
|
|
| |
CARECLOUD,
INC. |
|
|
| |
Security |
14167R100 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
CCLD |
|
|
|
Meeting Date |
22-May-2023 |
|
| |
ISIN |
US14167R1005 |
|
|
|
Agenda |
935818635 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1) |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Anne Busquet |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Lawrence Sharnak |
|
|
|
For |
|
For |
|
|
| |
2) |
Nonbinding Say-On-Pay Proposal:
ADVISORY VOTE TO
APPROVE THE EXECUTIVE COMPENSATION
PROGRAMS OF THE COMPANY NOTED IN
PROPOSAL 2. |
Management |
|
For |
|
For |
|
|
| |
3) |
Nonbinding Say-On-Pay Frequency
Proposal:
ADVISORY VOTE ON THE FREQUENCY TO VOTE ON
THE EXECUTIVE COMPENSATION OF THE NAMED
EXECUTIVES NOTED IN PROPOSAL 3. |
Management |
|
1 Year |
|
For |
|
|
| |
TREACE
MEDICAL CONCEPTS, INC. |
|
|
| |
Security |
89455T109 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
TMCI |
|
|
|
Meeting Date |
23-May-2023 |
|
| |
ISIN |
US89455T1097 |
|
|
|
Agenda |
935803773 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Lance A. Berry |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Elizabeth S. Hanna |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Jane E. Kiernan |
|
|
|
For |
|
For |
|
|
| |
2. |
Proposal to ratify the appointment
of Grant Thornton LLP
as independent registered public accounting firm for the
year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
MERCK
& CO., INC. |
|
|
| |
Security |
58933Y105 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
MRK |
|
|
|
Meeting Date |
23-May-2023 |
|
| |
ISIN |
US58933Y1055 |
|
|
|
Agenda |
935809080 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Douglas
M. Baker, Jr. |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Mary
Ellen Coe |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Pamela
J. Craig |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Robert
M. Davis |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Thomas
H. Glocer |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Risa
J. Lavizzo-Mourey, M.D. |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Stephen
L. Mayo, Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Paul
B. Rothman, M.D. |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Patricia
F. Russo |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Christine
E. Seidman, M.D. |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: Inge
G. Thulin |
Management |
|
For |
|
For |
|
|
| |
1l. |
Election of Director: Kathy
J. Warden |
Management |
|
For |
|
For |
|
|
| |
1m. |
Election of Director: Peter
C. Wendell |
Management |
|
For |
|
For |
|
|
| |
2. |
Non-binding advisory vote to
approve the compensation
of our named executive officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
Non-binding advisory vote to
approve the frequency of
future votes to approve the compensation of our named
executive officers. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Ratification of the appointment
of the Company's
independent registered public accounting firm for 2023. |
Management |
|
For |
|
For |
|
|
| |
5. |
Shareholder proposal regarding
business operations in
China. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
6. |
Shareholder proposal regarding
access to COVID-19
products. |
Shareholder |
|
Against |
|
For |
|
|
| |
7. |
Shareholder proposal regarding
indirect political
spending. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
8. |
Shareholder proposal regarding
patents and access. |
Shareholder |
|
Against |
|
For |
|
|
| |
9. |
Shareholder proposal regarding
a congruency report of
partnerships with globalist organizations. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
10. |
Shareholder proposal regarding
an independent board
chairman. |
Shareholder |
|
Against |
|
For |
|
|
| |
HENRY
SCHEIN, INC. |
|
|
| |
Security |
806407102 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
HSIC |
|
|
|
Meeting Date |
23-May-2023 |
|
| |
ISIN |
US8064071025 |
|
|
|
Agenda |
935809636 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Mohamad
Ali |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Stanley
M. Bergman |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: James
P. Breslawski |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Deborah
Derby |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Joseph
L. Herring |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Kurt
P. Kuehn |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Philip
A. Laskawy |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Anne
H. Margulies |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Mark
E. Mlotek |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Steven
Paladino |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: Carol
Raphael |
Management |
|
For |
|
For |
|
|
| |
1l. |
Election of Director: Scott
Serota |
Management |
|
For |
|
For |
|
|
| |
1m. |
Election of Director: Bradley
T. Sheares, Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1n. |
Election of Director: Reed
V. Tuckson, M.D., FACP |
Management |
|
For |
|
For |
|
|
| |
2. |
Proposal to amend and restate
the Company's 2015 Non-
Employee Director Stock Incentive Plan. |
Management |
|
For |
|
For |
|
|
| |
3. |
Proposal to approve, by non-binding
vote, the 2022
compensation paid to the Company's Named Executive
Officers. |
Management |
|
For |
|
For |
|
|
| |
4. |
Proposal to recommend, by non-binding
vote, the
frequency of future advisory votes on executive
compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
5. |
Proposal to ratify the selection
of BDO USA, LLP as the
Company's independent registered public accounting firm
for the fiscal year ending December 30, 2023. |
Management |
|
For |
|
For |
|
|
| |
WATERS
CORPORATION |
|
|
| |
Security |
941848103 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
WAT |
|
|
|
Meeting Date |
23-May-2023 |
|
| |
ISIN |
US9418481035 |
|
|
|
Agenda |
935817481 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1.1 |
Election of Director: Dr. Flemming
Ornskov, M.D., M.P.H. |
Management |
|
For |
|
For |
|
|
| |
1.2 |
Election of Director: Linda
Baddour |
Management |
|
For |
|
For |
|
|
| |
1.3 |
Election of Director: Dr. Udit
Batra, Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1.4 |
Election of Director: Dan Brennan |
Management |
|
For |
|
For |
|
|
| |
1.5 |
Election of Director: Richard
Fearon |
Management |
|
For |
|
For |
|
|
| |
1.6 |
Election of Director: Dr. Pearl
S. Huang, Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1.7 |
Election of Director: Wei Jiang |
Management |
|
For |
|
For |
|
|
| |
1.8 |
Election of Director: Christopher
A. Kuebler |
Management |
|
For |
|
For |
|
|
| |
1.9 |
Election of Director: Mark
Vergnano |
Management |
|
For |
|
For |
|
|
| |
2. |
To ratify the selection of
PricewaterhouseCoopers LLP as
the Company's independent registered public accounting
firm for the fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve, by non-binding
vote, executive
compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
To approve, by non-binding
vote, the frequency of
executive compensation votes. |
Management |
|
1 Year |
|
For |
|
|
| |
THERMO
FISHER SCIENTIFIC INC. |
|
|
| |
Security |
883556102 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
TMO |
|
|
|
Meeting Date |
24-May-2023 |
|
| |
ISIN |
US8835561023 |
|
|
|
Agenda |
935803709 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Marc
N. Casper |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Nelson
J. Chai |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Ruby
R. Chandy |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: C. Martin
Harris |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Tyler
Jacks |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: R. Alexandra
Keith |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: James
C. Mullen |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Lars
R. Sørensen |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Debora
L. Spar |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Scott
M. Sperling |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: Dion
J. Weisler |
Management |
|
For |
|
For |
|
|
| |
2. |
An advisory vote to approve
named executive officer
compensation. |
Management |
|
For |
|
For |
|
|
| |
3. |
An advisory vote on the frequency
of future named
executive officer advisory votes. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Ratification of the Audit Committee's
selection of
PricewaterhouseCoopers LLP as the Company's
independent auditors for 2023. |
Management |
|
For |
|
For |
|
|
| |
5. |
Approval of the Company's Amended
and Restated 2013
Stock Incentive Plan. |
Management |
|
For |
|
For |
|
|
| |
6. |
Approval of the Company's 2023
Global Employee Stock
Purchase Plan. |
Management |
|
For |
|
For |
|
|
| |
TANDEM
DIABETES CARE, INC. |
|
|
| |
Security |
875372203 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
TNDM |
|
|
|
Meeting Date |
24-May-2023 |
|
| |
ISIN |
US8753722037 |
|
|
|
Agenda |
935806123 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Kim D.
Blickenstaff |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Myoungil
Cha |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Peyton
R. Howell |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Joao
Paulo Falcao Malagueira |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Kathleen
McGroddy-Goetz |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: John
F. Sheridan |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Christopher
J. Twomey |
Management |
|
For |
|
For |
|
|
| |
2. |
To approve the Company's 2023
Long-Term Incentive
Plan, which will replace the 2013 Stock Incentive Plan
expiring on November 15, 2023. |
Management |
|
Against |
|
Against |
|
|
| |
3. |
To approve, on a non-binding,
advisory basis, the
compensation of our named executive officers. |
Management |
|
For |
|
For |
|
|
| |
4. |
To ratify the appointment of
Ernst & Young LLP as our
independent registered public accounting firm for the
fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
SPROUTS
FARMERS MARKET, INC. |
|
|
| |
Security |
85208M102 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
SFM |
|
|
|
Meeting Date |
24-May-2023 |
|
| |
ISIN |
US85208M1027 |
|
|
|
Agenda |
935814649 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Joel D. Anderson |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Terri Funk Graham |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Doug G. Rauch |
|
|
|
For |
|
For |
|
|
| |
2. |
To vote on a non-binding advisory
resolution to approve
the compensation paid to our named executive officers
for fiscal 2022 ("say-on-pay"). |
Management |
|
For |
|
For |
|
|
| |
3. |
To ratify the appointment of
PricewaterhouseCoopers
LLP as our independent registered public accounting firm
for the fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
INTEGER
HOLDINGS CORPORATION |
|
|
| |
Security |
45826H109 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
ITGR |
|
|
|
Meeting Date |
24-May-2023 |
|
| |
ISIN |
US45826H1095 |
|
|
|
Agenda |
935818293 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director for a
one-year term: Sheila Antrum |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director for a
one-year term: Pamela G. Bailey |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director for a
one-year term: Cheryl C. Capps |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director for a
one-year term: Joseph W.
Dziedzic |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director for a
one-year term: James F.
Hinrichs |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director for a
one-year term: Jean Hobby |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director for a
one-year term: Tyrone Jeffers |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director for a
one-year term: M. Craig Maxwell |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director for a
one-year term: Filippo Passerini |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director for a
one-year term: Donald J.
Spence |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director for a
one-year term: William B.
Summers, Jr. |
Management |
|
For |
|
For |
|
|
| |
2. |
To ratify the appointment of
Deloitte & Touche LLP as the
independent registered public accounting firm for Integer
Holdings Corporation for fiscal year 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve, on an advisory
basis, the compensation of
our named executive officers. |
Management |
|
For |
|
For |
|
|
| |
4. |
To approve, on an advisory
basis, the frequency of future
advisory votes on compensation of our named executive
officers. |
Management |
|
1 Year |
|
For |
|
|
| |
DENTSPLY
SIRONA INC. |
|
|
| |
Security |
24906P109 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
XRAY |
|
|
|
Meeting Date |
24-May-2023 |
|
| |
ISIN |
US24906P1093 |
|
|
|
Agenda |
935821074 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Eric
K. Brandt |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Simon
D. Campion |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Willie
A. Deese |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Betsy
D. Holden |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Clyde
R. Hosein |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Harry
M. Kraemer, Jr. |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Gregory
T. Lucier |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Jonathan
J. Mazelsky |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Leslie
F. Varon |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Janet
S. Vergis |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: Dorothea
Wenzel |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of the appointment
of
PricewaterhouseCoopers LLP as the Company's
independent registered public accountants for 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Approval, by non-binding vote,
of the Company's
executive compensation for 2022. |
Management |
|
For |
|
For |
|
|
| |
4. |
Approval, on a non-binding
advisory basis, of the
frequency of holding the say-on-pay vote. |
Management |
|
1 Year |
|
For |
|
|
| |
IRHYTHM
TECHNOLOGIES, INC. |
|
|
| |
Security |
450056106 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
IRTC |
|
|
|
Meeting Date |
24-May-2023 |
|
| |
ISIN |
US4500561067 |
|
|
|
Agenda |
935821238 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
C. Noel Bairey Merz MD |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Quentin S. Blackford |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Bruce G. Bodaken |
|
|
|
For |
|
For |
|
|
| |
|
|
4 |
Karen Ling |
|
|
|
For |
|
For |
|
|
| |
|
|
5 |
Mark J. Rubash |
|
|
|
For |
|
For |
|
|
| |
|
|
6 |
Ralph Snyderman, M.D. |
|
|
|
For |
|
For |
|
|
| |
|
|
7 |
Abhijit Y. Talwalkar |
|
|
|
For |
|
For |
|
|
| |
2. |
To ratify the appointment of
PricewaterhouseCoopers
LLP as our independent registered public accounting firm
for our fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory vote to approve Named
Executive Officer
compensation. |
Management |
|
For |
|
For |
|
|
| |
NEURONETICS,
INC. |
|
|
| |
Security |
64131A105 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
STIM |
|
|
|
Meeting Date |
25-May-2023 |
|
| |
ISIN |
US64131A1051 |
|
|
|
Agenda |
935817289 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
John K. Bakewell |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Joseph H. Capper |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Robert A. Cascella |
|
|
|
For |
|
For |
|
|
| |
|
|
4 |
Sheryl L. Conley |
|
|
|
For |
|
For |
|
|
| |
|
|
5 |
Wilfred E. Jaeger |
|
|
|
For |
|
For |
|
|
| |
|
|
6 |
Glenn P. Muir |
|
|
|
For |
|
For |
|
|
| |
|
|
7 |
Megan Rosengarten |
|
|
|
For |
|
For |
|
|
| |
|
|
8 |
Keith J. Sullivan |
|
|
|
For |
|
For |
|
|
| |
2. |
Ratification of the selection
of KPMG LLP as our
independent registered public accounting firm. |
Management |
|
For |
|
For |
|
|
| |
FLOWERS
FOODS, INC. |
|
|
| |
Security |
343498101 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
FLO |
|
|
|
Meeting Date |
25-May-2023 |
|
| |
ISIN |
US3434981011 |
|
|
|
Agenda |
935817354 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director to serve
for a term of one year:
George E. Deese |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director to serve
for a term of one year:
Edward J. Casey, Jr. |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director to serve
for a term of one year:
Thomas C. Chubb, III |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director to serve
for a term of one year:
Rhonda Gass |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director to serve
for a term of one year:
Margaret G. Lewis |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director to serve
for a term of one year: W.
Jameson McFadden |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director to serve
for a term of one year: A.
Ryals McMullian |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director to serve
for a term of one year:
James T. Spear |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director to serve
for a term of one year:
Melvin T. Stith, Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director to serve
for a term of one year: Terry
S. Thomas |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director to serve
for a term of one year: C.
Martin Wood III |
Management |
|
For |
|
For |
|
|
| |
2. |
Advisory vote to approve the
compensation of the
company's named executive officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory vote on the frequency
of future advisory votes to
approve the compensation of the company's named
executive officers. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Approve the amendment and restatement
of the Flowers
Foods, Inc. 2014 Omnibus Equity and Incentive
Compensation Plan. |
Management |
|
For |
|
For |
|
|
| |
5. |
Ratify the appointment of PricewaterhouseCoopers
LLP
as the independent registered public accounting firm for
Flowers Foods, Inc. for the fiscal year ending December
30, 2023. |
Management |
|
For |
|
For |
|
|
| |
PHENOMEX
INC. |
|
|
| |
Security |
084310101 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
CELL |
|
|
|
Meeting Date |
25-May-2023 |
|
| |
ISIN |
US0843101017 |
|
|
|
Agenda |
935817556 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
John Chiminski |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Peter Silvester |
|
|
|
For |
|
For |
|
|
| |
2. |
Ratification of the appointment
of KPMG LLP as our
independent registered public accounting firm for the
fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Approval, on an advisory basis,
of the compensation of
our named executive officers. |
Management |
|
For |
|
For |
|
|
| |
TELADOC
HEALTH, INC. |
|
|
| |
Security |
87918A105 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
TDOC |
|
|
|
Meeting Date |
25-May-2023 |
|
| |
ISIN |
US87918A1051 |
|
|
|
Agenda |
935819423 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Karen
L. Daniel |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Sandra
L. Fenwick |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Jason
Gorevic |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Catherine
A. Jacobson |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Thomas
G. McKinley |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Kenneth
H. Paulus |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: David
L. Shedlarz |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Mark
Douglas Smith, M.D., MBA |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: David
B. Snow, Jr. |
Management |
|
For |
|
For |
|
|
| |
2. |
Approve, on an advisory basis,
the compensation of
Teladoc Health's named executive officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
Approve the Teladoc Health,
Inc. 2023 Incentive Award
Plan. |
Management |
|
Against |
|
Against |
|
|
| |
4. |
Approve an amendment to the
Teladoc Health, Inc. 2015
Employee Stock Purchase Plan. |
Management |
|
For |
|
For |
|
|
| |
5. |
Ratify the appointment of Ernst
& Young LLP as Teladoc
Health's independent registered public accounting firm for
the fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
6. |
Stockholder proposal entitled
"Fair Elections". |
Shareholder |
|
Against |
|
For |
|
|
| |
NEVRO
CORP. |
|
|
| |
Security |
64157F103 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
NVRO |
|
|
|
Meeting Date |
25-May-2023 |
|
| |
ISIN |
US64157F1030 |
|
|
|
Agenda |
935820387 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
D. Keith Grossman |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Michael DeMane |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Frank Fischer |
|
|
|
For |
|
For |
|
|
| |
|
|
4 |
Sri Kosaraju |
|
|
|
For |
|
For |
|
|
| |
|
|
5 |
Shawn T McCormick |
|
|
|
For |
|
For |
|
|
| |
|
|
6 |
Kevin O'Boyle |
|
|
|
For |
|
For |
|
|
| |
|
|
7 |
Karen Prange |
|
|
|
For |
|
For |
|
|
| |
|
|
8 |
Susan Siegel |
|
|
|
For |
|
For |
|
|
| |
|
|
9 |
Elizabeth Weatherman |
|
|
|
For |
|
For |
|
|
| |
2. |
To ratify the selection, by
the Audit Committee of the
Company's Board of Directors, of
PricewaterhouseCoopers LLP as the independent
registered public accounting firm of the Company for its
fiscal year ending December 31, 2023 |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve, on a non-binding,
advisory basis, the
compensation of the named executive officers as
disclosed in the Company's proxy statement in
accordance with the compensation disclosure rules of the
Securities and Exchange Commission |
Management |
|
For |
|
For |
|
|
| |
TENET
HEALTHCARE CORPORATION |
|
|
| |
Security |
88033G407 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
THC |
|
|
|
Meeting Date |
25-May-2023 |
|
| |
ISIN |
US88033G4073 |
|
|
|
Agenda |
935821593 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: J. Robert
Kerrey |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: James
L. Bierman |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Richard
W. Fisher |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Meghan
M. FitzGerald |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Cecil
D. Haney |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Christopher
S. Lynch |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Richard
J. Mark |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Tammy
Romo |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Saumya
Sutaria |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Nadja
Y. West |
Management |
|
For |
|
For |
|
|
| |
2. |
To approve, on an advisory
basis, the Company's
executive compensation. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve, on an advisory
basis, the frequency of future
advisory votes on executive compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
To ratify the selection of
Deloitte & Touche LLP as the
Company's independent registered public accountants for
the year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
5. |
Shareholder Proposal requesting
a report on patients'
right to access abortion in emergencies. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
ILLUMINA,
INC. |
|
|
| |
Security |
452327109 |
|
|
|
Meeting Type |
Contested-Annual |
| |
Ticker Symbol |
ILMN |
|
|
|
Meeting Date |
25-May-2023 |
|
| |
ISIN |
US4523271090 |
|
|
|
Agenda |
935854516 - Opposition |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
ICAHN NOMINEE: Vincent J. Intrieri |
Management |
|
For |
|
For |
|
|
| |
1b. |
ICAHN NOMINEE: Jesse A. Lynn |
Management |
|
Withheld |
|
Against |
|
|
| |
1c. |
ICAHN NOMINEE: Andrew J. Teno |
Management |
|
For |
|
For |
|
|
| |
1d. |
ACCEPTABLE COMPANY NOMINEE:
Frances Arnold |
Management |
|
For |
|
|
|
|
| |
1e. |
ACCEPTABLE COMPANY NOMINEE:
Caroline D. Dorsa |
Management |
|
For |
|
|
|
|
| |
1f. |
ACCEPTABLE COMPANY NOMINEE:
Scott Gottlieb |
Management |
|
For |
|
|
|
|
| |
1g. |
ACCEPTABLE COMPANY NOMINEE:
Gary S. Guthart |
Management |
|
For |
|
|
|
|
| |
1h. |
ACCEPTABLE COMPANY NOMINEE:
Philip W. Schiller |
Management |
|
For |
|
|
|
|
| |
1i. |
ACCEPTABLE COMPANY NOMINEE:
Susan E. Siegel |
Management |
|
For |
|
|
|
|
| |
1j. |
OPPOSED COMPANY NOMINEE: Francis
A. deSouza |
Management |
|
For |
|
Against |
|
|
| |
1k. |
OPPOSED COMPANY NOMINEE: Robert
S. Epstein |
Management |
|
Withheld |
|
For |
|
|
| |
1l. |
OPPOSED COMPANY NOMINEE: John
W. Thompson |
Management |
|
Withheld |
|
For |
|
|
| |
2. |
TO RATIFY THE APPOINTMENT OF
ERNST & YOUNG
LLP AS ILLUMINA'S INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR
ENDING DECEMBER 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
TO APPROVE, ON AN ADVISORY
BASIS, THE
COMPENSATION OF THE "NAMED EXECUTIVE
OFFICERS" AS DISCLOSED IN THE COMPANY'S
PROXY STATEMENT. |
Management |
|
For |
|
Against |
|
|
| |
4. |
TO APPROVE, ON AN ADVISORY
BASIS, THE
FREQUENCY OF HOLDING AN ADVISORY VOTE TO
APPROVE THE COMPENSATION PROVIDED TO THE
COMPANY'S "NAMED EXECUTIVE OFFICERS". |
Management |
|
1 Year |
|
For |
|
|
| |
5. |
To approve certain amendments
to the Illumina, Inc.
2015 Stock and Incentive Plan. |
Management |
|
For |
|
|
|
|
| |
SMILEDIRECTCLUB,
INC. |
|
|
| |
Security |
83192H106 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
SDC |
|
|
|
Meeting Date |
01-Jun-2023 |
|
| |
ISIN |
US83192H1068 |
|
|
|
Agenda |
935827646 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
David Katzman |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Susan Greenspon Rammelt |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Edward W. Ward, III |
|
|
|
For |
|
For |
|
|
| |
2. |
Ratification of Ernst &
Young LLP as the company's
independent registered accounting firm for the fiscal year
ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory vote to approve the
company's named executive
officer compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
Approval of amendment to the
company's Amended and
Restated Certificate of Incorporation. |
Management |
|
For |
|
For |
|
|
| |
GLAUKOS
CORPORATION |
|
|
| |
Security |
377322102 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
GKOS |
|
|
|
Meeting Date |
01-Jun-2023 |
|
| |
ISIN |
US3773221029 |
|
|
|
Agenda |
935833930 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Denice M. Torres |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Aimee S. Weisner |
|
|
|
For |
|
For |
|
|
| |
2. |
Approval, on an advisory basis,
of the compensation of
the Company's named executive officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
Ratification of the appointment
of Ernst & Young LLP as
the Company's independent registered public accounting
firm for the year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
ACADIA
PHARMACEUTICALS INC. |
|
|
| |
Security |
004225108 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
ACAD |
|
|
|
Meeting Date |
01-Jun-2023 |
|
| |
ISIN |
US0042251084 |
|
|
|
Agenda |
935860913 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
James M. Daly |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Edmund P. Harrigan |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Adora Ndu |
|
|
|
For |
|
For |
|
|
| |
2. |
To approve, on an advisory
basis, the compensation of
the Company's named executive officers, as disclosed in
this proxy statement. |
Management |
|
For |
|
For |
|
|
| |
3. |
To indicate, on an advisory
basis, the preferred frequency
of stockholder advisory votes on the compensation of the
Company's named executive officers. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
To ratify the selection of
Ernst & Young LLP as the
Company's independent registered public accounting firm
for the fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
TINGYI
(CAYMAN ISLANDS) HOLDING CORP |
|
|
| |
Security |
G8878S103 |
|
|
|
Meeting Type |
Annual General Meeting |
| |
Ticker Symbol |
|
|
|
|
Meeting Date |
05-Jun-2023 |
|
| |
ISIN |
KYG8878S1030 |
|
|
|
Agenda |
717097186 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
CMMT |
PLEASE
NOTE THAT THE COMPANY NOTICE AND
PROXY FORM ARE AVAILABLE BY CLICKING-ON THE
URL LINKS:-
https://www1.hkexnews.hk/listedco/listconews/sehk/2023/
0421/2023042100233.pdf-AND-
https://www1.hkexnews.hk/listedco/listconews/sehk/2023/
0421/2023042100281.pdf |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
PLEASE NOTE THAT SHAREHOLDERS
ARE
ALLOWED TO VOTE 'IN FAVOR' OR 'AGAINST' FOR-
ALL RESOLUTIONS, ABSTAIN IS NOT A VOTING
OPTION ON THIS MEETING |
Non-Voting |
|
|
|
|
|
|
| |
1 |
TO RECEIVE AND CONSIDER THE
AUDITED
ACCOUNTS AND THE REPORTS OF THE DIRECTORS
AND AUDITORS FOR THE YEAR ENDED 31
DECEMBER 2022 |
Management |
|
For |
|
For |
|
|
| |
2 |
TO APPROVE THE PAYMENT OF A
FINAL DIVIDEND
FOR THE YEAR ENDED 31 DECEMBER 2022 |
Management |
|
For |
|
For |
|
|
| |
3 |
TO APPROVE THE PAYMENT OF A
SPECIAL FINAL
DIVIDEND FOR THE YEAR ENDED 31 DECEMBER
2022 |
Management |
|
For |
|
For |
|
|
| |
4 |
TO RE-ELECT MR. JUNICHIRO IDA
AS AN
EXECUTIVE DIRECTOR AND TO AUTHORIZE THE
DIRECTORS TO FIX HIS REMUNERATION |
Management |
|
Against |
|
Against |
|
|
| |
5 |
TO RE-ELECT MR. WEI HONG-CHEN
AS AN
EXECUTIVE DIRECTOR AND TO AUTHORIZE THE
DIRECTORS TO FIX HIS REMUNERATION |
Management |
|
Against |
|
Against |
|
|
| |
6 |
TO RE-ELECT MR. HIROMU FUKADA
AS AN
INDEPENDENT NON-EXECUTIVE DIRECTOR AND TO
AUTHORIZE THE DIRECTORS TO FIX HIS
REMUNERATION |
Management |
|
For |
|
For |
|
|
| |
7 |
TO RE-APPOINT AUDITORS OF THE
COMPANY AND
AUTHORISE THE DIRECTORS TO FIX THEIR
REMUNERATION |
Management |
|
For |
|
For |
|
|
| |
8 |
TO CONSIDER AND APPROVE THE
GENERAL
MANDATE TO ISSUE SHARES |
Management |
|
Against |
|
Against |
|
|
| |
9 |
TO CONSIDER AND APPROVE THE
GENERAL
MANDATE TO BUY BACK SHARES OF THE
COMPANY |
Management |
|
For |
|
For |
|
|
| |
10 |
TO CONSIDER AND APPROVE THAT
THE TOTAL
NUMBER OF SHARES WHICH ARE BOUGHT BACK
BY THE COMPANY SHALL BE ADDED TO THE TOTAL
NUMBER OF SHARES WHICH MAY BE ALLOTED
PURSUANT TO THE GENERAL MANDATE FOR ISSUE
OF SHARES |
Management |
|
Against |
|
Against |
|
|
| |
11 |
TO APPROVE THE ADOPTION OF
THE AMENDED
AND RESTATED MEMORANDUM AND ARTICLES OF
ASSOCIATION OF THE COMPANY IN SUBSTITUTION
FOR AND TO THE EXCLUSION OF THE EXISTING
MEMORANDUM AND ARTICLES OF ASSOCIATION OF
THE COMPANY WITH IMMEDIATE EFFECT |
Management |
|
For |
|
For |
|
|
| |
CMMT |
24 APR 2023: PLEASE NOTE THAT
THIS IS A OF
REVISION DUE TO DELETION OF-COMMENT. IF YOU
HAVE ALREADY SENT IN YOUR VOTES, PLEASE DO
NOT VOTE AGAIN-UNLESS YOU DECIDE TO AMEND
YOUR ORIGINAL INSTRUCTIONS. THANK YOU |
Non-Voting |
|
|
|
|
|
|
| |
UNITEDHEALTH
GROUP INCORPORATED |
|
|
| |
Security |
91324P102 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
UNH |
|
|
|
Meeting Date |
05-Jun-2023 |
|
| |
ISIN |
US91324P1021 |
|
|
|
Agenda |
935835237 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Timothy
Flynn |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Paul
Garcia |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Kristen
Gil |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Stephen
Hemsley |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Michele
Hooper |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: F. William
McNabb III |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Valerie
Montgomery Rice, M.D. |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: John
Noseworthy, M.D. |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Andrew
Witty |
Management |
|
For |
|
For |
|
|
| |
2. |
Advisory approval of the Company's
executive
compensation. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory approval of the frequency
of holding future say-
on-pay votes. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Ratification of the appointment
of Deloitte & Touche LLP
as the independent registered public accounting firm for
the Company for the year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
5. |
If properly presented at the
2023 Annual Meeting of
Shareholders, the shareholder proposal seeking a third-
party racial equity audit. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
6. |
If properly presented at the
2023 Annual Meeting of
Shareholders, the shareholder proposal requiring a
political contributions congruency report. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
7. |
If properly presented at the
2023 Annual Meeting of
Shareholders, the shareholder proposal seeking
shareholder ratification of termination pay. |
Shareholder |
|
Against |
|
For |
|
|
| |
INVITAE
CORPORATION |
|
|
| |
Security |
46185L103 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
NVTA |
|
|
|
Meeting Date |
05-Jun-2023 |
|
| |
ISIN |
US46185L1035 |
|
|
|
Agenda |
935837635 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Class I Director:
Geoffrey S. Crouse |
Management |
|
Abstain |
|
Against |
|
|
| |
1b. |
Election of Class I Director:
Christine M. Gorjanc |
Management |
|
Abstain |
|
Against |
|
|
| |
1c. |
Election of Class I Director:
Kenneth D. Knight |
Management |
|
For |
|
For |
|
|
| |
2. |
Approval of, for purposes of
complying with New York
Stock Exchange listing rules, the issuance of shares of
our common stock pursuant to the conversion of Notes
and/or exercise of Warrants and the related change of
control. |
Management |
|
For |
|
For |
|
|
| |
3. |
Approval of, on a non-binding
advisory basis, the
compensation paid by us to our named executive officers. |
Management |
|
For |
|
For |
|
|
| |
4. |
Ratification of the appointment
of Ernst & Young LLP as
our independent registered public accounting firm for the
year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
CHINA
MENGNIU DAIRY CO LTD |
|
|
| |
Security |
G21096105 |
|
|
|
Meeting Type |
Annual General Meeting |
| |
Ticker Symbol |
|
|
|
|
Meeting Date |
06-Jun-2023 |
|
| |
ISIN |
KYG210961051 |
|
|
|
Agenda |
717123397 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
CMMT |
PLEASE
NOTE THAT THE COMPANY NOTICE AND
PROXY FORM ARE AVAILABLE BY CLICKING-ON THE
URL LINKS:-
https://www1.hkexnews.hk/listedco/listconews/sehk/2023/
0426/2023042600827.pdf-AND-
https://www1.hkexnews.hk/listedco/listconews/sehk/2023/
0426/2023042600926.pdf |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
PLEASE NOTE THAT SHAREHOLDERS
ARE
ALLOWED TO VOTE 'IN FAVOR' OR 'AGAINST' FOR-
ALL RESOLUTIONS, ABSTAIN IS NOT A VOTING
OPTION ON THIS MEETING |
Non-Voting |
|
|
|
|
|
|
| |
1 |
TO REVIEW AND CONSIDER THE
AUDITED
FINANCIAL STATEMENTS AND THE REPORTS OF
THE DIRECTORS AND THE INDEPENDENT
AUDITORS FOR THE YEAR ENDED 31 DECEMBER
2022 |
Management |
|
For |
|
For |
|
|
| |
2 |
TO APPROVE THE PROPOSED FINAL
DIVIDEND OF
RMB0.402 PER SHARE FOR THE YEAR ENDED 31
DECEMBER 2022 |
Management |
|
For |
|
For |
|
|
| |
3.A |
TO RE-ELECT MR. LU MINFANG
AS DIRECTOR AND
AUTHORISE THE BOARD OF DIRECTORS OF THE
COMPANY TO FIX HIS REMUNERATION |
Management |
|
For |
|
For |
|
|
| |
3.B |
TO RE-ELECT MR. SIMON DOMINIC
STEVENS AS
DIRECTOR AND AUTHORISE THE BOARD OF
DIRECTORS OF THE COMPANY TO FIX HIS
REMUNERATION |
Management |
|
For |
|
For |
|
|
| |
3.C |
TO RE-ELECT MR. GE JUN AS DIRECTOR
AND
AUTHORISE THE BOARD OF DIRECTORS OF THE
COMPANY TO FIX HIS REMUNERATION |
Management |
|
For |
|
For |
|
|
| |
4 |
TO RE-APPOINT KPMG AS THE AUDITORS
OF THE
COMPANY AND AUTHORISE THE BOARD OF
DIRECTORS OF THE COMPANY TO FIX THEIR
REMUNERATION FOR THE YEAR ENDING 31
DECEMBER 2023 |
Management |
|
For |
|
For |
|
|
| |
5 |
ORDINARY RESOLUTION NO. 5 SET
OUT IN THE
NOTICE OF AGM (TO GIVE A GENERAL MANDATE TO
THE DIRECTORS TO REPURCHASE SHARES IN THE
COMPANY NOT EXCEEDING 10% OF THE ISSUED
SHARE CAPITAL OF THE COMPANY) |
Management |
|
For |
|
For |
|
|
| |
6 |
ORDINARY RESOLUTION NO. 6 SET
OUT IN THE
NOTICE OF AGM (TO GIVE A GENERAL MANDATE TO
THE DIRECTORS TO ALLOT, ISSUE AND DEAL WITH
ADDITIONAL SHARES NOT EXCEEDING 10% OF THE
ISSUED SHARE CAPITAL OF THE COMPANY) |
Management |
|
Against |
|
Against |
|
|
| |
7 |
SPECIAL RESOLUTION NO. 7 SET
OUT IN THE
NOTICE OF AGM (TO APPROVE THE AMENDMENTS
RELATING TO CORE STANDARDS (AS DEFINED IN
THE NOTICE OF AGM) TO THE EXISTING
MEMORANDUM AND ARTICLES OF ASSOCIATION
(AS DEFINED IN THE NOTICE OF AGM)) |
Management |
|
For |
|
For |
|
|
| |
8 |
SPECIAL RESOLUTION NO. 8 SET
OUT IN THE
NOTICE OF AGM (TO APPROVE THE OTHER
AMENDMENTS (AS DEFINED IN THE NOTICE OF
AGM) TO THE EXISTING MEMORANDUM AND
ARTICLES OF ASSOCIATION) |
Management |
|
For |
|
For |
|
|
| |
9 |
SPECIAL
RESOLUTION NO. 9 SET OUT IN THE
NOTICE OF AGM (TO APPROVE THE ADOPTION OF
THE NEW MEMORANDUM AND ARTICLES OF
ASSOCIATION (AS DEFINED IN THE NOTICE OF
AGM) IN SUBSTITUTION FOR AND TO THE
EXCLUSION OF THE EXISTING MEMORANDUM AND
ARTICLES OF ASSOCIATION) (WHICH, FOR THE
AVOIDANCE OF DOUBT, IS SUBJECT TO THE
SPECIAL RESOLUTIONS NOS. 7 AND 8 BEING
PASSED) |
Management |
|
For |
|
For |
|
|
| |
DAVITA
INC. |
|
|
| |
Security |
23918K108 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
DVA |
|
|
|
Meeting Date |
06-Jun-2023 |
|
| |
ISIN |
US23918K1088 |
|
|
|
Agenda |
935837952 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Pamela
M. Arway |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Charles
G. Berg |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Barbara
J. Desoer |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Jason
M. Hollar |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Gregory
J. Moore, MD, PhD |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: John
M. Nehra |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Javier
J. Rodriguez |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Adam
H. Schechter |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Phyllis
R. Yale |
Management |
|
For |
|
For |
|
|
| |
2. |
To ratify the appointment of
KPMG LLP as our
independent registered public accounting firm for fiscal
year 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve, on an advisory
basis, the compensation of
our named executive officers. |
Management |
|
For |
|
For |
|
|
| |
4. |
To approve, on an advisory
basis, the frequency of future
advisory votes on named executive officer compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
5. |
To approve an amendment and
restatement of the
Company's Restated Certificate of Incorporation to
provide for the exculpation of officers as permitted by
Delaware law. |
Management |
|
For |
|
For |
|
|
| |
GERRESHEIMER
AG |
|
|
| |
Security |
D2852S109 |
|
|
|
Meeting Type |
Annual General Meeting |
| |
Ticker Symbol |
|
|
|
|
Meeting Date |
07-Jun-2023 |
|
| |
ISIN |
DE000A0LD6E6 |
|
|
|
Agenda |
717143779 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
CMMT |
VOTING MUST BE LODGED WITH
SHAREHOLDER
DETAILS AS PROVIDED BY YOUR CUSTODIAN.-IF NO
SHAREHOLDER DETAILS ARE PROVIDED, YOUR
INSTRUCTION MAY BE REJECTED. |
Non-Voting |
|
|
|
|
|
|
| |
1 |
RECEIVE FINANCIAL STATEMENTS
AND
STATUTORY REPORTS FOR SHORT FISCAL YEAR
2022 |
Non-Voting |
|
|
|
|
|
|
| |
2 |
APPROVE ALLOCATION OF INCOME
AND DIVIDENDS
OF EUR 1.25 PER SHARE |
Management |
|
No Action |
|
|
|
|
| |
3 |
APPROVE DISCHARGE OF MANAGEMENT
BOARD
FOR FISCAL YEAR 2022 |
Management |
|
No Action |
|
|
|
|
| |
4 |
APPROVE DISCHARGE OF SUPERVISORY
BOARD
FOR FISCAL YEAR 2022 |
Management |
|
No Action |
|
|
|
|
| |
5 |
RATIFY DELOITTE GMBH AS AUDITORS
FOR FISCAL
YEAR 2023 AND FOR THE REVIEW OF INTERIM
FINANCIAL STATEMENTS FOR THE FIRST HALF OF
FISCAL YEAR 2023 |
Management |
|
No Action |
|
|
|
|
| |
6 |
APPROVE REMUNERATION REPORT |
Management |
|
No Action |
|
|
|
|
| |
7 |
APPROVE VIRTUAL-ONLY SHAREHOLDER
MEETINGS UNTIL 2025 |
Management |
|
No Action |
|
|
|
|
| |
8 |
APPROVE CREATION OF EUR 6.9
MILLION POOL OF
AUTHORIZED CAPITAL I WITH OR WITHOUT
EXCLUSION OF PREEMPTIVE RIGHTS |
Management |
|
No Action |
|
|
|
|
| |
9 |
APPROVE CREATION OF EUR 3.5
MILLION POOL OF
AUTHORIZED CAPITAL II WITH OR WITHOUT
EXCLUSION OF PREEMPTIVE RIGHTS |
Management |
|
No Action |
|
|
|
|
| |
10 |
APPROVE ISSUANCE OF WARRANTS/BONDS
WITH
WARRANTS ATTACHED/CONVERTIBLE BONDS
WITHOUT PREEMPTIVE RIGHTS UP TO AGGREGATE
NOMINAL AMOUNT OF EUR 500 MILLION; APPROVE
CREATION OF EUR 3.5 MILLION POOL OF CAPITAL
TO GUARANTEE CONVERSION RIGHTS |
Management |
|
No Action |
|
|
|
|
| |
CMMT |
FROM
10TH FEBRUARY, BROADRIDGE WILL CODE
ALL AGENDAS FOR GERMAN MEETINGS IN-ENGLISH
ONLY. IF YOU WISH TO SEE THE AGENDA IN
GERMAN, THIS WILL BE MADE-AVAILABLE AS A LINK
UNDER THE MATERIAL URL DROPDOWN AT THE
TOP OF THE BALLOT.-THE GERMAN AGENDAS FOR
ANY EXISTING OR PAST MEETINGS WILL REMAIN IN
PLACE.-FOR FURTHER INFORMATION, PLEASE
CONTACT YOUR CLIENT SERVICE
REPRESENTATIVE. |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
ACCORDING
TO GERMAN LAW, IN CASE OF
SPECIFIC CONFLICTS OF INTEREST IN-
CONNECTION WITH SPECIFIC ITEMS OF THE
AGENDA FOR THE GENERAL MEETING YOU ARE-
NOT ENTITLED TO EXERCISE YOUR VOTING
RIGHTS. FURTHER, YOUR VOTING RIGHT MIGHT-BE
EXCLUDED WHEN YOUR SHARE IN VOTING RIGHTS
HAS REACHED CERTAIN THRESHOLDS-AND YOU
HAVE NOT COMPLIED WITH ANY OF YOUR
MANDATORY VOTING RIGHTS-NOTIFICATIONS
PURSUANT TO THE GERMAN SECURITIES TRADING
ACT (WPHG). FOR-QUESTIONS IN THIS REGARD
PLEASE CONTACT YOUR CLIENT SERVICE
REPRESENTATIVE-FOR CLARIFICATION. IF YOU DO
NOT HAVE ANY INDICATION REGARDING SUCH
CONFLICT-OF INTEREST, OR ANOTHER EXCLUSION
FROM VOTING, PLEASE SUBMIT YOUR VOTE AS-
USUAL. |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
INFORMATION
ON COUNTER PROPOSALS CAN BE
FOUND DIRECTLY ON THE ISSUER'S-WEBSITE
(PLEASE REFER TO THE MATERIAL URL SECTION
OF THE APPLICATION). IF YOU-WISH TO ACT ON
THESE ITEMS, YOU WILL NEED TO REQUEST A
MEETING ATTEND AND-VOTE YOUR SHARES
DIRECTLY AT THE COMPANY'S MEETING. COUNTER
PROPOSALS CANNOT-BE REFLECTED ON THE
BALLOT ON PROXYEDGE. |
Non-Voting |
|
|
|
|
|
|
| |
CMMT |
INTERMEDIARY
CLIENTS ONLY - PLEASE NOTE
THAT IF YOU ARE CLASSIFIED AS AN-
INTERMEDIARY CLIENT UNDER THE SHAREHOLDER
RIGHTS DIRECTIVE II, YOU SHOULD BE-PROVIDING
THE UNDERLYING SHAREHOLDER INFORMATION
AT THE VOTE INSTRUCTION-LEVEL. IF YOU ARE
UNSURE ON HOW TO PROVIDE THIS LEVEL OF
DATA TO BROADRIDGE-OUTSIDE OF PROXYEDGE,
PLEASE SPEAK TO YOUR DEDICATED CLIENT
SERVICE-REPRESENTATIVE FOR ASSISTANCE |
Non-Voting |
|
|
|
|
|
|
| |
SOVOS
BRANDS INC. |
|
|
| |
Security |
84612U107 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
SOVO |
|
|
|
Meeting Date |
07-Jun-2023 |
|
| |
ISIN |
US84612U1079 |
|
|
|
Agenda |
935842953 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of the Class II Director
to serve until the 2026
Annual Meeting of Stockholders: David W. Roberts |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of the Class II Director
to serve until the 2026
Annual Meeting of Stockholders: Vijayanthimala (Mala)
Singh |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of the appointment
of Deloitte & Touche LLP
as our independent registered public accounting firm for
the fiscal year ending December 30, 2023. |
Management |
|
For |
|
For |
|
|
| |
GLOBUS
MEDICAL, INC. |
|
|
| |
Security |
379577208 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
GMED |
|
|
|
Meeting Date |
07-Jun-2023 |
|
| |
ISIN |
US3795772082 |
|
|
|
Agenda |
935847713 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Daniel
T. Scavilla |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Robert
Douglas |
Management |
|
For |
|
For |
|
|
| |
2. |
The approval of the amendment
to the 2021 Equity
Incentive Plan. |
Management |
|
Against |
|
Against |
|
|
| |
3. |
To ratify the appointment of
Deloitte & Touche LLP as the
Company's independent registered public accounting firm
for the year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
4. |
To approve, in an advisory
vote, the compensation of the
Company's named executive officers (the Say-on-Pay
Vote). |
Management |
|
For |
|
For |
|
|
| |
HESKA
CORPORATION |
|
|
| |
Security |
42805E306 |
|
|
|
Meeting Type |
Special |
| |
Ticker Symbol |
HSKA |
|
|
|
Meeting Date |
07-Jun-2023 |
|
| |
ISIN |
US42805E3062 |
|
|
|
Agenda |
935869050 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
To
adopt and approve the Agreement and Plan of Merger
with Antech Diagnostics, Inc., a California corporation,
Helsinki Merger Sub LLC, a Delaware limited liability
company, and, solely for purposes of Section 9.15 of the
Merger Agreement, Mars, Incorporated, a Delaware
corporation (the "Merger Proposal"). |
Management |
|
For |
|
For |
|
|
| |
2. |
To approve, on a non-binding,
advisory basis, the
compensation that may be paid or become payable to our
named executive officers that is based on or otherwise
relates to the merger. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve one or more adjournments
of the Special
Meeting, if necessary, to solicit additional proxies if a
quorum is not present or there are not sufficient votes
cast at the Special Meeting to approve the Merger
Proposal. |
Management |
|
For |
|
For |
|
|
| |
EXACT
SCIENCES CORPORATION |
|
|
| |
Security |
30063P105 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
EXAS |
|
|
|
Meeting Date |
08-Jun-2023 |
|
| |
ISIN |
US30063P1057 |
|
|
|
Agenda |
935836176 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Class II Director
to serve for three-year term:
D. Scott Coward |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Class II Director
to serve for three-year term:
James Doyle |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Class II Director
to serve for three-year term:
Freda Lewis-Hall |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Class II Director
to serve for three-year term:
Kathleen Sebelius |
Management |
|
For |
|
For |
|
|
| |
2. |
To ratify the selection of
PricewaterhouseCoopers LLP as
our independent registered public accounting firm for
2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve, on an advisory
basis, the compensation of
our named executive officers. |
Management |
|
For |
|
For |
|
|
| |
4. |
To approve, on an advisory
basis, the frequency of future
advisory votes on executive compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
5. |
To approve an Amendment to
our Sixth Amended and
Restated Certificate of Incorporation to declassify our
Board of Directors. |
Management |
|
For |
|
For |
|
|
| |
6. |
To approve Amendment No. 2
to the Exact Sciences
Corporation 2019 Omnibus Long-Term Incentive Plan. |
Management |
|
Against |
|
Against |
|
|
| |
EVOLENT
HEALTH, INC. |
|
|
| |
Security |
30050B101 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
EVH |
|
|
|
Meeting Date |
08-Jun-2023 |
|
| |
ISIN |
US30050B1017 |
|
|
|
Agenda |
935843513 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Craig
Barbarosh |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Seth
Blackley |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: M. Bridget
Duffy, MD |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Peter
Grua |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Diane
Holder |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: Richard
Jelinek |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Kim Keck |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Cheryl
Scott |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: Tunde
Sotunde, MD |
Management |
|
For |
|
For |
|
|
| |
2. |
Proposal to ratify the appointment
of Deloitte & Touche
LLP as our independent registered public accounting firm
for the fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Proposal to approve the compensation
of our named
executive officers for 2022 on an advisory basis. |
Management |
|
For |
|
For |
|
|
| |
4. |
Proposal to approve an amendment
to the Amended and
Restated Evolent Health, Inc. 2015 Omnibus Incentive
Compensation Plan. |
Management |
|
Against |
|
Against |
|
|
| |
REGENERON
PHARMACEUTICALS, INC. |
|
|
| |
Security |
75886F107 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
REGN |
|
|
|
Meeting Date |
09-Jun-2023 |
|
| |
ISIN |
US75886F1075 |
|
|
|
Agenda |
935835338 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Joseph
L. Goldstein, M.D. |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Christine
A. Poon |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Craig
B. Thompson, M.D. |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Huda
Y. Zoghbi, M.D. |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of the appointment
of
PricewaterhouseCoopers LLP as the Company's
independent registered public accounting firm for the
fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Proposal to approve, on an
advisory basis, executive
compensation. |
Management |
|
For |
|
For |
|
|
| |
4. |
Proposal to approve, on an
advisory basis, the frequency
of future advisory votes on executive compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
5. |
Non-binding shareholder proposal,
if properly presented,
requesting report on a process by which access to
medicine is considered in matters related to protecting
intellectual property. |
Shareholder |
|
Against |
|
For |
|
|
| |
NATERA,
INC. |
|
|
| |
Security |
632307104 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
NTRA |
|
|
|
Meeting Date |
09-Jun-2023 |
|
| |
ISIN |
US6323071042 |
|
|
|
Agenda |
935840529 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Rowan Chapman |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Herm Rosenman |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Jonathan Sheena |
|
|
|
For |
|
For |
|
|
| |
2. |
To ratify the appointment of
Ernst & Young LLP as
Natera, Inc.'s independent registered public accounting
firm for the fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve, on an advisory
(non-binding) basis, the
compensation of Natera, Inc.'s named executive officers
as disclosed in the proxy statement. |
Management |
|
For |
|
For |
|
|
| |
NUVASIVE,
INC. |
|
|
| |
Security |
670704105 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
NUVA |
|
|
|
Meeting Date |
09-Jun-2023 |
|
| |
ISIN |
US6707041058 |
|
|
|
Agenda |
935867121 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1.1 |
Election of Class I Director:
J. Christopher Barry |
Management |
|
For |
|
For |
|
|
| |
1.2 |
Election of Class I Director:
Leslie V. Norwalk, Esq. |
Management |
|
For |
|
For |
|
|
| |
1.3 |
Election of Class I Director:
Amy Belt Raimundo |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of the appointment
of Ernst & Young LLP as
the Company's independent registered public accounting
firm for the fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Approval of a non-binding advisory
resolution regarding
the compensation of the Company's named executive
officers for the fiscal year ended December 31, 2022. |
Management |
|
For |
|
For |
|
|
| |
4. |
Approval of a non-binding advisory
vote on the frequency
of the stockholders advisory vote on the compensation of
the Company's named executive officers. |
Management |
|
1 Year |
|
For |
|
|
| |
2SEVENTY
BIO, INC. |
|
|
| |
Security |
901384107 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
TSVT |
|
|
|
Meeting Date |
13-Jun-2023 |
|
| |
ISIN |
US9013841070 |
|
|
|
Agenda |
935843119 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Daniel S. Lynch |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Sarah Glickman |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Wei Lin, M.D. |
|
|
|
For |
|
For |
|
|
| |
2. |
To ratify the selection of
Ernst & Young LLP as our
independent registered public accounting firm for the
fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve an amendment to
our Amended and
Restated Certificate of Incorporation to limit the liability of
certain officers of 2seventy bio, Inc. as permitted by
recent amendments to Delaware law. |
Management |
|
For |
|
For |
|
|
| |
GUARDANT
HEALTH, INC. |
|
|
| |
Security |
40131M109 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
GH |
|
|
|
Meeting Date |
14-Jun-2023 |
|
| |
ISIN |
US40131M1099 |
|
|
|
Agenda |
935837849 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Class II Director:
Ian Clark |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Class II Director:
Meghan Joyce |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Class II Director:
Samir Kaul |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of the appointment
of Deloitte & Touche LLP
as Guardant Health, Inc.'s independent registered public
accounting firm for the year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Non-binding advisory vote to
approve Guardant Health,
Inc.'s named executive officer compensation. |
Management |
|
For |
|
For |
|
|
| |
INTELLIA
THERAPEUTICS, INC. |
|
|
| |
Security |
45826J105 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
NTLA |
|
|
|
Meeting Date |
14-Jun-2023 |
|
| |
ISIN |
US45826J1051 |
|
|
|
Agenda |
935838562 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Muna Bhanji, R.Ph. |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
John F. Crowley |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Jesse Goodman, MD, MPH |
|
|
|
For |
|
For |
|
|
| |
2. |
Ratification of the appointment
of Deloitte & Touche LLP
as Intellia's independent registered public accounting firm
for the fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Approve, on a non-binding advisory
basis, the
compensation of the named executive officers. |
Management |
|
For |
|
For |
|
|
| |
4. |
Approval of an amendment to
our Second Amended and
Restated Certificate of Incorporation to increase the
number of authorized shares of common stock from
120,000,000 to 240,000,000. |
Management |
|
For |
|
For |
|
|
| |
INCYTE
CORPORATION |
|
|
| |
Security |
45337C102 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
INCY |
|
|
|
Meeting Date |
14-Jun-2023 |
|
| |
ISIN |
US45337C1027 |
|
|
|
Agenda |
935840719 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1.1 |
Election of Director: Julian
C. Baker |
Management |
|
For |
|
For |
|
|
| |
1.2 |
Election of Director: Jean-Jacques
Bienaimé |
Management |
|
For |
|
For |
|
|
| |
1.3 |
Election of Director: Otis
W. Brawley |
Management |
|
For |
|
For |
|
|
| |
1.4 |
Election of Director: Paul
J. Clancy |
Management |
|
For |
|
For |
|
|
| |
1.5 |
Election of Director: Jacqualyn
A. Fouse |
Management |
|
For |
|
For |
|
|
| |
1.6 |
Election of Director: Edmund
P. Harrigan |
Management |
|
For |
|
For |
|
|
| |
1.7 |
Election of Director: Katherine
A. High |
Management |
|
For |
|
For |
|
|
| |
1.8 |
Election of Director: Hervé
Hoppenot |
Management |
|
For |
|
For |
|
|
| |
1.9 |
Election of Director: Susanne
Schaffert |
Management |
|
For |
|
For |
|
|
| |
2. |
Approve, on a non-binding,
advisory basis, the
compensation of the Company's named executive
officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
Approve, on a non-binding,
advisory basis, the frequency
of future advisory votes on the compensation of the
Company's named executive officers. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Approve an amendment to the
Company's Amended and
Restated 2010 Stock Incentive Plan. |
Management |
|
Against |
|
Against |
|
|
| |
5. |
Approve an amendment to the
Company's 1997
Employee Stock Purchase Plan. |
Management |
|
For |
|
For |
|
|
| |
6. |
Ratify the appointment of Ernst
& Young LLP as the
Company's independent registered public accounting firm
for 2023. |
Management |
|
For |
|
For |
|
|
| |
10X
GENOMICS, INC. |
|
|
| |
Security |
88025U109 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
TXG |
|
|
|
Meeting Date |
14-Jun-2023 |
|
| |
ISIN |
US88025U1097 |
|
|
|
Agenda |
935853095 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1.1 |
Election of Class I Director
to serve a three-year term
expiring at the 2026 annual meeting: Benjamin J.
Hindson, Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1.2 |
Election of Class I Director
to serve a three-year term
expiring at the 2026 annual meeting: Serge Saxonov,
Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1.3 |
Election of Class I Director
to serve a three-year term
expiring at the 2026 annual meeting: John R.
Stuelpnagel, D.V.M. |
Management |
|
For |
|
For |
|
|
| |
2. |
Ratification of the appointment
of Ernst & Young LLP as
our independent registered public accounting firm for the
fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
A vote to approve, on a non-binding,
advisory basis, the
compensation of our named executive officers. |
Management |
|
For |
|
For |
|
|
| |
GOODRX
HOLDINGS, INC. |
|
|
| |
Security |
38246G108 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
GDRX |
|
|
|
Meeting Date |
14-Jun-2023 |
|
| |
ISIN |
US38246G1085 |
|
|
|
Agenda |
935856851 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Julie Bradley |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Dipanjan Deb |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Stephen LeSieur |
|
|
|
For |
|
For |
|
|
| |
|
|
4 |
Gregory Mondre |
|
|
|
For |
|
For |
|
|
| |
2. |
Ratification of the appointment
of
PricewaterhouseCoopers LLP as the Company's
independent registered public accounting firm for the
fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
Approval, on an advisory (non-binding)
basis, of the
compensation of the Company's named executive
officers. |
Management |
|
For |
|
For |
|
|
| |
TEVA
PHARMACEUTICAL INDUSTRIES LIMITED |
|
|
| |
Security |
881624209 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
TEVA |
|
|
|
Meeting Date |
15-Jun-2023 |
|
| |
ISIN |
US8816242098 |
|
|
|
Agenda |
935846507 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1A. |
Election of Director: Dr. Sol
J. Barer |
Management |
|
For |
|
For |
|
|
| |
1B. |
Election of Director: M. Braverman-Blumenstyk |
Management |
|
Abstain |
|
Against |
|
|
| |
1C. |
Election of Director: Janet
S. Vergis |
Management |
|
For |
|
For |
|
|
| |
2. |
To approve, on a non-binding
advisory basis, the
compensation for Teva's named executive officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
To appoint Kesselman &
Kesselman, a member of
PricewaterhouseCoopers International Ltd., as Teva's
independent registered public accounting firm until Teva's
2024 annual meeting of shareholders. |
Management |
|
For |
|
For |
|
|
| |
TEVA
PHARMACEUTICAL INDUSTRIES LIMITED |
|
|
| |
Security |
881624209 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
TEVA |
|
|
|
Meeting Date |
15-Jun-2023 |
|
| |
ISIN |
US8816242098 |
|
|
|
Agenda |
935867599 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1A. |
Election of Director: Dr. Sol
J. Barer |
Management |
|
For |
|
For |
|
|
| |
1B. |
Election of Director: M. Braverman-Blumenstyk |
Management |
|
Abstain |
|
Against |
|
|
| |
1C. |
Election of Director: Janet
S. Vergis |
Management |
|
For |
|
For |
|
|
| |
2. |
To approve, on a non-binding
advisory basis, the
compensation for Teva's named executive officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
To appoint Kesselman &
Kesselman, a member of
PricewaterhouseCoopers International Ltd., as Teva's
independent registered public accounting firm until Teva's
2024 annual meeting of shareholders. |
Management |
|
For |
|
For |
|
|
| |
BELLUS
HEALTH INC. |
|
|
| |
Security |
07987C204 |
|
|
|
Meeting Type |
Special |
| |
Ticker Symbol |
BLU |
|
|
|
Meeting Date |
16-Jun-2023 |
|
| |
ISIN |
CA07987C2040 |
|
|
|
Agenda |
935879823 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1 |
To
consider and, if deemed advisable, to pass, with or
without variation, a special resolution to approve a
proposed plan of arrangement involving BELLUS Health
Inc., 14934792 Canada Inc. and GSK plc, pursuant to
section 192 of the Canada Business Corporations Act.
The full text of the special resolution is set forth in
Appendix B to the accompanying management
information circular of BELLUS Health Inc. |
Management |
|
For |
|
For |
|
|
| |
ORTHOFIX
MEDICAL INC. |
|
|
| |
Security |
68752M108 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
OFIX |
|
|
|
Meeting Date |
19-Jun-2023 |
|
| |
ISIN |
US68752M1080 |
|
|
|
Agenda |
935860925 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1.1 |
Election of Director: Wayne
Burris |
Management |
|
For |
|
For |
|
|
| |
1.2 |
Election of Director: Catherine
M. Burzik |
Management |
|
For |
|
For |
|
|
| |
1.3 |
Election of Director: Stuart
M. Essig, Ph.D. |
Management |
|
For |
|
For |
|
|
| |
1.4 |
Election of Director: Jason
M. Hannon |
Management |
|
For |
|
For |
|
|
| |
1.5 |
Election of Director: John
B. Henneman, III |
Management |
|
For |
|
For |
|
|
| |
1.6 |
Election of Director: James
F. Hinrichs |
Management |
|
For |
|
For |
|
|
| |
1.7 |
Election of Director: Shweta
Singh Maniar |
Management |
|
For |
|
For |
|
|
| |
1.8 |
Election of Director: Michael
E. Paolucci |
Management |
|
For |
|
For |
|
|
| |
1.9 |
Election of Director: Keith
C. Valentine |
Management |
|
For |
|
For |
|
|
| |
2. |
Advisory and Non-Binding Vote
to Approve Executive
Compensation |
Management |
|
For |
|
For |
|
|
| |
3. |
Ratification of the Appointment
of Ernst & Young LLP as
Independent Registered Public Accounting Firm for the
Fiscal Year Ending December 31, 2023 |
Management |
|
For |
|
For |
|
|
| |
4. |
Approval of an Amendment and
Restatement of the
Certificate of Incorporation to Increase the Authorized
Number of Shares of Common Stock from 50 Million to
100 Million |
Management |
|
For |
|
For |
|
|
| |
5. |
Approval of an Amendment and
Restatement of the
Certificate of Incorporation to Provide for Exculpation of
Officers as Permitted by Recent Amendments to
Delaware Law |
Management |
|
For |
|
For |
|
|
| |
6. |
Approval of an Amendment and
Restatement of the
Certificate of Incorporation to Add Forum Selection
Provisions |
Management |
|
For |
|
For |
|
|
| |
7. |
Approval
of Amendment No. 4 to the Amended and
Restated 2012 Long-Term Incentive Plan to Increase the
Number of Shares of Common Stock Authorized for
Issuance Thereunder by 2,900,000 and to Amend Certain
Other Provisions Related to the Repayment,
Reimbursement and Forfeiture of Awards Thereunder. |
Management |
|
Against |
|
Against |
|
|
| |
8. |
Approval of Amendment No. 3
to the Second Amended
and Restated Stock Purchase Plan to Increase the
Number of Shares of Common Stock Authorized for
Issuance Thereunder by 750,000. |
Management |
|
For |
|
For |
|
|
| |
9. |
Advisory Vote on the Frequency
of Future Advisory Votes
to Approve Executive Compensation |
Management |
|
1 Year |
|
For |
|
|
| |
YAKULT
HONSHA CO.,LTD. |
|
|
| |
Security |
J95468120 |
|
|
|
Meeting Type |
Annual General Meeting |
| |
Ticker Symbol |
|
|
|
|
Meeting Date |
21-Jun-2023 |
|
| |
ISIN |
JP3931600005 |
|
|
|
Agenda |
717312451 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
|
Please reference meeting materials. |
Non-Voting |
|
|
|
|
|
|
| |
1.1 |
Appoint a Director Narita,
Hiroshi |
Management |
|
For |
|
For |
|
|
| |
1.2 |
Appoint a Director Wakabayashi,
Hiroshi |
Management |
|
For |
|
For |
|
|
| |
1.3 |
Appoint a Director Doi, Akifumi |
Management |
|
For |
|
For |
|
|
| |
1.4 |
Appoint a Director Imada, Masao |
Management |
|
For |
|
For |
|
|
| |
1.5 |
Appoint a Director Hirano,
Koichi |
Management |
|
For |
|
For |
|
|
| |
1.6 |
Appoint a Director Yasuda,
Ryuji |
Management |
|
For |
|
For |
|
|
| |
1.7 |
Appoint a Director Tobe, Naoko |
Management |
|
For |
|
For |
|
|
| |
1.8 |
Appoint a Director Shimbo,
Katsuyoshi |
Management |
|
For |
|
For |
|
|
| |
1.9 |
Appoint a Director Nagasawa,
Yumiko |
Management |
|
For |
|
For |
|
|
| |
1.10 |
Appoint a Director Akutsu,
Satoshi |
Management |
|
For |
|
For |
|
|
| |
1.11 |
Appoint a Director Naito, Manabu |
Management |
|
For |
|
For |
|
|
| |
1.12 |
Appoint a Director Nagira,
Masatoshi |
Management |
|
For |
|
For |
|
|
| |
1.13 |
Appoint a Director Hoshiko,
Hideaki |
Management |
|
For |
|
For |
|
|
| |
1.14 |
Appoint a Director Shimada,
Junichi |
Management |
|
For |
|
For |
|
|
| |
1.15 |
Appoint a Director Matthew
Digby |
Management |
|
For |
|
For |
|
|
| |
2 |
Approve Details of the Restricted-Stock
Compensation to
be received by Directors (Excluding Outside Directors
and Part-time Directors) |
Management |
|
For |
|
For |
|
|
| |
3 |
Approve Details of the Compensation
to be received by
Corporate Auditors |
Management |
|
For |
|
For |
|
|
| |
PETIQ,
INC. |
|
|
| |
Security |
71639T106 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
PETQ |
|
|
|
Meeting Date |
21-Jun-2023 |
|
| |
ISIN |
US71639T1060 |
|
|
|
Agenda |
935854287 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: McCord
Christensen |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Kimberly
Lefko |
Management |
|
For |
|
For |
|
|
| |
2. |
To ratify the selection of
KPMG LLP as our independent
registered public accounting firm for the fiscal year
ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve, on an advisory,
non-binding basis, the
compensation of our named executive officers. |
Management |
|
For |
|
For |
|
|
| |
SILK
ROAD MEDICAL, INC. |
|
|
| |
Security |
82710M100 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
SILK |
|
|
|
Meeting Date |
21-Jun-2023 |
|
| |
ISIN |
US82710M1009 |
|
|
|
Agenda |
935860280 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Class I Director
to serve until our 2024 annual
meeting: Rick D. Anderson |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Class I Director
to serve until our 2024 annual
meeting: Jack W. Lasersohn |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Class I Director
to serve until our 2024 annual
meeting: Erica J. Rogers |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Class III Director
to serve until our 2024
annual meeting: Elizabeth H. Weatherman |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Class III Director
to serve until our 2024
annual meeting: Donald J. Zurbay |
Management |
|
For |
|
For |
|
|
| |
2. |
To approve Named Executive
Officer Compensation on
an advisory basis. |
Management |
|
For |
|
For |
|
|
| |
3. |
To adopt and approve an amendment
to our Certificate of
Incorporation to eliminate or limit the personal liability of
officers. |
Management |
|
For |
|
For |
|
|
| |
4. |
To ratify the appointment of
PricewaterhouseCoopers
LLP as our independent registered public accounting firm
for our fiscal year ending December 31, 2023. |
Management |
|
For |
|
For |
|
|
| |
PETCO
HEALTH AND WELLNESS COMPANY, INC. |
|
|
| |
Security |
71601V105 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
WOOF |
|
|
|
Meeting Date |
22-Jun-2023 |
|
| |
ISIN |
US71601V1052 |
|
|
|
Agenda |
935854453 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1. |
DIRECTOR |
Management |
|
|
|
|
|
|
| |
|
|
1 |
Gary Briggs |
|
|
|
For |
|
For |
|
|
| |
|
|
2 |
Nishad Chande |
|
|
|
For |
|
For |
|
|
| |
|
|
3 |
Mary Sullivan |
|
|
|
For |
|
For |
|
|
| |
2. |
To approve, on a non-binding,
advisory basis, the
compensation of the Company's named executive
officers. |
Management |
|
For |
|
For |
|
|
| |
3. |
To approve the First Amendment
to the Company's 2021
Equity Incentive Plan to increase the number of shares of
Class A Common Stock authorized for issuance under
the plan. |
Management |
|
Against |
|
Against |
|
|
| |
4. |
To approve the Amendment to
the Company's Second
Amended and Restated Certificate of Incorporation to
limit the liability of certain officers as permitted by
Delaware law. |
Management |
|
For |
|
For |
|
|
| |
5. |
To ratify the appointment of
Ernst & Young LLP as the
Company's independent registered public accounting firm
for the fiscal year ending February 3, 2024. |
Management |
|
For |
|
For |
|
|
| |
THE
KROGER CO. |
|
|
| |
Security |
501044101 |
|
|
|
Meeting Type |
Annual |
| |
Ticker Symbol |
KR |
|
|
|
Meeting Date |
22-Jun-2023 |
|
| |
ISIN |
US5010441013 |
|
|
|
Agenda |
935864579 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1a. |
Election of Director: Nora
A. Aufreiter |
Management |
|
For |
|
For |
|
|
| |
1b. |
Election of Director: Kevin
M. Brown |
Management |
|
For |
|
For |
|
|
| |
1c. |
Election of Director: Elaine
L. Chao |
Management |
|
For |
|
For |
|
|
| |
1d. |
Election of Director: Anne
Gates |
Management |
|
For |
|
For |
|
|
| |
1e. |
Election of Director: Karen
M. Hoguet |
Management |
|
For |
|
For |
|
|
| |
1f. |
Election of Director: W. Rodney
McMullen |
Management |
|
For |
|
For |
|
|
| |
1g. |
Election of Director: Clyde
R. Moore |
Management |
|
For |
|
For |
|
|
| |
1h. |
Election of Director: Ronald
L. Sargent |
Management |
|
For |
|
For |
|
|
| |
1i. |
Election of Director: J. Amanda
Sourry Knox |
Management |
|
For |
|
For |
|
|
| |
1j. |
Election of Director: Mark
S. Sutton |
Management |
|
For |
|
For |
|
|
| |
1k. |
Election of Director: Ashok
Vemuri |
Management |
|
For |
|
For |
|
|
| |
2. |
Approval, on an advisory basis,
of Kroger's executive
compensation. |
Management |
|
For |
|
For |
|
|
| |
3. |
Advisory Vote on Frequency
of Future Votes on
Executive Compensation. |
Management |
|
1 Year |
|
For |
|
|
| |
4. |
Ratification of PricewaterhouseCoopers
LLP, as auditors. |
Management |
|
For |
|
For |
|
|
| |
5. |
Report on Public Health Costs
from Sale of Tobacco
Products. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
6. |
Listing of Charitable Contributions
of $10,000 or More. |
Shareholder |
|
Against |
|
For |
|
|
| |
7. |
Report on Recyclability of
Packaging. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
8. |
Report on Racial and Gender
Pay Gaps. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
9. |
Report on EEO Policy Risks. |
Shareholder |
|
Abstain |
|
Against |
|
|
| |
KIKKOMAN
CORPORATION |
|
|
| |
Security |
J32620106 |
|
|
|
Meeting Type |
Annual General Meeting |
| |
Ticker Symbol |
|
|
|
|
Meeting Date |
27-Jun-2023 |
|
| |
ISIN |
JP3240400006 |
|
|
|
Agenda |
717320282 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
|
Please reference meeting materials. |
Non-Voting |
|
|
|
|
|
|
| |
1 |
Approve Appropriation of Surplus |
Management |
|
For |
|
For |
|
|
| |
2.1 |
Appoint a Director Mogi, Yuzaburo |
Management |
|
For |
|
For |
|
|
| |
2.2 |
Appoint a Director Horikiri,
Noriaki |
Management |
|
For |
|
For |
|
|
| |
2.3 |
Appoint a Director Nakano,
Shozaburo |
Management |
|
For |
|
For |
|
|
| |
2.4 |
Appoint a Director Shimada,
Masanao |
Management |
|
For |
|
For |
|
|
| |
2.5 |
Appoint a Director Mogi, Osamu |
Management |
|
For |
|
For |
|
|
| |
2.6 |
Appoint a Director Matsuyama,
Asahi |
Management |
|
For |
|
For |
|
|
| |
2.7 |
Appoint a Director Kamiyama,
Takao |
Management |
|
For |
|
For |
|
|
| |
2.8 |
Appoint a Director Fukui, Toshihiko |
Management |
|
For |
|
For |
|
|
| |
2.9 |
Appoint a Director Inokuchi,
Takeo |
Management |
|
For |
|
For |
|
|
| |
2.10 |
Appoint a Director Iino, Masako |
Management |
|
For |
|
For |
|
|
| |
2.11 |
Appoint a Director Sugiyama,
Shinsuke |
Management |
|
For |
|
For |
|
|
| |
3 |
Appoint a Substitute Corporate
Auditor Endo, Kazuyoshi |
Management |
|
For |
|
For |
|
|
| |
MEIJI
HOLDINGS CO.,LTD. |
|
|
| |
Security |
J41729104 |
|
|
|
Meeting Type |
Annual General Meeting |
| |
Ticker Symbol |
|
|
|
|
Meeting Date |
29-Jun-2023 |
|
| |
ISIN |
JP3918000005 |
|
|
|
Agenda |
717353685 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
|
Please reference meeting materials. |
Non-Voting |
|
|
|
|
|
|
| |
1.1 |
Appoint a Director Kawamura,
Kazuo |
Management |
|
For |
|
For |
|
|
| |
1.2 |
Appoint a Director Kobayashi,
Daikichiro |
Management |
|
For |
|
For |
|
|
| |
1.3 |
Appoint a Director Matsuda,
Katsunari |
Management |
|
For |
|
For |
|
|
| |
1.4 |
Appoint a Director Shiozaki,
Koichiro |
Management |
|
For |
|
For |
|
|
| |
1.5 |
Appoint a Director Furuta,
Jun |
Management |
|
For |
|
For |
|
|
| |
1.6 |
Appoint a Director Matsumura,
Mariko |
Management |
|
For |
|
For |
|
|
| |
1.7 |
Appoint a Director Kawata,
Masaya |
Management |
|
For |
|
For |
|
|
| |
1.8 |
Appoint a Director Kuboyama,
Michiko |
Management |
|
For |
|
For |
|
|
| |
1.9 |
Appoint a Director Peter D.
Pedersen |
Management |
|
For |
|
For |
|
|
| |
2 |
Appoint a Substitute Corporate
Auditor Komatsu,
Masakazu |
Management |
|
For |
|
For |
|
|
| |
MORINAGA
MILK INDUSTRY CO.,LTD. |
|
|
| |
Security |
J46410114 |
|
|
|
Meeting Type |
Annual General Meeting |
| |
Ticker Symbol |
|
|
|
|
Meeting Date |
29-Jun-2023 |
|
| |
ISIN |
JP3926800008 |
|
|
|
Agenda |
717378194 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
|
Please reference meeting materials. |
Non-Voting |
|
|
|
|
|
|
| |
1 |
Approve Appropriation of Surplus |
Management |
|
For |
|
For |
|
|
| |
2.1 |
Appoint a Director Miyahara,
Michio |
Management |
|
For |
|
For |
|
|
| |
2.2 |
Appoint a Director Onuki, Yoichi |
Management |
|
For |
|
For |
|
|
| |
2.3 |
Appoint a Director Okawa, Teiichiro |
Management |
|
For |
|
For |
|
|
| |
2.4 |
Appoint a Director Minato,
Tsuyoshi |
Management |
|
For |
|
For |
|
|
| |
2.5 |
Appoint a Director Yanagida,
Yasuhiko |
Management |
|
For |
|
For |
|
|
| |
2.6 |
Appoint a Director Hyodo, Hitoshi |
Management |
|
For |
|
For |
|
|
| |
2.7 |
Appoint a Director Nozaki,
Akihiro |
Management |
|
For |
|
For |
|
|
| |
2.8 |
Appoint a Director Yanagida,
Takahiro |
Management |
|
For |
|
For |
|
|
| |
2.9 |
Appoint a Director Tominaga,
Yukari |
Management |
|
For |
|
For |
|
|
| |
2.10 |
Appoint a Director Nakamura,
Hiroshi |
Management |
|
For |
|
For |
|
|
| |
2.11 |
Appoint a Director Ikeda, Takayuki |
Management |
|
For |
|
For |
|
|
| |
2.12 |
Appoint a Director Yoshinaga,
Yasuyuki |
Management |
|
For |
|
For |
|
|
| |
3 |
Appoint a Corporate Auditor
Yamamoto, Mayumi |
Management |
|
For |
|
For |
|
|
| |
4 |
Appoint a Substitute Corporate
Auditor Suzuki, Michio |
Management |
|
For |
|
For |
|
|
| |
BELLUS
HEALTH INC. |
|
|
| |
Security |
07987C204 |
|
|
|
Meeting Type |
Annual and Special Meeting |
| |
Ticker Symbol |
BLU |
|
|
|
Meeting Date |
30-Jun-2023 |
|
| |
ISIN |
CA07987C2040 |
|
|
|
Agenda |
935889230 - Management |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Item |
Proposal |
Proposed
by |
|
| Vote |
For/Against
Management |
|
|
| |
1A |
Election of Director - Dr.
Francesco Bellini, O.C. |
Management |
|
For |
|
For |
|
|
| |
1B |
Election of Director - Roberto
Bellini |
Management |
|
For |
|
For |
|
|
| |
1C |
Election of Director - Dr.
Youssef L. Bennani |
Management |
|
For |
|
For |
|
|
| |
1D |
Election of Director - Franklin
M. Berger, CFA |
Management |
|
For |
|
For |
|
|
| |
1E |
Election of Director - Dr.
Clarissa Desjardins |
Management |
|
For |
|
For |
|
|
| |
1F |
Election of Director - Pierre
Larochelle |
Management |
|
For |
|
For |
|
|
| |
1G |
Election of Director - Dr.
William Mezzanotte |
Management |
|
For |
|
For |
|
|
| |
1H |
Election of Director - Joseph
Rus |
Management |
|
For |
|
For |
|
|
| |
2 |
Appointment of KPMG LLP as
Auditors of the Company
for the ensuing year and authorizing the Audit Committee
to fix their remuneration. |
Management |
|
For |
|
For |
|
|
| |
3 |
Ratification and confirmation
of a resolution approving the
unallocated options under the Stock Option Plan. |
Management |
|
Against |
|
Against |
|
|
Pursuant to the requirements
of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
*Print the name and title of each signing officer
under his or her signature.